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Pluripotency is defined as the ability of a cell to give rise to all the cell types of the 
adult  organism.  In  vivo this  property  is  possessed  transiently  by the  cells  of  the 
epiblast in the developing embryo but it can be maintained indefinitely by deriving 
embryonic stem (ES) cells. How the pluripotent state is established in the cells of the 
early embryo and how it is ‘captured’ and maintained in the form of ES cells is a 
fascinating question for biology with practical implications. It is hoped that ES cells 
will  be  of  use  in  biomedical  research  and  cell  replacement  therapy.  Our 
understanding of their biology and our ability to manipulate the cells in vitro will be 
of great importance if these hopes are to be realised.
The starting point for the work presented in this thesis was the development of a 
novel culture condition for the derivation and maintenance of mouse ES cells (Q-L. 
Ying and J. Nichols). The media is formed by the addition of three small molecule 
inhibitors  to  a  previously  described  serum-free  media,  N2B27,  and  is  termed  3i 
(three  inhibitors).The  inhibitors  are  SU5402,  PD184352 and CHIRON99021,  and 
they  inhibit  the  FGF  receptor,  mitogen  activated  protein/extracellular  signal-
regulated  kinase  (ERK)  kinase  (MEK),  and  glycogen  synthase  kinase  3  (GSK3) 
respectively. 
I attempt to further our understanding of pluripotency and self-renewal in ES cells by 
genetic  and  biochemical  examination  of  ES  cells  cultured  in  3i.  Analysis  of 
intracellular signalling pathways together with descriptions of genetic mutants for the 
targets of the inhibitors validates the mode of action and the specificity of the three 
inhibitors. Self-renewal of mouse ES cells is considered dependent on activation of 
STAT3  through  provision  of  the  cytokine  leukaemia  inhibitory  factor  (LIF).  I 
demonstrate unequivocally that this pathway is not required for self-renewal in 3i by 
characterising  Stat3-null  ES  cells.  Further  experiments  reveal  that  preventing 
activation of ERK downstream of the growth factor FGF4, produced by the ES cells 
themselves,  is  key  to  preventing  differentiation.  Pleiotropic  effects  of  GSK3 
inhibition are observed and candidate GSK3 targets with known or predicted effects 
on self-renewal are investigated as potential  downstream effectors.  I  propose that 
activation  of  canonical  Wnt  signalling,  together  with  a  global  derepression  of 
biosynthetic capacity, mediate the pro-self-renewal effects of GSK3 inhibition. 
The description of culture conditions that function independently of signalling 
pathways previously thought essential for self-renewal provides fresh insight into the 
nature of ES cell self-renewal and the relationship of ES cells to the pluripotent cells 
of the developing embryo. There are practical implications for ES cell biology as 
there is reason to hope that the new conditions will translate more readily to other 
mammalian species to facilitate the derivation of ES cells and will provide an 
optimal platform for differentiation of ES cells into somatic cell types of interest.
iii
“There is a theory which states that if ever anyone discovers exactly what the 
universe is for and why it is here, it will instantly disappear and be replaced by 
something even more bizarre and inexplicable.
“There is another theory which states that this has already happened.”
Douglas Adams
The Restaurant at the End of the Universe
The Hitchhiker’s Guide to the Galaxy
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Chapter 1: General Introduction
Chapter 1: General Introduction
1.1 What are Stem Cells and why should we study them?
Stem cells are defined by two properties: long-term self-renewal and the ability to 
differentiate (Gardner and Beddington, 1988). Self-renewal is the division of a cell to 
give rise to two daughter cells,  at least one of which is identical to the cell from 
which  they  arose.  Differentiation  occurs  when  the  stem  cell  becomes  a  more 
specialized cell type and loses the capacity for self-renewal. Stem cells can give rise 
to  one  or  more  distinct  cell  types.  These  properties  make  stem  cells  extremely 
interesting in the study of development, disease and cancer.
Stem cells have attracted a large amount of attention in recent years because it is 
believed that they will one day provide a limitless source of tissue for the treatment 
of  degenerative  disease  (Gardner,  2007).  Diseases  such  as  Type  1  diabetes  and 
Parkinson’s disease result from the loss of specialized cell types and a subsequent 
loss of function in the affected tissue. It is hoped that science will be able to recreate 
the lost cells  in vitro and so provide an unlimited source of cells for replacement 
therapies. While this application of stem cells is extremely exciting the realisation is 
a long way off. It has proved extremely difficult to impose one particular cell fate on 
cells removed from their natural environment and issues such as immune rejection 
would create difficulties for transplant patients. However, for scientists the attraction 
of stem cells goes beyond the headline. Stem cell biology is the study of how cells 
make cell fate decisions. That is, how they decide whether to continue dividing as a 
stem  cell  (self-renewing)  or  to  differentiate  into  a  specialized  cell  type.  Our 
understanding  of  these  cell  fate  decisions  underlies  our  understanding  of 
developmental biology and will ultimately determine our ability to manipulate stem 
cells to achieve our goals. 
A more tangible use of stem cells is in providing model systems for drug discovery 
and for the study of cancer (Smith,  2001). Stem cells grown  in vitro  can provide 
1
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clinically relevant cell types on a large scale that can be used for high throughput 
drug screening. It is also believed that many cancers contain a population of cells that 
behave as stem cells (reviewed in (Reya et al., 2001)). That is, cells which retain the 
ability  to  proliferate  and  to  give  rise  to  the  different  cell  types  that  compose  a 
tumour.  Such cells, if they are not destroyed by cancer treatments, can reinitiate a 
cancer. Therefore, cancer treatments designed to target the stem cell compartment of 
a cancer would prove more effective in long-term treatments. 
Scientists  broadly categorise stem cells  into two subgroups: adult  and embryonic. 
Adult stem cells persist throughout the life of an organism. They are responsible for 
the replacement of tissues lost during normal turnover or as a result of injury (Dor 
and Melton, 2004). They are tissue-restricted, generally only giving rise to cell-types 
of the organ in which they are found. Where they have been described they exist in a 
compartment of the tissue known as the niche (Zhang et al., 2003; Alvarez-Buylla 
and Lim, 2004; Watt et al., 2006) which is thought to provide signals that regulate 
stem cell replication and differentiation (Scadden, 2006). Their numbers are tightly 
regulated and maintained throughout the life of the organism and they are generally 
slow-cycling but possess the ability to respond to demand by proliferating rapidly to 
provide a source of cells for tissue homeostasis or repair. Stem cells residing in the 
adult tissues are extremely interesting for several reasons. Understanding how they 
are regulated in vivo provides insights into how the body maintains and repairs itself, 
the consequences if the stem cell compartment is lost or becomes deregulated and the 
idea  that  diseases  might  be  treated  by  manipulating  these  cells  in  their  normal 
environment.  Furthermore,  adult  stem  cells  have  been  instructed  during  the 
development of the organism to acquire a restricted cell fate. Thus, they are closer to 
fully specialized cell types and may therefore be more readily manipulated to adopt a 
given cell fate if they can be isolated and expanded in vitro.
Embryonic stem (ES) cells are unique in their ability to differentiate into cells from 
each of the three germ layers, ectoderm, endoderm and mesoderm – they can make 
all the tissues of the adult organism (a property termed pluripotency) (Smith, 2006). 
This, together with their ability to multiply in culture without apparent limit, makes 
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them an attractive source for the in vitro generation of cell types that may be of use 
to  study  disease  or  to  provide  a  limitless  source  of  cells  for  cell-replacement 
therapies. ES cells differ significantly from adult stem cells in that they are derived 
from a cell type that exists only transiently in the expanding epiblast of the embryo. 
This distinction is critical because it means that ES cells are defined as an  in vitro 
cell type, existing only in cell culture. The origin of ES cells in the early embryo 
provides  a  window into  the  processes  of  early  development  which are  otherwise 
difficult to access but the artificial environment in which ES cells necessarily exist 
means inferences drawn from experiments about the developing embryo, performed 
on ES cells, must be interpreted with caution. It is hoped that by understanding the 
molecular mechanisms that regulate self-renewal and differentiation of ES cells we 
can gain insights  into early development  and eventually control  the behaviour  of 
these cells in vitro and hence provide cell types of clinical relevance.
1.2 Background to Embryonic Stem Cells
1.2.1 Origin of Embryonic Stem Cells 
The observation that embryos grafted into mice produced teratocarcinomas (Stevens, 
1968; Solter et al., 1970; Stevens, 1970) from which pluripotent stem cells could be 
derived gave rise to the idea that it should be possible to derive pluripotent cell lines 
direct  from the embryo.  The observation that coculture with fibroblasts supported 
growth of embryonal-carcinoma (EC) cells (Martin and Evans, 1975b), and that these 
cells  retained a high differentiation  capacity,  was a  critical  step towards the first 
derivation  direct  from  the  embryo.  In  1981  Evans  and  Kaufman  (Evans  and 
Kaufman,  1981), and Martin (Martin,  1981) succeeded in establishing pluripotent 
cell lines by plating delayed-implantation blastocysts or inner cell masses isolated 
from the  expanded late  blastocyst  by immunosurgery  onto  a  layer  of  mitotically 
inactivated STO fibroblasts. The resulting cell lines displayed characteristics of EC 
cells  but  retained  a  normal  karyotype  whereas  EC  cells  normally  display 
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aneuploidies.  Martin  termed  the  new  cell  lines  embryonic  stem  (ES)  cells  to 
distinguish them from their tumour-derived counterparts.
ES cells were shown to derive from the epiblast, the cells that would normally go on 
to  form the  embryo  proper  (Fig1.1).  In  fact,  ES  cells  can  be  derived  with  high 
efficiency if the epiblast is isolated by micro-dissection (Brook and Gardner, 1997). 
During preimplantation development the first lineage segregation occurs when the 
trophectoderm is  specified.  At  the  8-cell  stage embryos  undergo compaction  and 
cells  become  polarised  with  a  clear  distinction  of  inside  to  outside.  Subsequent 
divisions establish the outer cells, the trophectoderm and the inner cells, the inner 
cell mass (ICM). The trophectoderm gives rise to the placenta while the ICM will 
give rise to the developing embryo and associated yolk sack, allantois and amnion 
(Rossant and Tam, 2004). These two cell populations can be distinguished by the 
expression  of  marker  genes  such  as  Cdx2 and  Eomes (Strumpf  et  al.,  2005) 
(trophoblast)  or  Oct4  (Palmieri  et  al.,  1994;  Nichols  et  al.,  1998)  and  Nanog 
(Chambers  et  al.,  2003;  Mitsui  et  al.,  2003;  Chazaud  et  al.,  2006)  (ICM).  The 
trophectoderm secretes fluid internally to form a cavity known as the blastocoel. The 
ICM becomes localised to one side of the cavity forming the distinctive structure 
known  as  the  blastocyst.  The  second  lineage  segregation  is  the  separation  of 
primitive endoderm (PrE) or hypoblast  and epiblast  from the ICM. PrE will only 
contribute to extraembryonic tissues while the epiblast goes on to form the embryo 
itself  (Gardner  and Beddington,  1988).  The PrE is  distinguishable  by E4.5 as an 
epithelial  layer  formed on the surface of the ICM exposed to the blastocoel.  This 
segregation begins to take place at around E3.5 when individual cells of the ICM 
begin  to  display  different  gene  expression  patterns  (Chazaud  et  al.,  2006).  The 
epiblast cells can be distinguished by expression of the pluripotency marker Nanog 
and the PrE cells by the markers Gata-4 and -6 (Fig1.1). By E4.5 their expression is 
mutually exclusive and the lineages are established.
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ES cells are normally derived from embryos harvested at developmental stage E3.5 
(Evans  and  Kaufman,  1981;  Martin,  1981)  although  they  have  been  derived  by 
culturing  cells  taken  from  the  8-cell  embryo  (Meissner  and  Jaenisch,  2006). 
Although the pluripotent cells of an E6.0 embryo have not committed to a particular 
germ  layer  (Lawson  et  al.,  1991)  they  have  lost  the  capacity  to  form ES  cells 
indicating  that  there  is  a  developmental  ‘window’ during  which  it  is  possible  to 
capture the ES cell state. The derivation of ES cells can be facilitated by inducing 
delayed implantation, known as diapause (Evans and Kaufman, 1981). Diapause is a 
natural phenomenon whereby pregnant mice still nursing young pups can delay the 
implantation of developing embryos for up to one month (Ozias and Weitlauf, 1971), 
effectively stalling their development. Diapause can be experimentally induced by 
tamoxifen  injection  or  ovariectomy  allowing  researchers  to  isolate  blastocysts 
arrested preimplantation. 
The pluripotency of ES and EC cells can be tested by inducing differentiation in vivo 
or  in  vitro.  Expanding  lines  from  single  cells  generates  clones  that  can  be 
differentiated  through  embryoid  body  formation  (Martin  and  Evans,  1975a)  or 
teratocarcinoma  formation  following  injection  of  cells  subcutaneously  (Martin, 
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1981). If cell types from all three germ layers are detected the cells from which they 
originated are described as pluripotent. The most stringent test of cultured pluripotent 
cells  is  their  ability  to  contribute  to  chimaeras.  Following  injection  into  the 
developing embryo both EC cells  (Brinster,  1974) and ES cells  can contribute  to 
tissues of the adult mouse. However, ES cells contribute with greater efficiency and 
do not display tissue biases as EC cells do. Furthermore, ES cells can contribute to 
the germ line (Bradley et al., 1984) whereas EC cells have never been known to do 
so because their aneuploidies prevent progression through meiosis.   
1.2.1.1 The relationship between ES cells and the early embryo
ES cells  are derived from the epiblast  of the preimplantation embryo (Brook and 
Gardner, 1997). In vivo the pluripotent compartment exists only transiently. Thus, ES 
cells are defined as  in vitro cell lines. Although ES cells are often used to model 
early embryonic development the relationship between ES cells and the cells of the 
developing  embryo  is  not  entirely  clear.  Do  ES  cells  correspond  to  a  particular 
developmental time point and does the process of derivation and subsequent in vitro 
culture change their properties? A key observation is that upon reintroduction to the 
embryo ES cells can give rise to all cell types of the adult mouse but never contribute 
to extraembryonic tissues (Gardner, 1985; Rossant et al., 2003). This suggests that 
ES  cells  correspond  to  epiblast  cells  at  a  stage  beyond  specification  of  the 
trophectoderm and primitive endoderm. However, ES cells can be induced to form 
trophoblast by down-regulation of Oct4 (Niwa et al., 2000) or forced expression of 
Cdx2 (Niwa et al.,  2005). Formation of primitive endoderm occurs spontaneously 
under certain culture conditions and can be triggered by down-regulation of Nanog 
(Mitsui et  al.,  2003) or forced expression of Gata-4 or -6 (Fujikura et al.,  2002). 
These  differentiation  events  are  considered  illegitimate  because  they  do  not 
ordinarily occur in vivo and may represent a relaxation of developmental constraints 
associated with in vitro culture. 
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1.2.1.2 Lessons from epiblast stem cells
Recently, pluripotent cell lines were established from the post-implantation epiblast 
of the mouse embryo (EpiSCs, see below) (Brons et al., 2007; Tesar et al., 2007). 
The conditions used to establish and maintain these lines were identical to conditions 
optimised for the maintenance of hES cell lines based on the addition of activin and 
FGF2 to the media (Vallier et al., 2005). This, together with the report of rat EpiSCs 
(Brons et al., 2007), implies that there is cross-species conservation of a cell type that 
responds  to  these  signals.  Furthermore,  transcriptional  profiling  of  these  lines 
revealed that hES cells were more similar to mEpiSCs than they were to mES cells 
(Tesar et al., 2007). This strongly suggests that hES cells also correspond to this later 
stage of development. Paradoxically, EpiSCs (Brons et al., 2007) and hES cells (Xu 
et  al.,  2002)  can  spontaneously  differentiate  into  trophoblast  cells.  This 
developmental  pathway is  not  expected  to  be open to  cells  at  this  later  stage  of 
development and may reflect properties acquired upon in vitro culture. hES cells are 
derived  from  blastocyst  stage  embryos  and  were  initially  derived  under  culture 
conditions  very similar  to  those used to  establish  mES cells.  Importantly,  FGF2, 
which is  now considered essential  for hES cell  culture,  was not used in the first 
derivations (Thomson et al., 1998). This implies that the cells initially responding to 
in  vitro culture  correspond  to  a  different  developmental  stage  to  that  of  the 
established lines. During derivation and/or subsequent culture the cells presumably 
progress to the later, FGF- and activin-responsive, developmental stage reflected by 
EpiSCs. It remains  to be seen if  the cells  of the human pre-implantation epiblast 
share properties with their mouse counterparts and can be “captured” at this earlier 
stage. Anecdotal  reports indicate that it  is possible to convert ES cells to EpiSCs 
supporting the idea  that  development  can proceed from pre-  to  post-implantation 
epiblast in culture. In contrast, EpiSCs cannot be converted to an ES phenotype.
1.2.2 Self-Renewal
Self-renewal is the division of a cell to produce two daughter cells, one or both of 
which are identical to the parental cell from which they arose. ES cells possess the 
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ability to self-renew without apparent limit and to give rise to all the cell types of the 
adult  (Smith,  2001).  These properties  can be considered an  in  vitro phenomenon 
since the pluripotent cells of the embryo exist only transiently in vivo. The process of 
ES cell derivation is therefore the “capture” of a transient state. Maintenance of the 
pluripotent state in vitro is dependent on the expression of intracellular determinants 
and  on  extracellular  signals  (reviewed  in  (Chambers  and  Smith,  2004)).  The 
intracellular determinants of ES cell identity can be detected in the pluripotent cells 
of  the  embryo  where  they  perform  essential  roles  in  embryonic  development 
(Nichols et al., 1998; Mitsui et al., 2003) whereas the role of extracellular signals in 
self-renewal  may  be  solely  an  in  vitro phenomenon.  In  order  to  sustain  a  self-
renewing population of ES cells the culture environment must provide the nutrients 
and signals required to support cell division and to prevent apoptosis and must also 
inhibit  the natural  tendency of ES cells  to differentiate.  Variations on the culture 
environment exist and it is likely that different combinations of extracellular signals 
can support self-renewal. Fully defined conditions for the propagation of mES cells 
have  been  established  (Ying et  al.,  2003a)  and to  a  certain  extent  the  signalling 
pathways involved have been elucidated (Niwa et al., 1998; Burdon et al., 1999b; 
Matsuda et  al.,  1999; Ying et  al.,  2003a). However,  it  has become clear that  the 
findings in mES cells will not translate directly to hES cells (Thomson et al., 1998; 
Reubinoff et al., 2000; Daheron et al., 2004; Humphrey et al., 2004). Understanding 
the  differences  and similarities  between  mouse  and human  ES cells  will  help  to 
define the requirements for hES cell derivation, in vitro culture and differentiation.  
1.2.3 Intrinsic Determinants
The property of pluripotency is conferred by the expression of a set of transcription 
factors. Oct4, a Pou-domain transcription factor, was identified when its expression 
was observed in unfertilized oocytes, embryonic stem cells and primordial germ cells 
(Scholer  et  al.,  1989).  More  recently,  Nanog,  a  protein  whose  overexpression  is 
capable of maintaining cytokine-independent self-renewal, was identified (Chambers 
et  al.,  2003;  Mitsui  et  al.,  2003).  These  proteins  are  the  best  known markers  of 
pluripotency  both  in  vivo and  in  vitro and  their  expression  is  common  to  all 
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pluripotent cell types that can be maintained in vitro and across those species from 
which ES cells have been derived. 
1.2.3.1 Oct4 and Sox2
Oct4 is a member of a family of POU-domain transcription factors. It is expressed in 
the unfertilized egg and the early embryo and is down-regulated in the trophectoderm 
upon  segregation  from  the  inner  cell  mass  (Pesce  and  Scholer,  2001).  Oct4 
expression is maintained in the epiblast and segregated to migratory primordial germ 
cells (PGCs), persisting through genital ridge formation (Scholer et al., 1989).
Embryos  lacking  Oct4 form outgrowths  consisting  entirely  of  trophectoderm-like 
cells when plated on gelatine (Nichols et al., 1998). This observation suggested a role 
for  Oct4  in  inhibition  of  differentiation  into  trophectoderm,  supported  by  the 
observation  that  suppression  of  Oct4 expression  in  mES  cells  results  in 
‘dedifferentiation’  of  the  cells  into  trophectoderm  (Niwa  et  al.,  2000).  Oct4 
expression  is  continuously  required  for  the  maintenance  of  pluripotency  but  its 
expression is not sufficient. Removal of LIF results in differentiation even if Oct4 
levels are artificially maintained by an inducible transgene. Furthermore, the level of 
Oct4 expression is critical. Increasing expression to levels greater than 150% of wild-
type  levels  results  in  differentiation  into  mesoderm/endodermal  lineages  while  a 
reduction  to  less  than  50%  of  wild-type  levels  results  in  dedifferentiation  into 
trophectoderm (Niwa et al., 2000). 
Exactly how Oct4 controls cell  fate in ES cells and  in vivo remains unclear.  The 
sensitivity  of  ES  cells  to  levels  of  Oct4  suggests  that  interaction  with  other 
transcription factors and the relative level of expression of these is critical to Oct4 
function  (Niwa  et  al.,  2000).  Niwa  modelled  self-renewal  around  Oct4  and  its 
differing effects on target genes. Target genes were divided into three groups based 
on their response to Oct4 (activation or repression) and activated targets could be 
divided again based on whether or not they were repressed by high levels of Oct4, a 
phenomenon  known  as  ‘squelching’  (Scholer  et  al.,  1991).  In  such  a  model 
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interacting partners of Oct4 are key. Sox2 is known to be required for expression of 
Oct4 target genes in ES cells. The best characterised Oct4 target is Fgf4. Sox2 was 
identified as the factor required to activate Fgf4 expression together with Oct4 (Yuan 
et  al.,  1995).  Oct4  and Sox2 form a  ternary  complex  by binding  closely-spaced 
enhancer elements in the Fgf4 promoter. The spacing of the Oct4 and Sox2-binding 
sites is critical for promoter activity, seemingly because it facilitates Oct4 and Sox2 
interaction (Ambrosetti et al., 1997).  Another gene with ES cell specific expression, 
Utf1, is similarly regulated by Oct4 and Sox2 (Nishimoto et al., 1999). More recently 
it  has been shown that Oct4 and Sox2 reciprocally regulate  their  own expression 
(Tomioka et al., 2002; Chew et al., 2005).  Both Sox2 and Pou5f1 promoter regions 
contain  oct-sox  elements  that  have  been  shown  to  bind  Oct4  and  Sox2.  These 
findings,  together  with the demonstration that  expression of the key pluripotency 
gene, Nanog (see below), is regulated by Oct4 and Sox2 (Rodda et al., 2005), imply 
that the Oct4-Sox2 interaction is critical for maintenance of ES cells. Indeed, loss of 
Sox2 expression results in differentiation in a manner virtually identical to that seen 
upon suppression of Oct4 supporting the idea that the key role of Sox2 in ES cells is 
in the activation of Oct-Sox target genes. Surprisingly however loss of Sox2 could be 
rescued by the forced expression of Oct4. Oct-Sox target genes were activated in a 
Sox2-independent manner, probably as a result of redundancy with other Sox family 
members,  and pluripotency could  be  maintained  (Masui  et  al.,  2007).  This  work 
shows that the key contribution of Sox2 is in fact to maintain levels of Oct4 through 
regulation of transcription factors that affect Oct4 expression. 
Some light has been shed on the role of Oct4 through studies of its interactions with 
Cdx2, a marker of trophectoderm. It was found that overexpression of Cdx2 leads to 
trophectoderm  differentiation  in  a  manner  virtually  indistinguishable  from  that 
observed when Oct4 is extinguished (Niwa et al., 2005). Interestingly, differentiation 
proceeded in Cdx2-overexpressing cells even when Oct4 expression was artificially 
maintained  from  a  transgene  demonstrating  that  loss  of  Oct4 expression  is  not 
required for differentiation. Cdx2 and Oct4 are both capable of positively regulating 
their  own transcription and they reciprocally inhibit  one-another’s  activation.  The 
indication that Cdx2 and Oct4 physically interact and that this apparently neutralizes 
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their transcriptional activation functions suggests that the battle between these two 
transcription  factors  is  important  in  the  first  lineage  segregation  in  the  embryo 
(Smith, 2005). Indeed, both proteins can be detected in all cells of the 8-cell morula 
before becoming progressively restricted to the TE and ICM respectively (Niwa et 
al., 2005). Cdx2 expression is first observed just after compaction, at which point 
most cells express Cdx2 (Dietrich and Hiiragi, 2007). As the embryo becomes large 
enough  to  accommodate  inside  (inside  cells  are  those  completely  surrounded by 
other cells) and outside cells Cdx2 expression shows a strong bias for outside cells. 
Interestingly,  upregulation of Cdx2 initially shows no correlation with Oct4 levels 
with Oct4 expression remaining high in all blastomeres of the embryo until the late 
blastocyst stage when it becomes down-regulated in the Cdx2-high trophectoderm 
(Dietrich  and  Hiiragi,  2007).  The  fact  that  Cdx2  expression  is  established  and 
maintained in the presence of Oct4 and that this does not lead to immediate down-
regulation of Oct4 suggests that there are other regulatory mechanisms at play in the 
segregation of ICM and TE. Reciprocal regulation of Oct4 and Cdx2 may serve to 
reinforce  rather  than  establish  gene  expression  patterns  in  the  preimplantation 
embryo. 
1.2.3.2 Nanog
Nanog was  identified  independently  by  two  groups  through  a  functional  cDNA 
screen for genes conferring LIF-independent self-renewal (Chambers et al.,  2003) 
and  through  differential  expression  analysis  (Mitsui  et  al.,  2003).  Nanog  is  a 
divergent  homeodomain  protein  expressed  first  in  the  morula  with  high  levels 
persisting  in  the  early  blastocyst  and  declining  prior  to  implantation.  Following 
implantation  Nanog expression is restricted to a subset of epiblast  cells and upon 
entry to the primitive streak is rapidly down-regulated. Nanog can still be detected in 
PGCs during  migration  to  and colonisation  of  genital  ridges  but  is  subsequently 
down-regulated in the germ cell lineage. 
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Nanog overexpression can drive cytokine-independent self-renewal of ES cells. This 
ability  requires  the  continued  expression  of  Oct4.  Differentiation  caused  by  the 
elimination  of  Oct4 expression  can  be  rescued  by  transfection  with  an  Oct4-
expressing but not a Nanog-expressing plasmid (Chambers et al., 2003). This result 
also  implies  that  Nanog  can  direct  Oct4 expression  either  directly  or  indirectly. 
Nanog does not function through activation of the JAK/STAT pathway (see below 
for a discussion of JAK/STAT signalling) as Nanog-overexpressing cells continue to 
self-renew even  when  SOCS3,  a  potent  inhibitor  of  the  JAK/STAT pathway,  is 
overexpressed. However, self-renewal occurred with greater efficiency when Nanog-
overexpressing cells  were also stimulated with LIF, implying that these pathways 
function in parallel (Chambers et al., 2003). 
Nanog-null ES cells, generated by serial targeting of the Nanog locus to replace the 
homeodomain  by  homologous  recombination,  acquired  a  parietal  endoderm-like 
morphology and expressed markers of parietal and visceral endoderm. Expression of 
Oct4 and  Rex1 was reduced but not eliminated when the cells were maintained on 
STO feeders. In the absence of feeders their expression was completely eliminated 
while  expression  of  Gata6  was  further  induced  (Mitsui  et  al.,  2003).  Recently, 
however, these results have been brought into question by the finding that deletion of 
Nanog from  cells  expressing  an  inducible  form  of  Nanog,  and  subsequent 
suppression of Nanog expression, does not result in inevitable differentiation. These 
null cells can be passaged and grown long term in culture while retaining the ability 
to  form tissues  of  all  three  germ-layers  (Chambers  et  al.,  2007).  These  findings 
suggest that Nanog is required for the establishment of, but not maintenance of, a 
pluripotent  phenotype.  This  would predict  that  the  requirement  for  Nanog in  the 
developing  embryo  is  absolute,  and indeed this  seems to  be the  case.  At  3.5dpc 
Nanog-null  blastocysts  were  indistinguishable  from  normal  embryos.  By  E5.5 
embryos  consisted  entirely  of  disorganized  extraembryonic  tissues  with  no 
discernible  epiblast  or  extraembryonic  ectoderm.  Explanted  ICMs  failed  to 
proliferate and differentiated completely into parietal endoderm-like cells within 4 
days. The fact that no trophectoderm was observed implies that Nanog is required at 
a stage beyond the initial requirement for Oct4 (Mitsui et al., 2003). 
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It has been suggested that Nanog might function, at least in part, through inhibition 
of Gata factors (Mitsui et al., 2003; Chambers and Smith, 2004). Forced expression 
of  Gata4 or  Gata6 in  ES  cells  is  sufficient  to  drive  differentiation  into 
extraembryonic  endoderm  (Fujikura  et  al.,  2002)  while  Nanog-null  cells 
spontaneously differentiate into extraembryonic lineages expressing high levels of 
Gata-4 and  -6 (Mitsui  et  al.,  2003).  In  both cases  the  expression profile  is  very 
similar. A putative Nanog-binding site has also been identified in the enhancer region 
of Gata6 but has yet to be demonstrated to bind Nanog (Mitsui et al., 2003). Given 
that  Nanog overexpression  prevents  lineage  commitment  of  ES cells,  not  just  to 
endoderm, but also to cell  types of the ectoderm and mesoderm germ layers it  is 
unlikely that Nanog functions solely to inhibit Gata transcription factors.
Recently  Nanog has  been  demonstrated  to  interact  with Sall4  (Wu et  al.,  2006). 
Nanog  and  Sall4  appear  to  bind  together  to  their  own  promoter  regions  and  to 
positively regulate transcription forming a feed-forward loop. Sall4 was found to co-
occupy the promoter  regions  of many Nanog targets  implying  that  there  may be 
functional  significance  to  the  interaction.  A  separate  study  showed  that  Sall4 
regulated Oct4 expression and that depletion of Sall4 in the embryo resulted in Cdx2 
expression in the ICM, a phenotype consistent with loss of Oct4 (Zhang et al., 2006). 
However,  Sall4-null  ES  cells  have  been  derived  and  were  reported  to  have  a 
proliferation defect but no increase in differentiation (Sakaki-Yumoto et al., 2006). It 
has been suggested that the discrepancy between these findings and those of Zhang 
et al result from a failure to examine feeder-independent self-renewal (Zhang et al., 
2006) but the in vivo phenotype of Sall4-null blastocysts indicates that they remain 
capable of establishing the pluripotent compartment (Sakaki-Yumoto et al., 2006). 
The failure of these studies to agree on the role of Sall4 in ES cells and the early 
embryo  indicates  that  further  experiments  will  be  required  before  we  can  be 
confident that Sall4 is a significant player in the regulation of pluripotency.
 Nanog has been implicated in the establishment of a pluripotent epigenome. Nanog 
expression was found to enhance the efficiency of reprogramming of somatic cell 
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types to pluripotent cell types by cell fusion (Silva et al., 2006). This, together with 
the  observation  that  Nanog-null  cells,  while  retaining  the  ability  to  contribute  to 
chimeras, cannot contribute to the germ-line suggests that Nanog may play a role in 
establishing  the  pluripotent  state  during  normal  development  and  in  vitro during 
reprogramming. The observation that ES cells which have little or no Nanog can re-
express Nanog and remain pluripotent but that cells lacking Nanog are more prone to 
differentiation suggests that in the artificial context of ES cell in vitro culture Nanog 
supports  self-renewal  by ‘guarding’  or  resetting  the  pluripotent  state  of  the  cells 
(Chambers  et  al.,  2007).  This  is  consistent  with  the  reduction  in  spontaneous 
differentiation observed upon forced expression of Nanog (Chambers et al., 2003). In 
light of this, it was surprising to learn that Nanog was not one of four factors which, 
when expressed together, are capable of reprogramming somatic cells to pluripotency 
(Takahashi  and  Yamanaka,  2006).  However,  selection  for  reactivation  of  Nanog 
expression,  as  opposed  to  Fbx15,  another  gene  associated  with  pluripotency, 
enhanced  the  efficiency  of  reprogramming  to  pluripotency  (Okita  et  al.,  2007) 
suggesting there may be a role for the endogenous Nanog gene (see below for a more 
in depth discussion of reprogramming).
1.2.3.3 Pluripotency Network
As described above the transcription factors Oct4, Sox2 and Nanog play critical roles 
in the establishment  of the pluripotent epiblast  in vivo and in the maintenance of 
pluripotency in vitro. As a result a great deal of time and effort has been invested to 
attempt to describe their mechanism of action. 
Microarray  and  chromatin  immunoprecipitation  (ChIP)  experiments  have  been 
performed  to  identify  transcriptional  targets  of  the  three  transcription  factors. 
Experiments  designed  to  identify  promoter  regions  bound  by  these  transcription 
factors  on  a  genome  wide  scale  revealed  that  a  high  proportion  of  promoters 
occupied by one TF would also be occupied by the others (Boyer et al., 2005; Loh et 
al.,  2006).  This  suggests  that  they  cooperate  in  their  regulation  of  target  genes. 
Comparison of promoter occupation with global expression analyses revealed that 
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the TFs occupied the promoters of both active and inactive genes (Boyer et al., 2005) 
and both Oct4 and Nanog appeared capable of positive and negative regulation of 
transcription (Loh et al., 2006). Although it is not known how Oct4, Sox2 and Nanog 
might mediate both positive and negative effects on transcription it is notable that the 
active  genes  included  many  implicated  in  pluripotency  and  inactive  genes  were 
enriched for developmental regulators (Boyer et al., 2005). In one study the authors 
find that  RNAi-mediated  knock down of two positively regulated  targets  of both 
Nanog  and  Oct4  (Rif1 and  Esrrb)  results  in  differentiation  (Loh  et  al.,  2006), 
suggesting that  the  cooperation  of  these TFs is  of functional  significance  for the 
regulation of pluripotency. These global studies are flawed in that they clearly reveal 
the occupancy of many sites that have no functional relevance and because changes 
in gene expression levels upon differentiation are interpreted as direct targets failing 
to acknowledge the possibility that many changes are simply an indirect consequence 
of  differentiation.  However,  they  propose  a  framework  for  the  regulation  of  a 
pluripotent epigenome: the key pluripotency-associated TFs, by positively regulating 
their own and each other’s expression, form a stable feed-forward loop (Fig1.2). By 
silencing genes associated with specification of differentiated cell types they prevent 
differentiation, allowing the pluripotent compartment to expand in vivo and ES cells 
to be propagated indefinitely in vitro. This model is supported by a study of protein 
interactions which suggests that  the key TFs, Oct4 and Nanog, are part  of multi-
protein  complexes  (Wang  et  al.,  2006).  A  strong  bias  was  observed  among  the 
interacting proteins identified for knockout phenotypes (where studied) in the early 
embryo and ES-cell  associated expression patterns suggesting a functional role in 
pluripotent cells. The interacting proteins identified also tended to be part of known 
cofactor pathways involved in transcriptional repression. For example, Nanog can be 
linked to histone deacetylase (HDAC) and NuRD complexes through its association 
with Sall1/4 and Nac1 (Wang et al.,  2006).  This is consistent with the idea that 
pluripotency-associated  TFs  act  to  silence  expression  of  genes  associated  with 
lineage commitment. 
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Recent findings from in depth studies of single TFs may call for a re-evaluation of 
this network. Nanog is dispensable for the maintenance of ES cells (Chambers et al., 
2007) and the critical contribution of Sox2 appears to be the maintenance of  Oct4 
expression (Masui et al.,  2007). Only the expression of  Oct4 remains an absolute 
requirement for ES cell propagation although the requirement for Nanog and Sox2 
remains in the developing embryo.
1.2.4 Epigenetic Regulation of Pluripotency
ES cells possess highly dynamic, decondensed chromatin (Meshorer et al., 2006) as 
evidenced by the early replication of unexpressed genes during S-phase (Azuara et 
al., 2006); early replication is normally associated with actively transcribed loci. ES 
cells were also observed to have an interesting pattern of chromatin modifications. 
Large  regions  of  the  repressive  histone  mark,  trimethyl  histone  3  lysine  27 
(H3K27me3), were found to harbour smaller regions of the active mark H3K4me3 
and were termed ‘bivalent domains’ (Azuara et al., 2006; Bernstein et al., 2006). The 
coexistence of these marks  is provocative,  suggesting that  the chromatin is  being 
maintained as accessible but the genes are being kept silent by the repressive marks. 
Furthermore, the bivalent domains were enriched in regions encoding transcription 
factors that were not expressed or expressed at low levels. Methylation of H3K27 is 
mediated by Polycomb Repressive Complexes  (PRC) -1 and -2.  To investigate  a 
potential role for these complexes in pluripotency their binding to genomic DNA was 
mapped  by  chromatin  immunoprecipetation  (ChIP)  using  antibodies  against 
components of both complexes and interrogating microarrays representing promoter 
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sequences with the isolated genomic DNA (Boyer et al., 2006) (a technique known 
as ChIP on Chip). A group of promoters binding both PRC-1 and -2 were identified 
and found to be enriched for TFs with known roles in development. These genes also 
showed  preferential  upregulation  upon  differentiation  implying  a  functional 
significance  of  the  PRCs  in  silencing  genes  that  are  poised  to  be  expressed. 
Furthermore,  ES cells  lacking a component  of the PRC2 complex,  Eed,  and thus 
lacking H3K27me3 marks (Montgomery et al., 2005) showed loss of repression of 
the genes identified as bound by the PRC complexes. Together with the observation 
that  in  hES  cell  promoters  bound  by  the  polycomb  group  protein  Suz12  were 
enriched for binding sites for Oct4, Sox2 and Nanog (Lee et al., 2006) has lead to the 
hypothesis that PRCs may somehow be controlled by the core TFs of pluripotency. 
The significance of these findings must not be overstated however. Studies of global 
histone marks in hES cells reveals that although they too have bivalent domains, the 
co-existence of H3K27me3 and H3K4me3 is the rule rather than the exception (Pan 
et al., 2007; Zhao et al., 2007). The majority of promoters with the H3K27me3 mark 
also  had  the  H3K4me3  mark.  Furthermore,  pluripotency-associated  genes  were 
observed to acquire H3K4me3 during differentiation (Pan et al.,  2007), becoming 
bivalent as pluripotency was lost. Bivalent marks were associated with silent genes 
and were not a unique feature of pluripotent cells (Pan et al., 2007). Finally, when 
genes marked by different combinations of the two histone marks were examined for 
changes in expression during differentiation all combinations revealed a proportion 
of genes that responded rapidly (Pan et al., 2007). This also casts doubt on the idea 
that bivalent marks are associated with rapidly-responding genes. Finally,  the fact 
that ES cells can be maintained in the absence of functional PRCs argues against an 
essential  role  in  the  maintenance  of  pluripotency  (Montgomery  et  al.,  2005; 
Schoeftner et al., 2006; Pasini et al., 2007). 
A recent study has demonstrated a link between the core TFs of pluripotency and 
epigenetic regulators (Loh et al., 2007). Oct4 regulates the transcription of the H3K9 
demethylases  Jmjd1a and  Jmjd2c.  Jmjd1a demethylates  H3K9me2  while  Jmjd2c 
demethylates  H3K9me3.  RNAi  mediated  knock-down  of  either  results  in 
differentiation. The examination of gene expression changes following knock-down 
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and subsequent ChIP experiments revealed Tcl1 as a JMJD1A target while Nanog is 
a JMJD2C target. The increased H3K9me2 levels at the Tcl1 promoter reduce Oct4 
binding and hence Tcl1 expression. Differentiation as a result of knock-down could 
be rescued by simultaneous expression of  Tcl1 or stable expression of  Nanog for 
Jmjd1a and Jmjd2c respectively. These experiments link the activity of Oct4 targets 
to  modulation of the chromatin to  facilitate  expression of pluripotency-associated 
TFs (Niwa, 2007a). However, these experiments raise questions unaddressed by the 
authors: down-regulation of histone demethylases is predicted to result in increased 
methylation  of  H3K9  and  a  subsequent  reduction  in  transcription  but  the  up-
regulation of some genes upon down-regulation of  Jmjd1a or  Jmjd2c implies off-
target or secondary effects; it is surprising that loss of epigenetic modifiers and the 
resulting  changes  in  expression  of  hundreds  of  genes  can  be  rescued  by  the 
expression  of  a  single  transcription  factor  with  no  known  chromatin-modifying 
activity;  knock-down of  Jmjd1a can be rescued by  Tcl1  but not  Nanog  expression 
even though  Nanog  has previously been shown to rescue depletion of  Tcl1 in ES 
cells (Ivanova et al., 2006).
While the study of the epigenetic status of ES cells has recently received a great deal 
of attention it is worth considering a few points. Firstly, the pluripotent phenotype is 
dominant and capable of imposing itself on a somatic genome following cell fusion 
(Tada et al., 2001) and recently the generation of pluripotent cells from somatic cells 
has been achieved by the expression of 4 TFs (Takahashi and Yamanaka, 2006). This 
demonstrates that a terminally differentiated genome can be forced to reprogram by 
exposure to factors associated with pluripotency and that TFs alone are sufficient to 
direct the epigenetic changes required for reprogramming. Secondly, while in depth 
studies have clearly demonstrated the critical role of several TFs in the establishment 
and/or  maintenance  of  pluripotency,  ES  cells  have  been  shown to  tolerate  quite 
severe disruptions to their epigenetic machinery while retaining the characteristics of 
pluripotency (Montgomery et al., 2005; Pasini et al., 2007). In vivo, disruption of the 
epigenetic  machinery  results  in  severe  developmental  abnormalities  but  in  the 
majority of cases lethality occurs after the pluripotent compartment of the embryo 
has  been  established  and  in  most  cases  mutant  ES  cells  have  been  established 
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(reviewed  in  (Surani  et  al.,  2007)).  It  is  likely  that  the  TFs  of  the  pluripotency 
network  employ  chromatin  modifying  complexes  to  set  up  and  maintain  their 
transcriptional program but it is the action of the core TFs that directs the epigenetic 
modifications and not an epigenetic program that dictates expression of the TFs.  
 
1.2.5 Pluripotent Cell Types
ES cells are derived from the preimplantation embryo. Investigations into the nature 
of pluripotency have lead researchers to attempt the derivation of pluripotent cells 
from alternative  sources.  As  well  as  furthering  our  knowledge  of  developmental 
biology and epigenetic reprogramming it is hoped that it  will become possible to 
generate pluripotent cell types without use of human embryos. Cells with pluripotent 
properties  have  been  derived  from the  germ cell  lineage,  from post-implantation 
embryos (Brons et al., 2007; Tesar et al., 2007) and by reprogramming of somatic 
cells (Takahashi and Yamanaka, 2006). 
1.2.5.1 Embryonic Germ Cells and Spermatogonial Stem Cells
Pluripotent stem cells with properties similar to ES cells have been generated from 
various stages of germ cell development. The germ lineage is the only place apart 
from the  pluripotent  cells  of  the  pre-  and peri-implantation  embryo  where  genes 
associated with pluripotency are expressed. In vitro cell lines can be established from 
Primordial germ cells (PGCs) isolated from the E8.5-12.5 embryo and maintained 
long-term in culture on a feeder layer in media supplemented with stem cell factor 
(SCF, also known as steel factor),  LIF and basic fibroblast growth factor (bFGF) 
(Matsui et al., 1992; Resnick et al., 1992). These cells are known as embryonic germ 
(EG)  cells  and  they  express  markers  of  pluripotency,  are  capable  of  in  vitro 
differentiation into cells representative of the three germ layers, form teratomas when 
injected subcutaneously, and contribute extensively to chimaeras, including the germ 
line  (Labosky  et  al.,  1994),  following  blastocyst  injection  (Matsui  et  al.,  1992). 
Although  the  growth  factors  were  absolutely  required  for  establishment  of  the 
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primary  cultures,  established  cell  lines  could  be  maintained  in  ES  cell  growth 
conditions  (Matsui  et  al.,  1992).  PGCs  cannot  contribute  to  chimaeras  when 
transplanted directly to the embryo implying that the establishment of EG cells is a 
reprogramming event. 
Spermatogonial  stem cells  (SSCs) have been isolated from neonatal  mouse testis. 
Dissociated  testis  plated  in  glial  cell  line-derived  neurotrophic  factor  (GDNF), 
epidermal growth factor (EGF), bFGF, and LIF give rise to cell lines that express 
markers  of  spermatogonia  and  can  restore  fertility  to  infertile  mice  (Kanatsu-
Shinohara et al., 2003). The authors of this work noticed that ES-like cells appeared 
in the cultures, showed that these cells gained expression of ES cell markers SSEA1 
and Nanog, which are not expressed in SSCs, and that they could be propagated in 
ES cell culture conditions (Kanatsu-Shinohara et al., 2004). These cells were termed 
multipotent germ-line stem (mGS) cells and were phenotypically indistinguishable 
from ES cells with the exception of genomic imprinting.  mGS cells  could not be 
established by direct culture of testis in ES cell conditions and the establishment of 
SSCs is absolutely dependent on the presence of GDNF. mGS cells differentiated 
efficiently  in vitro,  in teratomas and contributed to chimaeras  including the germ 
line. It has since been shown that ES-like cells can be established from the testis of 
adult mice by isolating cells expressing GFP under the control of the Stra8 promoter 
(Guan et al., 2006) which marks spermatogonia. These cells could be expanded when 
plated directly in ES cell culture conditions without the requirement for prior culture 
in  GDNF-containing  culture  conditions.  The  cells  were  demonstrated  to  be 
pluripotent  by  contribution  to  germ-line  chimaeras  and  were  termed  multipotent 
adult  germline  stem cells  (maGSCs).  The  apparent  direct  conversion  of  SSCs  to 
pluripotent maGSCs implies that SSCs of the adult testis are themselves pluripotent 
or that they respond rapidly to the culture conditions to become ES-like cells. It is 
not clear why this group succeeded in establishing ES-like cells from adult testis and 
without the requirement for GDNF in primary cultures but the finding is extremely 
exciting because it promises that pluripotent stem cells will be derived without the 
need for embryos and that autologous stem cells might become available (Kanatsu-
Shinohara and Shinohara, 2006). 
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In the case of both EG and GS cells the contribution to chimaeras is proof of their 
pluripotency and distinguishes them from Epiblast Stem Cells (see below). In both 
cases the cells from which they are derived are not thought to be pluripotent and their 
derivation might therefore be considered a form of reprogramming. It is likely that 
cells of the germ line are particularly susceptible to reprogramming to pluripotency 
because they already express key TFs associated with a pluripotent phenotype. They 
are  also  thought  to  be  the  cells  responsible  for  initiating  spontaneous 
teratocarcinomas,  the tumours that arise when pluripotent cells are injected into a 
permissive  site,  suggesting  that  they  possess  or  are  predisposed  to  develop  the 
properties of self-renewal required for in vitro propagation. 
 
1.2.5.2 Reprogramming and Induced Pluripotent Stem Cells
Reprogramming refers to the process of altering the epigenetic program of a cell to 
change its developmental potential. Converting a somatic cell to a pluripotent cell 
has  long  been  the  goal  of  researchers.  Cloning  by  somatic  cell  nuclear  transfer 
(SCNT) requires that the genome of a terminally differentiated cell is reprogrammed 
to acquire the potential to produce all cell types of the developing organism ie. to 
totipotency. Reprogramming requires that the epigenetic marks are wiped from the 
genome to allow reexpression of silenced genes. If somatic cells could be induced to 
acquire pluripotency it would provide an alternative source to embryos and allow the 
production  of  patient-specific  stem  cells.  Reprogramming  has  been  achieved  by 
transferring the nucleus of a somatic cell to an enucleated egg (SCNT) and by fusing 
somatic cells with pluripotent cells.  SCNT still  requires the use of oocytes and is 
highly inefficient while cell fusion results in the production of tetraploid cells which 
could  not  be  used  in  cell  replacement  therapy  because  of  potential  problems 
including  tumorigenesis  of  tetraploid  cells  and  the  acquisition  of  non-autologous 
chromosomes from the pluripotent donor genome (Ambrosi and Rasmussen, 2005). 
Recently however it has been demonstrated that somatic cells can be reprogrammed 
by  the  introduction  of  4  genes  encoding  the  TFs  cMyc,  Oct4,  Sox2  and Klf4 
(Takahashi and Yamanaka, 2006). There is no need to use oocytes, the resulting cells 
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are diploid and the process has the potential to be used to generate patient-specific 
pluripotent cells. The cells produced by this process are termed induced pluripotent 
stem (iPS) cells.
It  has now been demonstrated that both mouse (Takahashi and Yamanaka,  2006; 
Wernig et al., 2007) and human (Takahashi et al., 2007; Yu et al., 2007) iPS cells can 
be derived. Thus, it is now possible to take cells from an adult human, convert them 
to  pluripotent  cell  lines  with apparently  limitless  capacity  for  expansion  and use 
these to generate clinically relevant cell types.  In a proof-of-principle experiment, 
carried out in mice, iPS cells were generated from skin cells of mice expressing the 
human sickle haemoglobin allele. The genetic defect was corrected in the iPS cells 
and the resulting cells used to generate haematopoietic progenitors which rescued the 
anaemia when transplanted (Hanna et al., 2007). 
iPS cells were first generated from mouse embryonic fibroblasts (MEFs). The 4 TFs 
were introduced  by retroviral  transfection  and ES-like  cells  were selected  for  by 
selecting for drug resistance under the control of the promoter of the pluripotency-
associated gene, Fbx15 (Takahashi and Yamanaka, 2006). ES-like cells were isolated 
and demonstrated to be very similar to ES cells, possessing pluripotency as assessed 
by  in  vitro differentiation  and teratoma  formation.  However,  the  cells  could  not 
contribute  to  the  germ-line  when  chimeras  were  formed  by  blastocyst  injection. 
Germ-line transmission was later achieved by selecting for the expression of Nanog 
(Okita  et  al.,  2007) or  Oct4 (Wernig  et  al.,  2007).  This  probably  reflects  a 
requirement for activation of the endogenous Oct4 and Nanog transgenes before true 
pluripotency is established (Silva and Smith, 2008). 
As yet it is not known how each of the 4 factors acts to convert the somatic cell 
genome to pluripotency. Oct4 and Sox2 most likely act to promote expression of the 
endogenous Oct4 and Sox2 genes (Tomioka et al., 2002; Okumura-Nakanishi et al., 
2005) as well as Nanog (Rodda et al., 2005). Once active this pluripotency network 
is expected to be self-promoting and will also begin to influence the activity of target 
genes whose expression or silencing is critical to the establishment of pluripotency. 
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cMyc  and  Klf4 may  act  as  oncogenes  to  transform  somatic  cells  to  the  highly 
proliferative, immortal phenotype of stem cells (Jaenisch and Young, 2008). It has 
also been suggested that cMyc can influence the structure of chromatin and may 
promote  a  more  open  conformation  which  is  more  amenable  to  the  epigenetic 
conversion  to  pluripotency  (Jaenisch  and  Young,  2008).  Klf4  is  capable  of 
influencing the activity of Oct4/Sox2 target genes (Nakatake et al., 2006) and may 
therefore act in a more direct manner to influence the expression of key target genes. 
Both cMyc and Klf4 are dispensable for the generation of iPS cells (Yu et al., 2007; 
Nakagawa  et  al.,  2008)  but  the  efficiency  and  speed  of  conversion  is  greatly 
enhanced by their inclusion. This is consistent with the view that the key factor is the 
master regulator of pluripotency, Oct4 (Jaenisch and Young, 2008).
However, several major problems must be overcome before iPS cells can be used in 
treatments  for  humans.  The  initial  conversion  is  currently  driven  by  genomic 
integration of the transgenes encoding the TFs. Ideally integration would be avoided 
to  prevent  integrative  mutagenesis.  Furthermore,  both  cMyc and  Klf4 are  known 
oncogenes. Although the retroviral insertions appear to be silenced in iPS cells they 
could become activated  upon differentiation.  Chimaeric  mice  generated  from iPS 
cells have been observed to form tumours, thought to result from reactivation of the 
cMyc transgene (Okita et al., 2007). To avoid these problems it is hoped that it will 
be possible to generate  iPS cells  without integrating the transgenes.  This may be 
possible by episomal expression of the TFs but the length of time and the high levels 
of  transgene  expression  required  may  mean  that  episomal  transfection  will  be 
ineffective.  An  alternative  would  be  to  use  recombinant  proteins.  It  has  been 
demonstrated that fusion of a TAT peptide to the protein of interest enhances cellular 
uptake (Peitz et al., 2002) which would clearly be necessary for recombinant TFs to 
work effectively.
1.2.5.3 Epiblast Stem Cells
Pluripotent cell lines have recently been derived from the post-implantation mouse 
and rat  embryos  (Brons et  al.,  2007; Tesar et  al.,  2007). They are established by 
23
Chapter 1: General Introduction
dissecting the epiblast of the E5.5-6.5 mouse embryo (E7.5 for the rat) and plating 
into conditions optimized for the growth of hES cells. They are termed epiblast stem 
cells  (EpiSCs)  to  reflect  their  tissue  of  origin.  The  cells  can  be  grown  without 
apparent  limit  in  culture  and  can  be  cloned,  albeit  with  low  efficiency.  Their 
pluripotency has been established through in vitro differentiation and observation of 
multi-lineage differentiation in teratomas following injection into permissive sites in 
immuno-compromised mice. ES cells cannot be maintained in EpiSC conditions and 
explanted ICMs differentiate  under these conditions.  Similarly,  EpiSCs cannot be 
maintained in ES cell  conditions and isolated epiblasts  cannot be expanded. This 
indicates that these are distinct cell types and this is confirmed by marker analysis. 
EpiSCs express genes normally expressed by the pre-gastrulation epiblast that are not 
detected  in  ES  cells,  for  example  Fgf5,  and  lack  expression  of  some  ES  cell-
associated genes such as  Rex1. EpiSCs are similar in this regard to the previously 
described  early  primitive  ectoderm-like  (EPL)  cells  which  are  induced  and 
maintained by an undefined activity in media conditioned by HepG2 cells (Rathjen et 
al., 1999). However, EPL cells can be reverted back to ES cells when the conditioned 
media is removed and LIF is present.
Contribution  to  chimeric  animals  following  morula  aggregation  or  blastocyst 
injection is a stringent test of pluripotency and of the ability of in vitro-cultured cells 
to re-enter their normal developmental program. ES cells contribute efficiently to all 
tissues  including  the  germ  line.  The  post-implantation  epiblast  is  considered 
pluripotent but EpiSCs could not contribute to chimeras (Brons et al., 2007; Tesar et 
al., 2007). This could simply be due to incompatibility between the EpiSCs and the 
cells of the ICM but it has significant implications for these cells. Firstly, if they do 
not contribute to chimeras their use in the generation of transgenic animals would not 
be  possible  which  is  disappointing  given  that  rat  EpiSCs  have  apparently  been 
established.  Secondly,  these cells  cannot formally be considered truly pluripotent. 
Although Tesar et al report induction of the PGC-specific genes Blimp1 and Stella in 
response to BMP4 they have not been shown to form functional gametes. 
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The most significant implication of the work on EpiSCs is a possible solution to the 
conundrum of the relationship between mouse and human ES cells. Although human 
ES cells were established from embryos at a similar developmental stage to those 
used in mES cell derivation and under conditions known to support mES cells they 
are  phenotypically  different.  They  share  expression  of  the  core  transcriptional 
machinery  of  ES  cells  but  differ  in  cell  surface  marker  expression  and  in  their 
appearance and behaviour. hES cells grow as large flattened colonies as opposed to 
the  rounded  up  morphology  exhibited  by  mES  cells  and  do  not  tolerate  well 
dissociation to single cells  as mES cells  do. The finding that mEpiSCs are more 
similar in their expression profile and in their pattern of Oct4 binding sites to hES 
cells  than  they  are  to  mES  cells  suggests  that  hES  cells  correspond  to  a  later 
developmental stage than previously assumed. The fact that they are derived from 
preimplantation embryos does not exclude this possibility since ‘development’ can 
continue  in  vitro and  the  stem  cells  derived  may  correspond  to  a  different 
developmental stage to the embryo from which they came. If this is indeed the case 
then the same questions of whether they are truly pluripotent will apply as this can 
never be tested through production of human chimeras. The intriguing possibility is 
that a hES cell that corresponds to mES cells has been ‘missed’ and that this might 
still  be  isolated  through  the  development  of  alternative  culture  conditions  or 
alternative methods of derivation.
1.3 Extracellular Signals
Initially, mES cells were derived and cultured on a layer of mitotically inactivated 
fibroblasts in serum-containing medium (Evans and Kaufman, 1981; Martin, 1981). 
The fibroblasts were thought to provide trophic factors that support self-renewal and 
were hence described as feeders. This was confirmed by the observation that feeders 
could be replaced by the addition of medium conditioned by buffalo rat liver cells 
(Smith  and Hooper,  1983).  Subsequent  fractionation  of  this  conditioned  medium 
identified leukaemia inhibitory factor (LIF) as the active component (Smith et al., 
1988;  Williams  et  al.,  1988).  Addition  of  recombinant  LIF  to  serum-containing 
medium is sufficient to support self-renewal. In 2003 it was demonstrated that serum 
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could be replaced by the addition of recombinant BMP4 and for the first time ES 
cells could be grown in fully defined conditions (Ying et al., 2003a). 
The apparent requirement for exogenous signals in the culture of ES cells has meant 
that a great deal of effort has gone into identifying signalling pathways that modulate 
self-renewal  and  the  investigation  of  their  downstream  targets.  However,  the 
requirement for a particular signal may be context-dependent. For example, BMP4 
normally  induces  differentiation  of  ES  cells  and  only  behaves  as  a  self-renewal 
signal in the presence of LIF. Therefore any given signalling pathway might promote 
self-renewal only when other particular pathways are active/inactive. It is also true 
that signalling pathways affecting ES cells may not serve the same function in the 
developing embryo and researchers must be cautious when interpreting their data in 
the context of development. It seems logical to look for a link between the core TFs 
of pluripotency and the signalling pathways that promote self-renewal but there are 
few, if any reports clearly linking the signalling pathways with direct regulation of 
the TFs. 
1.3.1 LIF and BMP Signalling
LIF is  a  member  of  the  IL6  family  of  cytokines  that  signal  through  a  common 
transmembrane receptor, gp130 (Boulton et al., 1994). Signalling mediated by gp130 
homodimers (Yoshida et al.,  1994) or by heterodimers consisting of gp130 and a 
related receptor such as the LIF receptor is capable of directing self-renewal in the 
presence  of  serum.  Following ligand-induced receptor  dimerization  there  are  two 
main signalling pathways that become activated (Fig1.3). The intracellular domain of 
gp130 recruits  tyrosine kinases such as the Janus Kinases (JAKs) (Boulton et al., 
1994). JAKs phosphorylate tyrosine residues on the intracellular domain of gp130, 
creating  binding  sites  for  STAT3.  Receptor-bound  STAT3  is  phosphorylated  on 
Tyr705 by JAKs before dimerizing and translocating to the nucleus where it acts to 
modulate  transcription of target genes.  STAT3 has been reported to have activity 
independent of Tyr705 phosphorylation through phosphorylation on Ser727. Ser727 
was observed to become phosphorylated in NS cells in response to Notch ligands and 
to  enhance  colony  formation  implying  a  role  in  cell  survival  (Androutsellis-
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Theotokis  et  al.,  2006).  Shp2 binds  a  distinct  phosphotyrosine  residue on gp130. 
Signalling downstream of Shp2 mediates activation of the MAP kinases ERK-1 and 
-2 (Burdon et al., 1999a). A well characterised STAT3 transcriptional target is Socs3 
(Auernhammer et al., 1999). SOCS3 mediates a negative feedback loop by binding to 
the gp130 receptor  and preventing activation of downstream signalling pathways. 
Forced expression of Socs3 causes differentiation of ES cells even in the presence of 
LIF. 
Activation  of  STAT3  was  demonstrated  to  be  the  critical  component  of  gp130 
signalling in directing self-renewal. Selective elimination of tyrosine residues from 
the  intracellular  domain  of  gp130  demonstrated  that  STAT3  binding  sites  were 
required  for  self-renewal  and that  a  chimeric  receptor  with  only  STAT3-binding 
tyrosines,  that  did  not  activate  ERK1/2,  was  capable  of  supporting  self-renewal 
(Niwa et  al.,  1998).  Furthermore,  a  STAT3-Oestrogen Receptor  (ER) fusion was 
capable of supporting self-renewal in the absence of exogenous LIF when activated 
by the addition of 4-hydroxy tamoxifen (4-HT) (Matsuda et al., 1999). 
STAT3 homodimers function as TFs and it is supposed that transcriptional targets of 
STAT3 mediate self-renewal. One group identified cMyc as a target of STAT3 and 
went  on  to  claim  that  constitutive  expression  of  cMyc  rendered  ES  cells  LIF-
independent (Cartwright et al., 2005b). The group propose that cMyc functions by 
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blocking differentiation but it is not clear how this is achieved nor is it clear if the 
effect remains dependent on the presence of serum in the culture medium. Klf4 has 
also been shown to be a downstream target of LIF. Its overexpression in ES cells 
lead  to  decreased  differentiation  in  EBs  and  enhanced  secondary  EB  formation 
suggesting that it promotes self-renewal (Li et al., 2005). The recent identification of 
cMyc  and  Klf4 as  two of four factors capable  of reprogramming somatic  cells  to 
pluripotency (Takahashi and Yamanaka, 2006) adds significance to their proposed 
roles  in  the  self-renewal  of  ES  cells  but  their  mechanisms  of  action  in  either 
reprogramming or self-renewal remain to be clearly defined.
Embryos  lacking  gp130 can  develop  normally  beyond  the  establishment  of  the 
pluripotent epiblast (Yoshida et al., 1996). It is therefore unclear if gp130-STAT3 
signalling plays any role in vivo analogous to the promotion of self-renewal seen in  
vitro. When gp130-/- embryos are induced to enter diapause and to arrest at the late 
blastocyst stage they are unable to re-enter normal development due to specific loss 
of the epiblast (Nichols et al., 2001). This demonstrates a requirement for signalling 
through gp130 to maintain the pluripotent compartment during diapause that may 
relate to its function in capturing and maintaining the pluripotent state in the form of 
ES cells in culture. Thus, the responsiveness of ES cells to LIF may have its origins 
in the phenomenon of diapause. This raises the possibility that LIF signalling will 
influence the epiblast and the establishment of ES cells only in species which exhibit 
diapause and may explain why hES cells are unresponsive to LIF (Thomson et al., 
1998; Daheron et al., 2004; Humphrey et al., 2004). However, the true test of human 
embryo responsiveness to LIF cannot be performed on established hES cell  lines 
because these cells appear to correspond to a distinct developmental stage (Tesar et 
al., 2007).
LIF  is  not  strictly  sufficient  for  self-renewal  since  the  addition  of  serum to  the 
medium is still required to support self-renewal. Upon removal of serum from the 
culture medium mES cells undergo neural differentiation, even in the presence of 
LIF. This prompted Ying  et al to propose that inhibition of neural differentiation 
might support serum-free self-renewal. Bone Morphogenetic Proteins (BMPs) were 
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known to inhibit neural differentiation and it was demonstrated that addition of BMP 
or the related GDF to serum-free medium containing LIF could support self-renewal 
(Ying et al., 2003a). The BMP pathway signals through SMAD1, 5 and 8 to induce 
expression of  ID proteins.  Constitutive  expression of  ID1,  2  or  3  is  sufficient  to 
replace the requirement for BMP or serum. 
mES  cells  can  now be  derived  and  cultured  in  defined  conditions  (although  the 
serum- derived albumin normally used in these conditions is not fully defined) and 
cells cultured under these conditions retain the ability to contribute to the developing 
embryo and to all tissues of the resulting adult mouse, including the germ line (Ying 
et al., 2003a). However, these experiments were restricted to 129 and 129-C57B6 F1 
mice  and have not  been demonstrated  to  support  derivation  from the recalcitrant 
C57B6 and CBA mouse strains. 
1.3.2 ERK1/2 Signalling
Mitogen activated protein kinases (MAPKs) connect cell surface receptor molecules 
with  their  down-stream  effectors  by  means  of  a  cascade  of  phosphorylation 
(reviewed  in  (Katz  et  al.,  2007)).  They  have  been  implicated  in  the  control  of 
virtually all cellular processes. Extracellular signal-regulated protein kinase-1 and -2 
(ERK1/2) are two MAPKs implicated in the regulation of ES cell self-renewal and in 
early embryonic cell fate choice. ERK1/2 function downstream of MEK1/2 and are 
activated in response to many extracellular cues including FGFs. FGF ligands engage 
with FGF receptors resulting in activation of the receptor tyrosine kinase activity. 
SH2 domain containing proteins including Shp2 and Grb2 are recruited and in turn 
recruit SOS which activates Ras and initiates the MAPK cascade to activate ERK1/2. 
Activated  ERK1/2 can act  on cytoplasmic  targets  and can also translocate  to the 
nucleus where it activates various TFs (Marais et al., 1993).
A negative role for ERK1/2 in self-renewal was indicated in a study demonstrating 
that  mutation  of  the  Shp2  binding  site  of  the  gp130  receptor,  which  prevents 
activation of the ERK1/2 pathway by LIF, significantly reduces the concentration of 
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cytokine required to support self-renewal (Burdon et al.,  1999b). In fact,  Shp2 is 
dispensable  for  ES  cell  self-renewal  as  ES  cells  lacking  functional  Shp2  were 
established. These cells demonstrated compromised differentiation and an increased 
sensitivity to LIF (Qu and Feng, 1998). Similarly, ES cells lacking functional Grb2, 
which  couples  to  SOS  to  activate  Ras,  can  be  derived  and  show  a  defect  in 
endodermal differentiation (Cheng et al., 1998). It has also been shown that a MEK-
inhibitor PD98059 (which inhibits activation of ERK1/2) inhibits differentiation as 
judged by the persistence of  Oct4  expression during EB differentiation (Burdon et 
al., 1999b). This study suggested that ERK signalling promotes differentiation and 
that LIF-mediated activation of gp130 therefore results in the activation of pathways 
with  opposing effects  on self-renewal.  Altering  the  balance  between STAT3 and 
ERK1/2  signalling  in  favour  of  STAT3  promoted  self-renewal.  More  recently  a 
novel  small  molecule,  named  Pluripotin,  was  identified  and  demonstrated  to  be 
capable of supporting LIF-independent self-renewal (Chen et al., 2006). It is believed 
to  act  in  part  by  the  inhibition  of  ERK1/2  phosphorylation.  Reduced  ERK1/2 
signalling is also likely to underlie the enhanced self-renewal seen in ES cells lacking 
Fgf4 (Wilder et al., 1997), since the high levels of FGF4 secreted by ES cells result 
in  auto-stimulation  of  the  ERK1/2  cascade  (Kunath  et  al.,  2007).  Furthermore, 
ablation  of suppressor of cytokine signalling 3 (SOCS3),  which is  a downstream 
target  of  STAT3 mediating  negative  feedback  regulation  of  gp130,  results  in  an 
increase in differentiation. This is a surprising result since SOCS3 mediates negative 
feedback and inhibits STAT3 signalling but the authors attribute the phenotype to an 
alteration in the balance of STAT3 and ERK1/2 signalling in favour of the ERK1/2 
cascade  (Forrai  et  al.,  2005),  presumably  because  SOCS3 normally  has  a  strong 
inhibitory effect on the MAPK pathway. 
More recent work proposes that the ERK signal promotes the transition of ES cells 
into  a  state  competent  to  respond  to  differentiation  cues  (Kunath  et  al.,  2007; 
Stavridis et al.,  2007). ES cells  lacking  Fgf4 or Erk2 failed to differentiate under 
conditions  that  normally  promote  neural  differentiation  or  in  response  to  BMP4 
which promotes non-neural differentiation (Kunath et al., 2007). These cells activate 
the  early  differentiation  marker  Fgf5 in  the  absence  of  LIF  but  this  was  fully 
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reversible and does not therefore represent a true differentiation event. Fgf4 null ES 
cell  differentiation  could  be  rescued  by  the  addition  of  recombinant  FGF4 
demonstrating  that  the  defect  could  be  attributed  to  a  loss  of  autocrine  FGF4 
signalling (Kunath et al.,  2007). It was also shown that a discrete period of FGF 
signalling  was  sufficient  to  allow  differentiation  supporting  the  idea  that  ERK 
signalling acts as a trigger for differentiation (Stavridis et al., 2007).
Observations in ES cells are consistent with findings in the preimplantation embryo. 
A  detailed  examination  of  the  localization  of  active  ERK  in  the  early  post-
implantation embryo shows that pERK is confined to extraembryonic tissues with the 
exception of dividing cells of the epiblast (Corson et al., 2003). Grb2-/- embryos fail 
to form primitive endoderm (PrE) and the mutually exclusive pattern of Gata6 and 
Nanog,  which  mark  PrE  and  epiblast  progenitors  respectively,  in  the  E3.5-4.5 
embryo is lost with Nanog expression becoming uniform in all the cells of the ICM 
(Chazaud et al., 2006). The phenotype of Fgf4-/- embryos and ES cells (Wilder et al., 
1997) is consistent with this although a detailed examination of the lineage markers 
has not been carried out in vivo. Furthermore, pharmacological inhibition of ERK 
signalling in 8 cell embryos prevents the formation of PrE in favour of an expanded, 
homogeneously  Nanog  positive  ICM  (Nichols  and  Silva,  unpublished).  The 
emerging picture is that autocrine FGF4 signalling activates ERK1/2 through Grb2 
and  MEK  leading  to  the  formation  of  PrE  in  the  embryo  and  promoting 
differentiation in ES cells. The downstream effectors have not yet been identified but 
it  has  been  reported  that  ES  cells  prevented  from  undergoing  endodermal 
differentiation  by FGFR inhibition  can  be  induced  to  differentiate  by the  forced 
expression of Gata factors (Fujikura et al., 2002) suggesting that Gata-4 and/or -6 
might be downstream targets of the ERK signal. Alternatively, the ERK cascade may 
act  to  down-regulate  Nanog,  permitting  expression  of  Gata  factors,  as  has  been 
suggested from studies in ES cells (Hamazaki et al., 2006). 
1.3.3 PI3K Signalling
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Phosphoinositide  3-kinase  (PI3K)  phosphorylates  phosphatidylinositol  (4,5) 
bisphosphate  (PIP2)  to  generate  phosphatidylinositol  (3,4,5)  triphosphate  (PIP3) 
which acts as a second messenger, binding proteins with pleckstrin homology (PH) 
domains  including  protein  kinase  B  (PKB,  also  known  as  AKT)  and  3-
phosphoinositide-dependent  protein  kinase  (PDK1).  PDK1  phosphorylates  and 
activates PKB, p70 ribosomal S6 kinase (S6K) and p90 ribosomal S6 kinase (RSK) 
(Williams et al., 2000) which mediate a number of downstream effects. PKB is the 
best studied of these targets in ES cells. Activation of PKB requires phosphorylation 
by PDK1 on Thr308 as well as PI3K-dependent phosphorylation at Ser473 (Alessi et 
al.,  1996).  PKB regulates  many  downstream targets  including  glycogen  synthase 
kinase  3 (GSK3) (Alessi  and  Cohen,  1998)  and mammalian  target  of  rapamycin 
(mTOR) (reviewed in (Hay and Sonenberg, 2004)) through inhibition of the tuberous 
sclerosis complex (TSC) (Manning and Cantley, 2003). PI3K is activated by many 
growth  factors  and  cytokines  including  LIF  and  insulin  which  is  an  important 
component of serum-free growth conditions and its activity has been shown to be 
important for cell survival and proliferation in many different cell types (Paling et al., 
2004; Takahashi et al., 2005). 
The PI3K pathway has also been implicated  in  growth and survival  of ES cells. 
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) negatively 
regulates PI3K signalling by dephosphorylating PIP3. ES cells lacking Pten exhibit 
increased  proliferation  rate  and  reduced  serum-dependence  (Sun  et  al.,  1999). 
Creating a double knockout of  Pten  and the ubiquitously expressed  Pkb isoform, 
Akt1, resulted in ES cells with PKB activity close to that of wild-type controls. Pten/
Akt1  double knockout ES cells had a much slower proliferation rate than  Pten null 
ES  cells,  slower  even  than  wild-type  cells,  indicating  that  PKB  was  the  key 
downstream effector in the Pten knockout (Stiles et al., 2002). Surprisingly, ES cells 
lacking  PDK1,  which  is  required  for  activation  of  PKB, did not  exhibit  reduced 
proliferation (Williams et al., 2000) suggesting that PKB is dispensible in ES cells, at 
least in the context of serum-containing culture media. It is possible that a phenotype 
would become apparent  if  these cells  were exposed to  culture  conditions  lacking 
serum or  serum-replacement,  both  of  which  may provide  alternative  growth  and 
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survival signals. A novel, ES-specific form of RAS (Eras) has been demonstrated to 
confer constitutive activity on the PI3K signalling pathway (Takahashi et al., 2003). 
Deletion of  Eras results in decreased proliferation and tumorigenicity of ES cells 
consistent with the Pten and Pkb knockout phenotypes (Stiles et al., 2002). However, 
mice  lacking  Eras are  viable  and  fertile  demonstrating  that  it  is  not  essential 
(Takahashi  et  al.,  2003).  An  in  vivo role  for  PTEN  was  demonstrated  by 
conditionally deleting Pten in the PGCs. This lead to testicular teratomas in all male 
mice and facilitated the derivation of pluripotent  EG cells  (Kimura  et  al.,  2003). 
These observations are consistent with increased cell  survival and proliferation in 
Pten null cells in the germ-line. It is not clear if the enhanced PI3K activity predicted 
in these cells (Sun et al., 1999) facilitates the acquisition of pluripotency during the 
derivation of EG cells  from PGCs but recent  work suggests that  PKB is  the key 
downstream effector and that its effect may be mediated through the inhibition of 
p53  (Kimura  et  al.,  2008).  This  effect  could  simply  be  an  enhancement  of  cell 
survival  but  it  has  been  suggested  that  p53  can  induce  differentiation  by  down-
regulation of Nanog (Lin et al., 2005). Inhibition of p53 and upregulation of Nanog 
would be predicted to enhance the establishment of pluripotent cells but this remains 
to be investigated. Activated AKT is also able to mediate self-renewal of GS cells 
but the primary effect  appears to be the enhancement  of proliferation (Lee et  al., 
2007). Interestingly, the spontaneous formation of mGS cells (Kanatsu-Shinohara et 
al., 2004) was not observed in cultures with activated AKT signalling suggesting that 
the  low frequency conversion  of  GS cells  to  multipotency  is  not  driven  by  this 
signalling pathway (Lee et al., 2007). 
mTOR regulates protein synthesis at least in part through the phosphorylation of p70 
S6 Kinase (p70S6K) and eukaryotic translation initiation factor 4E-binding protein 
(4E-BP1).  PI3K  signalling  can  positively  regulate  mTOR  and  it  is  therefore  an 
attractive candidate for a downstream effector. Embryos lacking mTor appear normal 
at  the  blastocyst  stage  but  cannot  give  rise  to  ES  cells  when  plated  in  culture. 
Conditional deletion of mTor in ES cells results in severe growth retardation. Again, 
this  phenotype is  consistent with the phenotypes  of mutations affecting the PI3K 
pathway.  The  studies  summarised  here  support  a  role  for  PI3K signalling  in  the 
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proliferation of ES cells but do not imply an instructive role in directing self-renewal. 
On the contrary, the fact that ES cells lacking the key signalling components PKB 
and PDK1 can be established and maintained implies  that  signalling through this 
pathway  is  non-essential  for  self-renewal.  However,  several  studies  suggest  that 
PI3K may act to suppress differentiation. 
Inhibition  of  PI3K  using  either  the  inhibitor  LY294002  or  a  dominant  negative 
subunit of PI3K resulted in differentiation even in the presence of LIF (Paling et al., 
2004).  The  authors  attributed  this  to  an  upregulation  of  ERK  activity  as  the 
differentiation could be rescued by the simultaneous inhibition of MEK. It has also 
been shown that expression of a constitutively active form of PKB can confer LIF-
independence on ES cells (Watanabe et al., 2006). However, this study relies heavily 
on short-term assays and offers no mechanism for the suppression of differentiation. 
This  work  is  supported  to  a  degree  by  the  identification  of  a  small  molecule, 
Pluripotin,  that  supports  self-renewal  through  up  regulation  of  PI3K  signalling 
together  with  inhibition  of  ERK1/2  signalling  (Chen et  al.,  2006)  but  it  remains 
unclear  what  the  critical  contribution  of  PI3K  upregulation  is  and  whether  this 
compound has any off-target activity. A possible mechanism for the action of PI3K 
is the inhibition of GSK3 through phosphorylation by PKB since GSK3 inhibitors 
have  been  implicated  in  the  maintenance  of  pluripotency  (Sato  et  al.,  2004).  In 
support of this Storm  et al showed that differentiation induced by PI3K inhibition 
can be rescued by simultaneous inhibition of GSK3 (Storm et al., 2007). They show 
that while Nanog levels decrease in response to PI3K inhibition, GSK3 inhibition 
maintains levels of Nanog. However, there is no evidence that PI3K inhibition results 
in increased GSK3 activity in ES cells or that Nanog is directly regulated by factors 
downstream of  GSK3 or  PI3K.  Furthermore,  ES  cells  have  been  generated  that 
express a form of GSK3 that is insensitive to phosphorylation by PKB (McManus et 
al., 2005) demonstrating that inhibition of GSK3 by PKB is not critical in ES cell 
self-renewal.
1.3.4 Canonical Wnt Signalling
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Binding of  Wnt ligands  to  the cell  surface  receptor  Frizzled  results  in signalling 
through Dishevelled to inactivate the destruction complex which is responsible for 
phosphorylating  β-catenin  and  targeting  it  for  proteolysis.  Inhibition  of  the 
destruction complex results in stabilization and nuclear accumulation of cytoplasmic 
β-catenin. The destruction complex kinase responsible for β-catenin phosphorylation 
is GSK3 so direct inhibition of GSK3 can mimic Wnt signalling (reviewed in (Patel 
et al., 2004)). However, GSK3 phosphorylates many targets other than β-catenin so 
its  inhibition  is  predicted  to  have  pleiotropic  effects  (reviewed  in  (Doble  and 
Woodgett, 2003)). 
Canonical  Wnt  signalling  has  been  implicated  in  the  regulation  of  ES  cell 
differentiation but reports are often conflicting (Haegele et al., 2003; Otero et al., 
2004),  perhaps  as  a  result  of  slightly  different  experimental  contexts.  The 
identification of a novel GSK3 inhibitor, BIO, and the claim that it can support self-
renewal (Sato et al., 2004) has given rise to the idea that Wnt signalling can support 
the self-renewal of pluripotent cells. The demonstration that BIO has a similar effect 
on both mouse and human ES cells also suggested that this was the first signalling 
pathway capable  of supporting self-renewal in common between the two species. 
However,  the  initial  work  using  this  compound  did  not  demonstrate  long-term 
propagation of ES cells and as with all pharmacological inhibitors the specificity was 
questioned.  Several  reports  have  however  claimed  that  Wnt3a  can  support  self-
renewal (Hao et al., 2006; Ogawa et al., 2006; Sato and Brivanlou, 2006) and show 
that this effect is mediated by β-catenin through the use of constitutively active forms 
of β-catenin (Ogawa et al., 2006). However, these studies rely heavily on the use of 
Wnt3a-conditioned  media  (CM)  and  on  undefined  culture  conditions  employing 
serum and/or feeders. The finding that CM but not recombinant Wnt3a could support 
self-renewal suggested that the CM contained additional factors (Ogawa et al., 2006). 
The  CM  was  found  to  weakly  activate  a  STAT3-reponsive  luciferase  reporter 
suggesting  that  it  contained  activity  similar  to  low  concentrations  of  LIF. 
Subsequently it was demonstrated that low LIF concentrations, normally not capable 
of supporting self-renewal, synergised with recombinant Wnt3a to support long-term 
self-renewal.  The same group found that BIO also activated a STAT3-responsive 
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reporter  suggesting  that  it  had  non-specific  effects  likely to  act  together  with  β-
catenin to promote self-renewal. 
Interestingly ES cells totally lacking in GSK3 (Doble et al., 2007), and therefore with 
high  levels  of  constitutively  active  β-catenin,  show  a  degree  of  resistance  to 
differentiation. Under normal self-renewal conditions the cells have high background 
differentiation,  probably as a result  of expression of lineage-associated genes, but 
when  induced  to  differentiate  ES  cells  persist  for  much  longer  than  wild-type 
controls.  This phenotype  suggests  that  targets  downstream of GSK3 can promote 
differentiation while others resist differentiation, perhaps by stabilization of the ES 
cell state (Arias and Hayward, 2006). 
1.4 Human Embryonic Stem Cells
hES cells were first derived in 1998 (Thomson et al., 1998). They were derived in 
conditions almost identical to those originally used to derive mouse ES cells but it 
was immediately clear that they could not be cultured under the same feeder-free 
conditions that support mES cells - the addition of recombinant LIF to the culture 
medium was not sufficient to inhibit differentiation (Thomson et al., 1998; Reubinoff 
et al., 2000; Daheron et al., 2004; Humphrey et al., 2004). Since 1998 many groups 
have developed conditions for the growth of hES cells, often attempting to develop 
systems  free  of  animal-derived  products  (Amit  et  al.,  2003;  Amit  et  al.,  2004). 
Perhaps the only universally accepted method for culturing hES cells is on a feeder 
layer  of mouse embryonic fibroblasts, in serum- or serum replacement-containing 
medium supplemented with basic fibroblast growth factor (FGF2). While there have 
been some demonstrations of hES cell culture in defined conditions these seem to 
rely on non-physiological concentrations of FGF2 or have not been demonstrated to 
support derivation of hES cells de novo. The molecular mechanisms that mediate the 
self-renewal signals derived from these culture conditions remain unknown.  
When investigating hES cells it is important to bear in mind some of the limitations 
as  compared  to  their  mouse  counterparts.  Firstly,  hES cells  survive poorly when 
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dissociated into single cells and exhibit poor cloning efficiency. This makes rigorous 
tests of their ability to self-renew in the absence of autocrine signals difficult to test. 
Secondly,  hES cells cannot be tested for their ability to contribute to chimeras as 
their mouse counterparts can. This is considered the most rigorous test of ‘normality’ 
for mES cells and in its absence hES cell culture conditions should be tested for their 
ability to support derivation de novo if they are to be considered robust conditions for 
hES cell culture. Furthermore, a normal karyotype and the ability to differentiate into 
cell types representative of all three germ layers should be maintained through an 
extended period of in vitro culture
1.4.1 Intracellular Determinants
Although hES cells differ from mES cells in the expression of certain cell surface 
markers they express the core TFs of pluripotency; OCT4, SOX2 and NANOG. The 
expression of these core factors suggests conservation of the mechanisms governing 
pluripotency despite the differences in culture requirements. However, global studies 
identifying targets of the core TFs in m and hES cells did not show a significant 
overlap between the two species. One explanation for these differences was recently 
revealed by the identification of a pluripotent cell type originating from the mouse 
post-implantation epiblast, a slightly later developmental stage to the blastocyst from 
which ES cells are derived. Through global transcriptional profiling hES cells were 
found to be more similar to mouse EpiSCs than ES cells. Although hES cells are 
derived from blastocyst-stage embryos it seems likely that the established cell lines 
correspond to a later developmental stage. If this is the case it provides a rationale for 
the reliance of hES cells on FGF2 and the lack of response to LIF. 
 
Analysis  of  the  intracellular  determinants  of  pluripotency  in  hES  cells  has  been 
limited to date with work focusing on defining the extracellular signals. As genetic 
experiments cannot be carried out on the early human embryo, confirming the role of 
the key transcription factors in early embryonic development is impossible. Studies 
will be limited to the effect of their manipulation  in vitro on the behaviour of hES 
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cells. Studies to date seem to imply similar roles for Oct4 and Nanog in self-renewal 
of hES cells to those characterised in mES cells.  
Nanog expression in the embryo has been examined by immunostaining and is found 
to be absent from the unfertilized egg and the early embryo with expression in the 
blastocyst  tightly  restricted  to  cells  of  the  ICM.  RNAi  knock-down  of  Nanog 
expression  in  hES  cells  resulted  in  increased  differentiation  and  upregulation  of 
markers  of  trophectoderm  and  extraembryonic  endoderm  (Hyslop  et  al.,  2005; 
Zaehres et al., 2005). This finding is consistent with the proposed role of Nanog in 
mES  cells  in  inhibition  of  differentiation  into  primitive  endoderm (Mitsui  et  al., 
2003)  although  trophectoderm differentiation  is  normally  observed  in  mES  cells 
upon down-regulation of Oct4 (Niwa et al., 2000). The effect of Oct4 knock-down in 
hES cells has been examined and results in clear differentiation with some evidence 
of  upregulation  of  TE  markers  (Matin  et  al.,  2004;  Zaehres  et  al.,  2005). 
Furthermore, overexpression of Nanog in hES cells supported culture in the absence 
of feeders or conditioned medium (Darr et al., 2006). However, this group also report 
that forced Nanog expression promotes a primitive-ectoderm-like phenotype in these 
cells. This is a surprising finding given that no such phenotype is observed in the 
mouse and that, with the benefit of hindsight, we know hES cells to correspond more 
closely to cells of the primitive ectoderm than cells of the ICM (Tesar et al., 2007). 
1.4.2 Extracellular Signals
Most hES cells are routinely cultured on feeders or in feeder-conditioned medium 
(Thomson et al., 1998; Xu et al., 2001; Amit et al.,  2003). In feeder-free systems 
substrates such as Matrigel are used for cell  attachment (Xu et al.,  2001). Where 
serum is not used commercially available serum-replacement usually is. All of these 
components  are  sources  of  undefined  signals.  The  best  established  medium 
supplement capable of supporting hES cell growth is FGF2 but how the signalling 
pathways  downstream  of  FGF2  contribute  to  self-renewal  remains  unknown. 
Recently James Thomson’s group provided the most convincing demonstration to 
date of hES cell self-renewal in defined conditions, including the derivation of two 
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new lines (Ludwig et al., 2006). However, their culture conditions were complex, 
with five different growth factors added, including high concentrations of FGF2, and 
a matrix composed of four different components used to aid cell attachment. Other 
signals have been implicated in the maintenance of hES cells, such as Wnt (Sato et 
al., 2004) and Activin (Vallier et al., 2004; James et al., 2005), but their requirement 
for  self-renewal  or  their  ability  to  support  self-renewal  requires  more  in  depth 
investigation. While advances have been made in our ability to derive and culture 
hES cells  under defined,  xeno-free conditions our understanding of the signalling 
pathways that support self-renewal remains poor. 
1.4.2.1 LIF/JAK/STAT 
Addition of exogenous LIF is sufficient to maintain mES cells in the presence of 
serum (Smith et al., 1988; Williams et al., 1988) or BMP (Ying et al., 2003a). The 
addition  of  LIF  to  hES  cells  is  not  however  sufficient  to  support  self-renewal. 
Several groups have reported that hES cells possess the machinery to respond to LIF 
and that addition of exogenous LIF leads to activation of STAT3 (Daheron et al., 
2004;  Humphrey  et  al.,  2004),  the  essential  downstream  component  of  the  LIF 
pathway  in  mES  cell  self-renewal  (Niwa  et  al.,  1998;  Matsuda  et  al.,  1999). 
However, the level of activation of STAT3 in hES cells is lower and the published 
results fail to establish that STAT3 is functional in hES cells. Furthermore, the effect 
of  inhibiting  STAT3 signalling  has  yet  to  be  investigated  in  hES cells.  While  it 
remains to be demonstrated if hES cells can self-renew in the absence of any STAT3 
activity,  and it remains to be rigorously tested if functional STAT3 signalling can 
affect self-renewal, the question of whether this pathway has any significant role to 
play  in  hES  cell  self-renewal  remains  open.  The  recent  finding  that  hES  cells 
correspond more closely to mouse EpiSCs than ES cells and that EpiSCs are also 
unresponsive to LIF (Brons et al., 2007; Tesar et al., 2007) supports the idea that hES 
cells are a fundamentally different cell type to mES cells and will not respond to LIF.
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1.4.2.2 FGF2  
In the initial derivation of hES cells FGF2 was not added to the culture medium but it 
was  identified  soon  thereafter  as  supportive  of  hES  cell  culture.  FGF2  is  now 
routinely added to the media for culture of hES cells though its role in promoting 
self-renewal remains undefined. It has been reported that hES cells produce several 
isoforms  of  FGF2  capable  of  activating  both  intracrine  and  autocrine  pathways 
(Dvorak  et  al.,  2005).  The  authors  demonstrate  that  the  low  molecular  weight 
isoform is secreted into the medium and that inhibition of signalling through FGFRs 
results in differentiation of hES cell colonies, characterized by the appearance of flat, 
alkaline phosphatase-negative cells in the centre of the colonies.  Inhibition of the 
FGFRs  is  accompanied  by  a  reduction  in  phosphorylation  of  mitogen  activated 
protein kinase kinase (MEK1/2) and their substrates ERK1/2, but the authors do not 
claim that  this  is  the direct  cause of the differentiation.  Addition of recombinant 
FGF2  did  not  affect  the  proliferation  of  the  cells  but  at  higher  concentrations 
(10/20ng/ml) resulted in a change in morphology to more tightly packed colonies 
lacking the flattened cells often observed around the edge of the colonies. This work 
provides evidence for the requirement for FGF-signalling to maintain hES cells but 
the molecular pathways involved remain undefined. 
More  recently  several  groups  have  advanced  towards  completely  defined  culture 
conditions for hES cell culture by increasing the concentration of FGF2 as high as 
100ng/ml  compared  to  a  supplement  of  4ng/ml  used  when cells  are  cultured  on 
feeders.  It  has been suggested that  the reason for this  could be trivial  – that  the 
stability of FGF2 is lower in unconditioned medium and that higher concentrations 
must  therefore  be added to  maintain  a  minimum threshold of  FGF2 and prevent 
exposure of the cells to periods of FGF2 deprivation. Another group has suggested 
that  the  combination  of  high  FGF2 and  BMP inhibition  by  Noggin  can  support 
feeder-free self-renewal. This finding may be specific to the conditions employed by 
this group which showed a high level of basal BMP signalling – a balance of signals 
must  be maintained to support self-renewal as demonstrated for mES cells  where 
BMP signals act to support self-renewal only in the context of media supplemented 
with LIF.
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FGFs can activate multiple signalling pathways including PI3K-AKT, MAPK-ERK, 
and PLC-PKC. All of these are likely to affect the growth of ES cells and the balance 
between self-renewal and differentiation that exists in any ES cell culture. Dissecting 
these  pathways  and  identifying  the  critical  components  for  self-renewal  should 
further our understanding of the basic biology of these cells. FGF2 has been used in 
the derivation of mouse EG cells, mGS cells (although it is not required once the 
lines are established) and in the derivation and culture of mouse EpiSCs suggesting a 
more general role for FGF signalling in promoting stem cell growth in vitro. FGFs 
are known to promote cell growth and proliferation.
1.4.2.3 Canonical Wnt Signalling
As discussed above, Wnt ligands and GSK3 inhibitors are capable of mediating the 
stabilisation  of  β-catenin  and  its  subsequent  nuclear  accumulation  allowing  it  to 
interact with cofactors and activate transcription of target genes. It was demonstrated 
by Sato et al that a pharmacological inhibitor of GSK-3β could support self-renewal 
of  both  mES  and  hES  cells  (Sato  et  al.,  2004).  However,  their  assay  examined 
growth over a short period and did not demonstrate self-renewal following passaging 
of the cells. Another study suggests that Wnt/β-catenin signalling promotes survival/
proliferation  of  hES cells  but  does  not  promote  self-renewal  over  longer  periods 
(Dravid et al., 2005). The data suggests that Wnt-signalling during a 4 day culture 
period in feeder-free conditions actually reduces the proportion of cells capable of 
forming alkaline-phosphatase positive colonies when the cells are seeded back onto 
feeders. Furthermore, 26 days of culture in the presence of Wnt-antagonists did not 
abolish  the  formation  of  AP+  colonies  demonstrating  that  Wnt-signalling  is  not 
required for self-renewal. Canonical Wnt signalling is likely to affect the balance of 
self-renewal  and  differentiation  in  hES  cells  and  effects  on  cell  metabolism  are 
anticipated, particularly when GSK3 inhibitors are employed. However, there is little 
evidence for a long-term self-renewal effect of this pathway on hES cells.  
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1.4.2.4 TGFβ/Activin/Nodal
TGFβ/Activin/Nodal signal through the TGFβ super-family of receptors to activate 
downstream signalling including phosphorylation of Smad2 and Smad3 (reviewed in 
(Shi and Massague, 2003)). Several groups have reported a positive role for TGFβ-
mediated signalling in the maintenance of pluripotency in hES cells  (Amit  et  al., 
2004;  Vallier  et  al.,  2004;  James  et  al.,  2005).  While  Amit  et  al present  no 
mechanism they  demonstrate  long-term  self-renewal  in  a  feeder-  and  serum-free 
system. Cells were cultured on a fibronectin substrate in media containing serum-
replacement,  TGFβ, LIF and FGF2 (Amit et  al.,  2004). Their results suggest that 
these conditions  support  self-renewal  with efficiency approaching that  seen when 
hES  cells  are  grown on  feeders.  The  interpretation  of  their  findings  is  however 
complicated  by the presence of the undefined serum-replacement.  Another  recent 
paper  reports  the  chance  finding  that  Activin  A  can  maintain  self-renewal  in 
combination  with  keratinocyte  growth  factor  (KGF)  and  nicotinamide,  which 
promote growth and survival of the cells(Beattie et al., 2005). Addition of the activin 
inhibitor follistatin to cultures on MEFs induced differentiation. This, in combination 
with  the  demonstration  that  MEFs  secrete  activin  A  into  the  culture  medium, 
suggests that TGFβ-signalling may underlie (at least in part) the ability of MEFs to 
support undifferentiated growth of hES cells. This finding is supported by a report 
that pharmacological inhibition of Smad2/3 phosphorylation results in differentiation 
of hES cells  cultured on Matrigel in MEF-CM (James et  al.,  2005). Furthermore, 
addition  of  Activin  A  to  non-conditioned,  chemically  defined  medium  lacking 
serum-replacement  was  found  to  maintain  expression  of  pluripotency  markers 
although  in  this  case  addition  of  Activin  A  was  not  sufficient  for  long-term 
maintenance of undifferentiated cultures. Long-term propagation of hES cells was 
achieved by supplementing defined media with both FGF2 and Activin or Nodal, 
coating tissue culture dishes in serum to aid cell attachment (Vallier et al., 2004). 
The  work  described  above  is  based  on  established  hES  cell  lines  and  lacks  the 
demonstration that these growth conditions can support  de novo derivation of ES 
cells, the most stringent test that can be applied in the human system. However, two 
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groups recently returned to the mouse with conditions optimised for hES cell culture. 
The subsequent derivation of EpiSCs from both the mouse and the rat suggests that 
these growth conditions do support the propagation of a distinct type of pluripotent 
cell (Brons et al., 2007; Tesar et al., 2007).  
1.5 Scope of the Project
ES cells are an in vitro phenomenon; the cells to which they are most closely related, 
the cells of the pluripotent epiblast, exist only transiently in vivo. Mouse (m) ES cells 
have only been established under defined conditions for the inbred 129 strain (Ying 
et al.,  2003a) while high efficiency derivation from C57Bl6 and CBA strains has 
only been achieved through the technically demanding procedure of microdissection 
and  culture  in  the  presence  of  serum  and  feeders  (Brook  and  Gardner,  1997). 
Furthermore, while human (h) ES cells have been derived (Thomson et al., 1998), it 
is clear that these cells do not respond to the culture conditions established for mES 
cells (Thomson et al., 1998; Daheron et al., 2004; Humphrey et al., 2004) and may in 
fact represent a distinct cell type (Tesar et al., 2007). This, together with the repeated 
failure to establish ES cells from rats or other mammalian species suggests that mES 
cells  are the exception and that  it  may not be possible  to  establish ES cells  that 
behave similarly  to those described for the mouse from other  species.  Mice may 
simply be unique or it may be that researchers are limited by the established culture 
conditions,  developed in  the artificial  environment  of  in  vitro tissue culture.  It  is 
hoped  that  by  better  understanding  the  nature  of  mES  cells  and  the  signalling 
pathways  involved  in  their  self-renewal  our  understanding  might  be  extended  to 
other species, in particular human. 
To this end it has been the long-term research interest of our group to develop fully 
defined culture conditions for mES cells that facilitate investigation of the molecular 
mechanisms governing self-renewal. A recently developed culture media based on a 
combination of three pharmacological inhibitors (named ‘3i’) has been demonstrated 
to support robust self-renewal. The aim of this project is to define the requirements 
for  the  individual  inhibitors  used  and  to  elucidate  the  underlying  mechanisms 
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governing  self-renewal.  I  demonstrate  that  3i  relieves  mES  cells  from  their 
dependence on signals previously thought essential for their propagation. It is our 
hope these culture conditions will support the derivation and propagation of ES cells 
from other mammalian species.
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Chapter 2. Materials and Methods 
2.1 Cell Culture Reagents
2.1.1 Media and Supplements
GMEM Complete: Glasgow Minimal Essential Medium (GMEM)
Foetal Calf Serum (10%)
Non-essential amino acids (Gibco, 11140-035)
L-Glutamine, 2mM (Gibco, 25030-024)
Sodium Pyruvate, 1mM (Gibco, 11360-039)
2-mercaptoethanol
LIF (100U/ml)
N2B27: 1:1 Neurobasal:DMEM:F-12 (Gibco, 21331-020)
L-Glutamine, 2mM (Gibco, 25030-024)
N2, 1:200
B27, 1:100 (Gibco, 17504-044)
2-mercaptoethanol
B27-free medium: As N2B27 but without B27 and using 1:100 N2
Insulin-free medium: As B27-free but using N2 supplement made without insulin




2i: N2B27 supplemented with:
PD0325901, 1μM 
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CHIR99021, 3μM 
PS: N2B27 supplemented with:
PD184352, 0.8μM 
SU5402, 2μM 
N2 (100x): Insulin (Sigma I-1882) 2.5mg/ml
Apo-transferrin (Sigma T-1147) 10mg/ml
BSA (Gibco 15260-037) 7.5mg/ml
Progesterone (Sigma P8783) 0.002 mg/ml
Putrescine (Sigma P5780) 1.6mg/ml
Na Selenite (Sigma S5261) 3μM
Dissolve in DMEM:F12 (Gibco 21331-020)
B27 (50x): Purchased from Gibco (17504-044).  See Brewer  et  al;  J.  Neurosc. 






















rHSA: Recombinant  human  serum albumin  (Cellastim,  Invitria)  used  in  place  of 
BSA in N2. Final concentration in media: 37.5μg/ml
2.1.2 Cytokines Growth Factors and inhibitors
LIF: 100U/ml. Conditioned media generated by transient transfection of Cos7 cells 
with plasmid encoding human LIF and harvesting conditioned 
media after 4 days.
BMP4: Recombinant human, 10ng/ml (R&D systems, 314-BP-010)
EGF: Recombinant human, 10ng/ml (Peprotech, 100-15)
FGF2: Recombinant human, 10ng/ml (Peprotech, 100-18B)
Wnt3a:Recombinant mouse, 100ng/ml (R and D systems, 1324-WN-002)
Inhibitors: PD184352 (Signalling Technologies, University of Dundee)
SU5402 (Calbiochem, 572630)
CHIR99021 (Signalling Technologies, University of Dundee)
PD173074 (Calbiochem, 341607)
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2.1.3 Other Tissue Culture Reagents
Antibiotics: Puromycin (Sigma, P9620): 1.0μg/ml, 0.5μg/ml serum-free, 2.0μg/ml 
for episomal transfections
Hygromycin  B  (Gibco,  10687-010):  150μg/ml,  100μg/ml 
serum-free
Zeocin (Gibco, R250-01): 200μg/ml
Gelatine (0.1% in PBS)
Trypsin: 0.25% Trypsin (Gibco, 15090-046)
1.3mM EDTA





ES cell line derived from 129/Ola mice.
E14 1V C
Subclone of E14Tg2a, tested for germ-line completency.
E14T
E14Tg2a derived cells  which maintain a stable integration of the large T-antigen 
under G418 selection.  
NanogT
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E14Tg2a derived cells  which maintain a stable integration of the large T-antigen 
under G418 selection and Nanog under puromycin selection.   
Oct4GIP
Derived from parental  line CGR8.  Stably express GFP and puromycin  resistance 
under  control  of  the  Oct4 promoter  (Ying  et  al.,  2002).  Addition  of  puromycin 
selects for Oct4-expressing ES cells. 
BT12
E14Tg2a-derived ES cells carrying a targeted deletion of  Nanog  (Chambers et al., 
2007). Express hygromycin resistance under the control of the endogenous  Nanog-
promoter. ES cells can be selected for using hygromycin.
44cre6
Independently E14Tg2a-derived Nanog-null cell line (Chambers et al., 2007).
Fgf4-heterozygous and –null
Obtained from Rizzino lab (Wilder et al., 1997). ES cells carrying targeted knockout 
of one or two Fgf4 alleles.
GSK3 double knockout 
Obtained from Bradley Doble and James Woodgett  (Doble et al.,  2007). ES cells 
with targeted knockout of both alleles of Gsk3-α and –β. 
β-catenin-heterozygous and -null
Obtained from Kemler group. ES cells carrying targeted knockout of one or both β-
catenin alleles. Heterozygous line has one null and one floxed allele. Null cells can 
be generate by expression of Cre recombinase.
Ecad-null
Obtained  from  Kemler  group  (Larue  et  al.,  1996).  ES  cells  carrying  targeted 
knockout of both Ecad alleles.
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Bcl2IP
E14Tg2a  ES  cells  stably  expressing  Bcl2  under  control  of  CAG  promoter. 
Puromycin resistant.
MTIP
E14Tg2a ES cells  carrying  a  stable  integration  of  pPy Floxed MT IP gfp (AGS 
1126). Puromycin resistant.
Y118F
E14Tg2a ES cells carrying a stable integration of pCAGgrgpY118FIZ (AGS 796). 
Can  be  maintained  in  media  supplemented  with  GCSF  instead  of  LIF.  Zeocin 
resistant. 
Klf4IH
E14Tg2a ES cells carrying a stable integration of pPyCAG KLF4 IH (AGS 1233). 
Hygromycin resistant. 
2.2 Cell Culture
2.2.1 Tissue Culture Routine
All cell lines were maintained in 37C, humidified incubators maintained at 7% CO2. 
For low oxygen experiments incubators were connected to a source of nitrogen and 
set to 5% O2.
2.2.1.1 Mouse Embryonic Stem Cells
mES cell lines were routinely cultured on gelatine-coated tissue culture flasks/plates 
(Iwaki) in GMEM complete media. Routine serum-free culture was performed using 
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N2B27 supplemented with LIF and BMP4. Media was changed daily and cells were 
passaged when approaching confluency. To passage, cells were washed in phosphate 
buffered saline (PBS), incubated with trypsin for approximately 2 minutes or until 
cells  detached,  resuspended  in  5-10  trypsin  volumes  of  media,  harvested   by 
centrifugation (1300rpm, 3mins) and replated at the required density. 
2.2.1.2 Mouse Neural Stem Cells
Mouse NS cells were derived by culturing ES cells as aggregates for 10-14 days in 
N2B27 alone before plating onto gelatine-coated plates in the presence of EGF and 
FGF. NS-like cells outgrew from attached aggregates and were thereafter maintained 
in  NS  cell  conditions  as  described  (Conti  et  al.,  2005).  Briefly,  NS  cells  were 
maintained  on gelatine-coated  plates  in  NS-A medium (Euroclone)  supplemented 
with  EGF  and  FGF2,  both  10ng/ml.  Cells  were  passaged  every  2-3  days  by 
trypsinisation. 
2.2.1.3 Other cell lines
Other cell lines, including Cos7 and MEFs, were cultured as for ES cells but LIF was 
not included in the media.
2.2.2 Substrates
2.2.2.1 Gelatine
Flasks/plates were covered with 0.1% gelatine in PBS for a minimum of 20 minutes 
at room temperature. Gelatine was aspirated and cells plated immediately.
2.2.2.2 Laminin
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Flasks/plates were covered with poly-L-ornithine and incubated at room temperature 
for  1hr.  Poly-L-ornithine  was  aspirated  and  flasks/plates  washed  twice  in  PBS. 
Flasks/plates were then covered with laminin and incubated at 37C for at least 1hr 
(overnight is fine). Laminin was aspirated and replaced with PBS/media until ready 
to use. 
2.2.3 Freezing
For long-term storage mESCs can be frozen and stored in liquid nitrogen. Cells were 
harvested  by  trypsinisation  and  2-3  million  cells  resuspended  in  0.5ml  media 
containing  10%  dimethyl-sulphoxide  (DMSO)  and  placed  in  cryovials  (Nunc, 
377224).  Vials  were  placed  immediately  at  -80C  and  after  overnight  storage 
transferred to liquid nitrogen.
2.2.4 Feeders – Mouse Embryonic Fibroblasts
Where  stated,  mESCs  were  grown  on  a  mitotically  inactivated  layer  of  mouse 
embryonic fibroblasts  (MEFs). MEFs were prepared from mid-gestation embryos. 
Embryos  were  dissociated  mechanically  and  by  trypsinisation  before  plating  on 
gelatine-coated  plastic  in  GMEM complete  (no LIF).  The  outgrowing cells  were 
passage 1 MEFs. For use as feeders confluent MEFs were mitotically inactivated by 
exposure to 10μg/ml Mitomycin C (Sigma, M4287) for 3 hours and then trypsinised 
and replated in the desired plates and flasks at a density equivalent to the confluent 
flask (approximately 1x105 cells/cm2). 
2.3 Manipulation of Cells 
2.3.1 Stable Transfections – Electroporation
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In order to stably integrate transgenes into mESCs plasmids encoding the desired 
construct  were  linearized  by restriction  digest  (enzyme  sca1  or  other  appropriate 
single-cutting  enzyme),  purified  by  ethanol  precipitation  and  electroporated  into 
cells. 10 million cells per transfection were harvested by trypsinisation, washed in 
PBS, resuspended in 800μL PBS and placed in an electroporation cuvette (Biorad, 
165-2081EDU). 50μg linearized DNA was added to  the cuvette.  Cells  were then 
electroporated  (Cap  3.0μF,  0.8kV)  and  transferred  to  9.2ml  pre-warmed  GMEM 
complete.  Cells  were  then  plated  in  gelatinized  10cm  tissue-culture  dishes  at  1 
million cells per dish in GMEM complete. 24 hours later the appropriate selective 
drugs were added. Cells were cultured for a further 9-11 days, changing media every 
2 days. Once colonies had reached a suitable size isolated colonies were ‘picked’ and 
transferred  to  gelatine-coated  96-well  tissue  culture  plates.  This  was  considered 
passage 1 for newly-derived transgenic lines. Lines were expanded by passaging to 
multi-well plates of increasing well size until sufficient cells were obtained to freeze 
down, typically a 6-well plate. 
2.3.2 Transient/Episomal Transfections – Lipofection
Forced expression of transgenes in mESCs can also be achieved by transfection of 
intact  plasmids  encoding  the  desired  transgene.  Plasmids  were  introduced  using 
Lipofectamine  2000  (Invitrogen,  11668-019).  mES  cells  were  harvested  by 
trypsinisation and pipetted up and down to ensure a single cell  suspension.  Cells 
were plated in gelatinized 6-well plates at 1 million/well in GMEM complete. 3μL 
Lipofectamine/well  was  mixed  in  250μL  GMEM  complete  without  serum  and 
incubated for 5 minutes at room temperature. 3μg plasmid DNA/ml was mixed in 
250μL GMEM complete without serum. The Lipofectamine and DNA mixes were 
combined and incubated for at least 20 minutes at room temperature. 30 minutes to 1 
hour after plating the cells 500μL of Lipofectamine/DNA mix was added to each 
well. 24 hours later media was changed and selection added where appropriate.
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2.3.3 Luciferase Assay
Luciferase assays were carried out by cotransfection of a renilla luciferase plasmid 
and the appropriate luciferase-reporter plasmid. The plasmids were introduced into 
ES cells  as described for lipofection above using 4μg reporter  plasmid DNA and 
0.2μg renilla plasmid DNA per well. The following day cells were trypsinised and 
replated in 24-well plates (1 6-well can be divided into 12 24-wells) containing the 
appropriate media. After a further 8-24 hours’ culture cells were washed once in PBS 
lysed on the wells in 100μL passive lysis buffer from the Promega Dual Luciferase 
Assay Kit and the lysates either frozen or used directly for a luciferase assay (see 
molecular  biology  methods).  To  assess  activation  of  canonical  Wnt  signalling  a 
TOPFlash (TCF/LEF reporter) plasmid was used. To assess STAT3 activity an acute 
phase response element (APRE) luciferase reporter (plasmid AGS 895) was used. 
2.3.4 Making Cos7-conditioned medium – FuGene Transfections
~106 Cos7 cells per plate were plated onto 10cm plates 24hrs prior to transfection. 
Cells  were  transfected  using  FuGene  (Roche,  11815091001)  according  to  the 
manufacturer’s  protocol.  GCSF-CM  was  generated  by  transfecting  with  plasmid 
pCAGGS-hGCSFb  (AGS  688).  Media  was  replaced  24hrs  after  transfection  to 
prevent carry over of FuGene. After 4 days’ further culture media was harvested and 
filtered. GCSF-CM was tested as described (Burdon et al., 1999b). See also ONPG 
assay. 
2.3.5 Clonal Assays
To assess the ability of single mES cells to form undifferentiated colonies cells were 
dissociated and plated at clonal density. Media containing the appropriate cytokines 
was placed in gelatinized 6-well plates which were placed in the incubator to pre-
equilibrate.  Cells  were  harvested  by  trypsinisation  and  a  single  cell  suspension 
ensured by pipetting up and down through a narrow-mouthed pipette.  Cells  were 
counted using a haemacytometer and diluted to a final cell density of 1000 cells/ml. 
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600μL of this cell suspension was added to each well to obtain a final cell number of 
600/well. Cells were allowed to grow for 6-7 days before they were fixed, stained for 
alkaline phosphatase (see molecular biology methods), and scored for the frequency 
of  undifferentiated  (alkaline  phosphatase-positive),  mixed  and  differentiated 
(alkaline phosphatase-negative) colonies by microscopy. 
2.3.6 Single Cell Deposition
96-well plates were gelatinized and 100μL of the desired media placed in each well. 
Plates were pre-equilibrated in 37C incubators prior to cell deposition. Single mES 
cells were deposited in individual wells of 96-well plates using a Mo-Flo cell sorter. 




0.5-2 million cells  were harvested by trypsinisation,  washed in PBS and lysed in 
buffer RLT (Qiagen RNeasy kit). Lysates were snap-frozen in Ethanol/dry ice and 
stored at -80C or used directly for RNA extraction. Lysates were homogenized by 
spinning through a Qiashredder (Qiagen, 79654) and subjected to RNA extraction 
using the RNeasy Kit (Qiagen, 74104) according to the manufacturer’s protocol and 
incorporating an on-column DNase digest (Qiagen, 79254) to remove genomic DNA. 
Eluted RNA concentration was determined by spectrophotometry. 
2.4.2 cDNA Synthesis
cDNA was synthesized using the Invitrogen Superscript III First-Strand Synthesis 
Kit (Invitrogen, 11752050) according to the manufacturer’s protocol using oligo-dT 
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primers. 0.5-2μg RNA was used as template. cDNA was diluted 1:10 in sterile water 
and used for PCR and qRT-PCR.
2.4.3 RT-PCR
Routine  RT-PCR  was  performed  using  Taq  (Qiagen,  201203).  Annealing 
temperatures and extension times were adjusted to optimise conditions for the given 
primer  pair.  Sequences  amplified  for  cloning  were  amplified  with  proof-reading 
Phusion DNA Polymerase (Finnzymes, F540). See table for primers and conditions. 
Table2.1. PCR primers.
Gene 5'-primer: 3'-primer: Annealing Temp. (°C) 
Gapd
h cccactaacatcaaatgggg ccttccacaatgccaaagtt 55
Nano
g caggtgtttgagggtagctc cggttcatcatggtacagtc 57
Oct3/4 gtgactgcctaccagaatga attgtccgcataggttggag 55
Rex1 ttggggcgagctcattactt ttgccacactctgcacacac 57
Fgf4 cacgagggacagtcttctgg cgtcggtaaagaaaggcaca 58
Sox1 cctcggatctctggtcaagt tacagagccggcagtcatac 55 (Use Q buffer)
T gtgactgcctaccagaatga attgtccgcataggttggag 56 (Add 5% DMSO)
2.4.3.1 Standard PCR
Routinely  2µl  of  cDNA template  is  amplified  in  a  25µl  reaction  volume as  per 
Qiagen standard PCR protocol (Qiagen, 201203). Thermal cycling was performed in 
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72ºC 10 minutes
4ºC ∝  
2.4.3.2 Blunt PCR for cloning
For cloning, 200ng of plasmid, or ES cell cDNA was used as a template for PCR in a 
50µl reaction volume as per manufacturer’s protocol (Phusion, High Fidelity Taq, 
Finnzymes,  F540).  Thermal  cycling  was performed  in  a  GeneAmp 9700 thermal 








DNA was run on an agarose gel to verify amplicon size. Clean PCR products of the 
correct size were used for ligation reactions.
2.4.3.3 Cloning of Bcl2
Bcl2 coding sequence was amplified from ES cell cDNA. Primers were designed to 
incorporate flanking Xho1 and Pac1 restriction sites.
5’ primer:                 Xho1        Kosak
agcCTCGAGgccgccaccATGGCGCAAGCCGGGAGAAC 
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To test for the presence of wild-type and null Stat3 alleles in ES cells genomic PCR 
was performed. The PCR mix, primers and cycle program were as follows:
Genomic DNA 5μL
10x Buffer 3μL
Primer 1 (10μM) 1μL
Primer 2 (10μM) 1μL















Real-time  quantitative  PCR  was  performed  using  the  Applied  Biosystems  7900 
machine. Either Sybr Green or Probe-based qRT-PCR was performed. 
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2.4.4.1 Sybr Green Real-Time PCR
Sybr Green real-time PCR employs a dye (Sybr Green) that specifically binds double 
stranded  (ds)  DNA  and  fluoresces  when  bound.  The  intensity  of  fluorescence 
therefore reflects the amount of dsDNA in the reaction. Reactions were performed in 
20μL  reaction  volumes  using  the  Sybr  Green  Master  Mix  (Applied  Biosystems, 
4309155), and the standard cycler programme. For each primer/probe combination a 
master mix was prepared for n+1 reactions and aliquoted into 96-well reaction plates 
to which 2μL cDNA was added directly. See table for primers.
Master Mix (per reaction):
Sybr Green Master Mix: 10μL
Primer (F+R, 10μM): 0.4μL
PCR-grade water: 7.6μL

















2.4.4.2 UPL Real-Time PCR
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96-well  plates  were used together  with the  fast  block,  Fast  TaqMan Master  Mix 
(Applied Biosystems, 4366073) and the fast protocol. Probes were obtained from the 
Roche Universal Probe Library (UPL) and primers designed using the Roche UPL 
software  (https://www.roche-applied-science.com).  UPL  probes  are  labelled  with 
FAM  which  fluoresces  upon  dissociation  from  the  synthetic  oligonucleotide. 
Dissociation occurs upon amplification of the target sequence allowing fluorescence 
levels  to  provide  a  read  out  of  PCR product  levels.  Probes  were used at  a  final 
concentration of 100nM and primers at 200nM. The reaction volume was 20μL. For 
each primer/probe combination a master  mix was prepared for n+1 reactions  and 
aliquoted into 96-well reaction plates to which 2μL cDNA was added directly. See 
table for primers and corresponding UPL probe numbers.  
Master Mix (per reaction):
Fast TaqMan Master Mix (2x): 10μl
Primer (F+R mix, 10μM): 0.4μL
Probe: 0.2μL
PCR-grade water: 7.4μL
Applied biosystems software automatically calculates  cycle  threshold (CT) values 
from the amplification curves. Technical duplicates of each reaction were performed 
and the CT values averaged before calculating relative expression. Relative levels of 
gene  expression  were  calculated  by  normalising  genes  of  interest  to  β-actin 
expression and arbitrarily  assigning  a  sample  as  the reference  to  which all  other 
samples  were  compared.  Errors  were  calculated  from  biological  duplicate  or 
triplicate samples. 
Table2.3. UPL Real-Time PCR primers and probes.
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2.4.5 Agarose Gel Electrophoresis
Agarose gels were prepared by melting agarose at the desired concentration (1-2%) 
in TBE buffer. Molten agarose was cooled, Sybr Safe nucleic acid dye (Invitrogen, 
S33102) added and gels poured in casting trays. Electrophoresis was performed in 
Gene Forward Primer Reverse Primer Probe
Actb ctaaggccaaccgtgaaaag accagaggcatacagggaca 64
Axin2 gcaggagcctcacccttc tgccagtttctttggctctt 50
Bcl2 agtacctgaaccggcatctg ggggccatatagttccacaaa 75
Bcl-xl tgaccacctagagccttgga tgttcccgtagagatccacaa 2
Cdx1 acgccctacgaatggatg cttggttcgggtcttaccg 70
Egr1 ccctatgagcacctgaccac tcgtttggctgggataactc 22
Fgf5 aaaacctggtgcaccctaga catcacattcccgaattaagc 29
Gata4 ggaagacaccccaatctcg catggccccacaattgac 13
Gata6 ggtctctacagcaagatgaatgg ggtctctacagcaagatgaatgg 40
Klf2 ctaaaggcgcatctgcgta tagtggcgggtaagctcgt 48
Klf4 cgggaagggagaagacact gagttcctcacgccaacg 62
Mcl1 taacccagccatggaagttt cagctttcatttcaccctttg 33
Myc cctagtgctgcatgaggagac tcttcctcatcttcttgctcttc 77
Nanog ttcttgcttacaagggtctgc agaggaagggcgaggaga 110
nMyc cctccggagaggataccttg tctctacggtgaccacatcg 69
Pou5f
1 gttggagaaggtggaaccaa ctccttctgcagggctttc 95
Rex1 tcttctctcaatagagtgagtgtgc gctttcttctgtgtgcagga 71
Socs3 atttcgcttcgggactagc aacttgctgtgggtgaccat 83
T cagcccacctactggctcta gagcctggggtgatggta 100
Tbx3 ttgcaaagggttttcgagac tgcagtgtgagctgctttct 51
Tcl1 cgtgtacttggatgagtttcgt gcaagatcacctggaatttttc 71
Zfx accgtccggtgcgtataa ttctcatcagccagaacacct 104
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Mupid gel tanks at 25-130V in 0.5x TBE buffer. Nucleic acid was visualized by UV 
transillumination and pictures taken using the G-box. 
2.4.6 Gel Extraction
Bands were purified from agarose gels  by cutting bands of the desired size on a 
transilluminator  and  purifying  nucleic  acids  using  the  Qiagen Gel  Extraction  Kit 
(Qiagen,  28704)  according  to  the  manufacturer’s  protocol.  The  concentration  of 
purified DNA was determined by spectrophotometry. DNA fragments were used in 
subsequent ligations. 
2.4.7 Spectrophotometry
Concentrations of nucleic acid were measured using a Nanodrop spectrophotometer.
2.4.8 TOPO-Cloning
PCR products were cloned into TOPO vector using the Zero Blunt TOP PCR cloning 
kit (Invitrogen, K2800-20) for blunt ended PCR products or the TOPO TA Cloning 
Kit (Invitrogen,  KNM4600-01) for PCR products with a polyA overhang. Colonies 
formed on ampicillin plates were miniprepped and test digested with EcoR1 to check 
for insertion of the PCR product. Minipreps carrying the insert were sequenced from 
M13F and M13R primers and the sequence checked for mutations before proceeding 
with subcloning reactions.
2.4.9 Ligations
Ligations  were carried out  using Quick Ligase  (NEB, M2200S) according to  the 
manufacturer’s  protocol. Ligation products were transformed into competent cells, 
plated on selective agar plates, colonies picked and miniprepped. Miniprepped DNA 
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was  checked  for  successful  ligation  by  restriction  digest  and  gel  electrophoresis 
before use in subsequent experiments.  
2.4.10 Restriction Digests and Ethanol Precipitation
All enzymes were obtained from New England Biolabs and used according to the 
manufacturer’s protocol.
For stable transfections plasmid DNA was linearised by digestion with Sca1.
DNA was purified from digest reactions by precipitation. 2.5 volumes 100% EtOH 
and 1/10 volume 3M Na Acetate were added to the reaction and precipitated DNA 
pelleted  by  centrifugation  at  maximum  speed  for  10mins  in  a  microcentrifuge. 
Supernatant was removed and the pellet washed in 70% EtOH followed by a further 
10mins centrifugation. The supernatant was removed, the pellet dried for 10-15mins 
and redissolved in dH2O or TE buffer.
2.4.11 Transformations
Plasmid  DNA was transformed into  competent  E. Coli  (DH5α).  50μL cells  were 
thawed on ice, incubated on ice with 1μL plasmid DNA for 20 minutes, heat shocked 
for 30 seconds at 37C, placed on ice for 2 minutes, 1ml LB added and tubes shaken 
at 37C for 1 hour before plating 10 or 100μL on the appropriate selective plates. 
Plates were incubated overnight at 37C.
2.4.12 Plasmid Purification 
Single bacterial colonies were picked from fresh plates into the required volume of 
LB  containing  the  appropriate  selection  (100μg/ml  ampicillin  or  50μg/ml 
kanamycin) and shaken overnight at 37C. Plasmid DNA was isolated by Miniprep 
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AGS 1126: pPy Floxed MT IP gfp
AGS 1233: pPyCAG KLF4 IH
pCAG Cre IRES GFP: Gift from Sandra Gomez Lopez
pPy Floxed Bcl2 IP gfp. 
PCR-amplified Bcl2 coding sequence was cloned into TOPO vector and verified by 
sequencing.  TOPO-Bcl2  and AGS 1126 were digested  with  Xho1 and Pac1 and 
fragments of the appropriate size isolated from agarose gels. Bcl2 coding sequence 
was then ligated into AGS 1126 to form pPy Floxed Bcl2 IP gfp. Cells expressing 
this construct can be reverted by exposure to Cre and sorting of GFP+ cells.  Cre 
recombinase  recombines  flox  sites  flanking  the  coding  sequence  and  puromycin 
resistance genes bringing GFP under control of the CAG promoter.
2.4.14 Preparation of genomic DNA
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Genomic  DNA  was  prepared  using  the  DNeasy  Blood  and  Tissue  Kit  (Qiagen, 
69504). At least 1 million cells were harvested by trypsinisation, washed in PBS and 
genomic DNA extracted according to the manufacturer’s protocol. Genomic DNA 
was used directly for PCR genotyping.
2.4.15 Western Blotting
2.4.15.1 Solutions and reagents





Running Buffer: NuPage MOPS, 20x (Invitrogen, NP0001)
Antioxidant: NuPage Antioxidant (Invitrogen, NP0005)
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Incubation Buffer: 5% dried, skimmed milk (Marvel)
0.15% NP40
In TBS




Stripping Buffer: 2% SDS 
62.5mM TRIS pH6.8
Gels: 10% NuPage Bis-Tris (Invitrogen, NP0301BOX)
12-14% NuPage Bis-Tris (Invitrogen, NP0321BOX)
MW marker: SeeBlue Plus2 (Invitrogen, LC5925)
Gel-tank: Novex Mini-Cell (Invitrogen, EI0001)
Membrane: Nitrocellulose (Hybond-ECL, Amersham, RPN203D)
ECL: ECL-plus (Amersham, RPN2132)
2.4.15.2 Sample Preparation
~2 million cells were lysed directly on the wells of 6-well plates in 250μL laemmli 
lysis buffer and transferred immediately to eppendorf tubes on ice. The samples were 
boiled for 5 minutes, sonicated briefly and subjected to SDS-PAGE directly or stored 
at -20C. 
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2.4.15.3 Running the Gel
10% or 12-14% Novex gels (Invitrogen) were used. The comb was removed, wells 
rinsed by pippetting running buffer into the wells and 20μL sample loaded per well. 
10μL  protein  standard  was  loaded  in  1  well.  Gels  were  run  at  200V  for 
approximately 1hr. 
2.4.15.4 Transfer
The gel was removed from its casing into transfer buffer, the foot and wells removed, 
and assembled  with the membrane  between 1 sponge and 2 sheets  wet Wattman 
paper either side, taking care to avoid bubbles. The assembly was transferred at 395 
amps for 70 minutes in a cold room in BioRad gel tanks.
2.4.15.5 Blocking, antibody incubation, washing and stripping
The membrane was placed protein side up in a 50ml tube and incubated for 2hrs in 
blocking solution. Primary antibodies were diluted in 5ml 5% milk and incubated 
with the membrane for 2hrs at RT or overnight at 4C. Secondary antibodies were 
diluted  in  5% milk  and incubated  with  the  membrane  for  1hr  at  RT.  Following 
primary and secondary antibody incubations membranes were washed 3 x 15 minutes 
in 30ml wash buffer. Membranes were incubated for 5 minutes with ECL, exposed to 
X-ray  film  and  developed.  If  membranes  were  to  be  reprobed  antibodies  were 
stripped by incubating for 30 minutes at 70C in stripping buffer. Following stripping 
membranes were re-blocked. See table for details of antibodies and concentrations.
Table2.4. Antibodies for immunoblotting and immunofluorescence (IF)




 p-β-catenin(ser33/37/thr41) Cell signalling 9561 1000
 p44/42 MAPK (ERK) Cell signalling 9102 1000
 
p-p44/42 
MAPK(thr202/tyr204) Cell signalling 9101 1000
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 AKT (PKB) R and D systems MAB2055 1000
 p-AKT(ser473) R and D systems AF887 1000
 p38 Cell Signalling 9212 1000
 p-p38(thr180/tyr182) Cell signalling 9211 500








Biotechnology sc-1237 100 (IF)
Myc
Santa Cruz
 Biotechnology sc-42 200
NRDG1 Cohen laboratory 1μg/ml
p-NRDG1 Cohen laboratory 1μg/ml
Alpha-Tubulin Abcam Ab7291 5000
Tuj1 Covance MMS-435P 400 (IF)
Stat3
BD Transduction




GSK3-α/β Biosource 44-610 1000
Id1 (c-20)
Santa Cruz
 Biotechnology sc-488 1000
Nestin DSHB 50 (IF)
Blbp N. Heins 500 (IF)
Rc2 DSHB 50 (IF)
Sox2 Chemicon AB5603 1000 (IF)
     
Secondar
y
ECL Mouse IgG, HRP-Linked 
Whole Ab Amersham NA931  2000-5000
ECL Rabbit IgG, HRP-Linked 
Whole Ab Amersham NA934 2000-5000




2.4.16.1 Buffers and Reagents
IPH BUFFER (as used in (Frank et al., 2003) for immunoprecipitation of cMyc from 




1 mM DTT before use 
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One tablet of protease inhibitor before use
A/G sepharose beads (Amersham)
2.4.16.2 Sample Preparation
mES cells  were  grown in  10cm dishes  in  the  appropriate  conditions.  Cells  were 
washed once in cold PBS and 1ml cold IPH buffer added directly to the plates. The 
plates were rocked at 4C for 30mins, lysates collected by scraping the plates with a 
cell scraper (Greiner) and pippeting the lysate into 1.5ml eppendorfs on ice. Lysates 
were spun in a microcentrifuge at 13000rpm at 4C for 1 minute and supernatants 
transferred to clean 1.5ml eppendorfs on ice. At this point 50μL lysate was removed 
from each sample, mixed with 2x laemmli buffer (see western blotting), and boiled 
for 5mins. These were input samples used as loading controls. 
2.4.16.3 Immunoprecipitation (IP)
20μL protein A sepharose bead slurry per sample was placed in 1.5ml eppendorfs, 
centrifuged, supernatant removed and beads washed in 0.5ml IPH buffer 2-3 times. 
2μg  appropriate  antibody  was  added  per  sample  and  cleared  lysate  (see  sample 
preparation) added to the beads and antibody. The tubes were tumbled for 4-6hrs at 
4C, beads pelleted by centrifugation, supernatant removed and beads washed in 1ml 
cold IPH buffer 5 times. On the last wash care was taken to remove all supernatant, 
30μL 2x Laemmli Buffer was added to the pelleted beads and samples were boiled 
for 5mins.  Lysates were stored at -20C or used directly for SDS-PAGE. Samples 
were processed as for western blotting.  
2.4.16.4 IP Controls 
MOCK: IP performed with alternative antibody, same isotype. In the case of cMyc 
IP anti-tubulin was used as a control. 
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Bead  Only:  IP  performed  without  antibody.  Controls  for  non-specific  binding  to 
beads.
No  lysate:  IP  performed  with  lysis  buffer  instead  of  cell  lysates.  Allows 
immunoglobulin bands to be unambiguously identified on immunoblots.
2.4.17 Alkaline Phosphatase Staining
Fixative: 65% Acetone
25% Citrate (Solution in kit)
8% Formaldehyde
Stain: From  Alkaline  Phosphatase  (AP)  kit  (Sigma  86R-1KT)  according  to 
manufacturer’s protocol
Adherent mES cells were washed once in PBS and fixed for 45 seconds in fixative. 
Plates were then washed in dH2O and alkaline phosphatase stain added. Plates were 
incubated with the stain for 30 mins in the dark, washed in dH2O and dried. Stained 
colonies were scored by eye using a dissecting microscope. Colonies are classified as 
undifferentiated (AP-positive), mixed or differentiated (AP-negative). 
2.4.18 Immunofluorescence
Expression  of  particular  proteins  in  adherent  cells  was  detected  by immunology. 
Cells were exposed to antibodies recognising the protein of interest and subsequently 
to  fluorescently  labelled  secondary  antibodies  (Alexa).  Staining  was  analysed  by 
fluorescence microscopy. 
Cells were fixed in 4% PFA for 15 minutes, blocked and permeablised in PBS, 0.1% 
Triton x100, 3% Goat/Donkey Serum, 1% BSA. Primary antibodies were incubated 
in the same buffer overnight at 4C. Secondary antibodies were incubated for 1hr at 
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RT. Plates were washed 3 x 15mins in PBS after primary and secondary antibody 
incubations. Nuclei were stained with DAPI. 
2.4.19 ONPG Assay










Expression of β-galactosidase from the Oct4 locus in D027 cells was quantitated in 
an ONPG assay as described (Burdon et al., 1999b). ES cells were plated at 5000 
cells per well in 24-well dishes and cultured for 6 days in the presence or varying 
concentrations of LIF or GCSF-conditioned medium. On day 6, cells were washed 
once with PBS and lysed in 0.4 ml of lysis buffer. Lysate (40μl) was mixed with 
100μl of ONPG buffer in a microtitre plate and incubated at 37°C for 2–4 hrs and the 
absorbance was read at 420 nm. All assays were performed in triplicate.
2.4.20 Luciferase Assay
Lysates  were prepared  as  described in  section  2.3.3.  Luminescence  was assessed 
using the dual luciferase reporter assay system (Promega, E1910). 10μl lysate was 
pipetted  into  a  well  of  a  96-well  plate.  Automated  injection  and  luminescence 
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readings were performed on a GloMax luminometer (Promega).  The luminometer 
was programmed as follows.
Injector 1, LARII: 50μl, 2 sec lag, 10 sec read
Injector 2, Stop and Glo: 50μl, 2 sec lag, 10 sec read
Final values were calculated as the ratio of luciferase to renilla luminescence. Values 
were averaged for 3 biological replicates. 
2.4.21 Flow Cytometry
2.4.21.1 Apoptosis Assay
ES cells cultured in the conditions of interest were harvested by trypsinisation. The 
proportion of apoptotic cells in the population was measured using the AnnexinV 
Apoptosis Kit (BD Biosciences, 556547) according to the manufacturer’s protocol. 
Fluorescence  was analysed  by flow cytometry  using a  Cyan  (DAKO).  Apoptotic 
cells  were  defined  as  those  cells  that  were  PI  negative  and  AnnexinV  positive. 
Unstained cells served as a negative population for calibration. As a positive control 
apoptosis was induced by 4hrs incubation with 4μM camptothecin (Sigma, C9911). 
Annexin  V  only-  and  PI  only-stained  cells  were  used  to  compensate  for  ‘bleed 
through’ between the FITC and PE channels. 
2.4.21.2 Sorting of GFP-positive and -negative cells
ES cells expressing GFP were separated from GFP-negative cells by flow cytometry 
using  a  MoFlo  (DAKO).  Wild-type  cells  were  used  to  set  the  parameters  for 
identification of GFP-positive cells. Dead cells were excluded by sorting for ToPro3-
negative  cells.  GFP-positive  and negative  cells  were  collected  in  the  appropriate 
media in separate tubes, counted and plated as required.
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Chapter 3: Analysis of intracellular signalling 
pathways and inhibitor specificity in three inhibitors 
(3i)
3.1 Introduction
Defined conditions for mouse ES cell culture and derivation were established in 2003 
(Ying et al., 2003a). A serum-free media composition containing the supplements N2 
and  B27,  known as  N2B27 (Ying  and  Smith,  2003),  was  used.  Addition  of  the 
cytokines  LIF  and  BMP4  was  sufficient  for  de  novo  derivation  and  clonal 
propagation of ES cells. If BMP4 is removed from the media the cells will eventually 
undergo  neural  differentiation  while  exposure  to  BMP4  alone  results  in 
differentiation into large, flattened cells of a non-neural lineage (Ying et al., 2003a). 
The  molecular  mechanisms  underlying  the  effects  of  LIF  and  BMP4 have  been 
investigated and the key downstream signalling molecules identified (Niwa et al., 
1998; Burdon et al., 1999b; Matsuda et al., 1999; Ying et al., 2003a). However, it has 
not been possible to derive ES cells from other species using these growth conditions 
and LIF does not support the culture of established hES cells (Thomson et al., 1998; 
Daheron et  al.,  2004; Humphrey et al.,  2004). It is therefore desirable to develop 
alternative culture conditions that will support ES cell  derivation from a range of 
mammalian species, demonstrating cross-species commonalities in ES cell biology, 
if they exist, and allowing researchers to extend their findings from the mouse model 
to rat, human and beyond. To this end our group undertook an examination of the 
effect of several well known pharmacological inhibitors on the self-renewal of mouse 
ES cells. 
3.1.1 Rationale for the study
As discussed in the introduction, many signalling pathways have been implicated in 
the regulation of self-renewal on mES cells. Although fully defined conditions for 
derivation and culture had been established their application was limited to 129 strain 
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mice (Ying et al., 2003a) and had not been successfully applied to any other species. 
The possibility  of developing culture  conditions  based on previous studies  which 
have demonstrated that the manipulation of other signalling pathways can influence 
the efficiency of self-renewal (Burdon et al., 1999b; Sato et al., 2004) was attractive 
to  further  our  understanding  of  pluripotency  and  to  extend  ES  cell  technology 
beyond 129 mice. 
Inhibition of ERK1/2 signalling has been shown to promote self-renewal in several 
previous studies (Burdon et al., 1999b; Buehr and Smith, 2003). In fact, through use 
of a MEK inhibitor ES cells were derived from CBA strain mice (Buehr and Smith, 
2003) without the need for the technically demanding technique of microdissection 
(Brook  and  Gardner,  1997).  Signalling  through  ERK1/2  can  be  activated  by 
cytokines and growth factors including LIF, FGFs and insulin (reviewed in (Katz et 
al., 2007)). It has been shown that altering the balance of LIF signalling in favour of 
Stat3 over ERK1/2 promotes self-renewal (Burdon et al., 1999b; Forrai et al., 2005) 
and pharmacological inhibition of MEK1/2 inhibits differentiation in EBs (Burdon et 
al.,  1999b).  ES  cells  express  FGF4  and  its  deletion  decreases  differentiation  in 
colony forming assays  (Wilder  et  al.,  1997) indicating that  autoinduction of FGF 
signalling  promotes  differentiation.  The MEK-ERK signalling cascade is  a  major 
downstream  pathway  of  FGF  signalling  and  given  what  is  known  about  the 
involvement of ERK1/2 signalling in self-renewal it seems likely that this pathway 
mediates the effect of FGF4. Blockade of the FGF4-MEK-ERK1/2 cascade became a 
focus in our investigations. 
Both  canonical  Wnt  signalling  and direct  inhibition  of  GSK3 have been used  to 
manipulate the in vitro culture of ES cells (Sato et al., 2004; Liu et al., 2006; Ogawa 
et  al.,  2006).  The  identification  of  a  novel  GSK3 inhibitor  named  BIO and  the 
demonstration that it could effect a short-term self-renewal benefit on the culture of 
m- and hES cells (Sato et al., 2004) has been at the centre of investigations largely 
focused  on  the  activation  of  β-catenin  and its  role  in  self-renewal.  Although the 
various studies in the literature fail to agree on the sufficiency of otherwise of β-
catenin activation for self-renewal and all of the studies to date rely on undefined 
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conditions  and often  the  poorly controlled  use  of  pharmacological  inhibitors  and 
conditioned  media  there  is  more  than  enough  evidence  to  justify  an  in-depth 
investigation  of  the  role  of  Wnt  signalling  and  GSK3 in  the  regulation  of  self-
renewal. 
3.1.2 Pharmacological inhibitors in the study of signalling
Signalling pathways can be activated by the provision of cytokines or growth factors 
in  the  culture  media.  The  limitations  of  this  become clear  when considering  the 
complexity  of  signalling.  Any given  growth  factor  might  activate  more  that  one 
molecular pathway and different signalling molecules can activate the same pathway. 
Furthermore, the output of a given pathway is influenced by the context in which it is 
activated;  pathways  may converge on targets  and act  synergistically  or they may 
cross-antagonise  one  another.  Therefore,  in  order  to  dissect  the  components  of 
signalling  pathways  biochemical  and  genetic  tools  must  be  employed. 
Pharmacological inhibitors are designed to target specific molecules to inhibit their 
function.  Inhibition  of  a  pathway  provides  a  complementary  approach  to  its 
activation and as the targets of an inhibitor can be downstream of a receptor and 
specific to a given signalling pathway they allow the different signalling arms to be 
isolated and analysed for their effects.  Inhibitors can also activate signalling if their 
target  molecules  are  themselves  inhibitors,  as  is  the  case  for  GSK3 (Doble  and 
Woodgett,  2003).  Caution  must  be  exercised  when  employing  inhibitors  and 
interpreting  their  effects  because  the  inhibitors  often  interact  with  molecules  not 
intended as their targets (Bain et al., 2007), particularly at high concentrations, and it 
is  impossible  to  know the  effect  of  an  inhibitor  on  all  the  signalling  molecules 
present in a cell. It is desirable therefore to use inhibitors that have been extensively 
characterised with regards to their specificity and where possible controls should be 
provided for the effect of an inhibitor by employing alternative inhibitors of the same 
pathway and genetic controls where the target molecule has been deleted (Bain et al., 
2007). Genetic manipulations are another means of studying signalling. They provide 
an  advantage  over  inhibitor  studies  because,  when  the  appropriate  rescue 
experiments are performed, the effect can be reliably attributed to a specific target 
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molecule. The disadvantage is the technically demanding and time consuming aspect 
of  genetically  modifying  cells  and  organisms.  The  use  of  inhibitors  also  allows 
studies to be carried out in genetically unmodified cells, an important consideration 
when working with the derivation and culture of ES cells. Thus, inhibitor studies and 
genetic manipulations provide complementary methods for the analysis of signalling 
pathways.
3.1.3 Inhibitors of the FGF-MEK-ERK1/2 signalling pathway
The FGF family consists of 22 ligands and 4 receptors (reviewed in (Eswarakumar et 
al., 2005)). ES cells express FGFR-1, -2 and -4 (Chen et al., 2000) and the ligand 
FGF4 (Rathjen et al., 1990; Ma et al., 1992). FGFRs are receptor tyrosine kinases 
(RTKs) and autophosphorylate tyrosine residues on their intracellular domains when 
ligand-bound. Phospho-tyrosine residues act as docking sites to recruit SH2-domain 
containing proteins. Recruitment of phospholipase C (PLC) results in its activation 
and downstream signalling activates Ca2+ release. The PI3K pathway is also activated 
through  the  recruitment  of  Gab1.  Through  Grb2  the  Ras-Raf-MAPK pathway  is 
activated  resulting  in  phosphorylation  and  activation  of  ERK1/2  (reviewed  in 
(Eswarakumar et al., 2005)). Inhibition of the FGFR is predicted to block activation 
of all of these downstream signalling pathways. In this study two structurally distinct 
FGFR  inhibitors  have  been  used  (Fig3.1).  A  class  of  compounds,  pyrido[2,3-
d]pyrimidines, were identified in a screen for inhibitors of FGF and PDGF receptors 
(Connolly, 1997). Modifications of this core identified PD173074 (PD17), a specific 
inhibitor of the FGFR (Mohammadi et al.,  1998). In another screen of chemicals, 
generated by attaching different chemical substituents to an oxindole core, SU5402 
(SU)  was  identified  as  an  inhibitor  of  FGFR1  (Mohammadi  et  al.,  1997).  Both 
inhibitors block autophosphorylation of the receptor in response to ligand binding. 
SU has an IC50 (the inhibitor concentration at which target activity is reduced by 
50%) of 10-20μM while PD17 is more potent with an IC50 of around 25nM. Both 
are reported to inhibit PDGFR at much higher concentrations while PD17 inhibits 
VEGFR at concentrations of 100-200nM. These compounds were used in parallel to 
assess the specificity of the effect for inhibition of the FGFR
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To specifically block activation of ERK1/2 inhibitors of the kinases responsible for 
their phosphorylation and activation, MEK1/2, were employed (Fig3.1). A variety of 
MEK inhibitors  are  commercially  available,  U0126 and PD98059 (PD98) having 
been used extensively in the  past.  PD98 was identified  in an  in  vitro  compound 
library screen for inhibitors of MEK but not ERK itself (Dudley et al., 1995). PD98 
was found to  inhibit  phosphorylation  of  the  downstream ERK target,  MBP, only 
when added to the in vitro system prior to the addition of ERK. This demonstrated 
that its effect was on the upstream kinase, MEK. Further investigation showed that 
PD98 bound to  inactive  MEK and prevented its  activation  by Raf  (Alessi  et  al., 
1995). The inhibitor was found to be specific by its lack of activity against a small 
panel of  in vitro kinases and against MEK homologues  in vivo. PD184352 (PD18) 
and PD0325901 (PD03) are derivatives of PD98 and were chosen for this study as 
both are reported to be more potent and more specific inhibitors of ERK1/2 than 
U0126  or  PD98  (reviewed  in(Bain  et  al.,  2007)).  PD18  is  reported  to  almost 
completely inhibit phosphorylation of ERK1/2 in response to EGF (as judged by the 
absence of detectable phosphorylated ERK1/2 when assessed by immunoblotting) at 
a concentration of 0.5μM, PD03 having a similar effect at just 25nM. Both have been 
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tested against a panel of more than 70 kinases for off-target effects revealing that 
even at higher concentrations none were significantly affected with the exception of 
MEK5. MEK5 was inhibited by PD18 at concentrations of 10-20μM and by PD03 at 
concentrations over 2μM. The kinase panel is by no means exhaustive with more 
than 500 kinases thought to be encoded in the human genome but it goes some way 
towards demonstrating specificity revealing that some widely used compounds have 
significant off-target effects and cannot be used reliably in signalling analysis (Bain 
et al., 2007). 
3.1.4 Inhibitors of GSK3
GSK3 has two isoforms, α and β. They are highly homologous but differ in their C-
terminal domains. Both isoforms are thought to be subject to the same regulatory 
pathways and appear to carry out largely the same functions. However, deletion of 
GSK3β is lethal and embryos die at around day 16 indicating that GSK3α cannot 
fully rescue the loss (Hoeflich et al., 2000). GSK3 has many molecular targets and is 
subject to regulation by multiple signalling pathways. Its cellular functions include 
regulation of glycogen metabolism, cell cycle and proliferation. The implication of 
GSK3 in human diseases including neurological disorders, cancer, bipolar disorder 
and non-insulin-dependent diabetes mellitus has created a great deal of interest in the 
development  of drugs to manipulate  its  function.  However the fact  that  GSK3 is 
involved in so many cellular processes also means that its inhibition is likely to have 
effects beyond those intended therapeutically (Doble and Woodgett, 2003). 
GSK3 is well known as a component of the canonical Wnt signalling pathway. It is a 
component  of  the  β-catenin  destruction  complex  which  also  includes  Axin,  a 
scaffolding protein, adenomatous polyposis coli (APC) and β-catenin itself. In this 
complex GSK3 is constitutively active and phosphorylates β-catenin on a series of 
serine residues, targeting it for ubiquitin-dependent proteolysis. In the presence of 
Wnt  ligands  signalling  through  the  receptor  Frizzled  and  Dishevelled  leads  to 
inactivation of GSK3 through a poorly defined mechanism. As part of the insulin 
signalling pathway GSK3 phosphorylates and inactivates glycogen synthase. Insulin 
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signals  through  PI3K  to  activate  PKB  which  in  turn  phosphorylates  GSK3  on 
Ser9/21 (α/β) (Cross et al., 1995), inactivating it and allowing glycogen synthase to 
become  dephosphorylated.  These  functions  of  GSK3  are  apparently  independent 
since signalling through PI3K does not affect  β-catenin phosphorylation and Wnt 
signalling  does  not  affect  the  insulin  pathway.  This  is  probably  achieved  by 
sequestering a proportion of GSK3 in the destruction complex. Inhibitors of GSK3 
are predicted to affect both pools mimicking canonical Wnt signalling and insulin 
signalling simultaneously. There are many known GSK3 targets not mentioned here 
which will also be affected by GSK3 inhibition (reviewed in (Doble and Woodgett, 
2003)). 
LiCl is the best known of the GSK3 inhibitors but relatively high concentrations are 
required  and  non-specific  effects  have  been  reported  (reviewed  in  (Bain  et  al., 
2007)).  Alternative  small  molecule  inhibitors  have  been  developed  including  the 
compounds  SB216763 (SB21) and SB415286 (SB41) (Smith  et  al.,  2001)  which 
have  been  tested  as  part  of  our  study.  Both have  been  tested  against  a  panel  of 
kinases and have been seen to affect a range of other kinases (Bain et al., 2007). In 
contrast  the inhibitor  CHIR99021 (CHIR, also known as CT99021) (Cline et  al., 
2002),  when  tested  against  the  same  panel  of  kinases  was  shown  to  have  no 
significant effect on any of the kinases tested with the exception of CDK2-CyclinA 
which was inhibited with 50-fold lower potency than GSK3 itself. As CHIR is the 
best characterised of the available GSK3 inhibitors and is recommended as a GSK3 
inhibitor by a group with expertise in GSK3 function and regulation this has been our 
inhibitor  of  choice  for  GSK3.  More  recently  a  novel  GSK3  inhibitor  has  been 
identified  and employed  in  the study of  ES cell  self-renewal  (Sato  et  al.,  2004). 
However questions have been raised over its specificity as it appears to interact with 
the FGFR (Zhen et al., 2007) and to activate Stat3 through an unknown mechanism 
(Ogawa  et  al.,  2006).  The  lack  of  a  thorough  study  on  the  specificity  of  this 
compound discouraged us from including it in our own experiments.  
3.1.5 Three inhibitors (3i)
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Using existing ES cell lines, conditions were established that supported robust self-
renewal and clonal propagation.  Using N2B27 (Ying and Smith,  2003) as a base 
inhibitors  were  added  at  the  following  concentrations:  PD184352 (Davies  et  al., 
2000), 0.8μM; SU5402 (Mohammadi et al., 1997), 2μM; CHIR99021(Cline et al., 
2002), 3μM. This combination of three inhibitors was termed ‘3i’. It was tested for 
its ability to support derivation de novo and lines were readily established from 129 
background mice (Ying et al, in press). After a period in culture these ES cells were 
tested  for  their  ability  to  contribute  to  the  embryo  by  injecting  them  into  host 
blastocysts.  High  contribution  was  observed  as  judged  by  extensive  coat-colour 
chimaerism and contribution to the germ line was confirmed by crossing chimaeras 
and observing transmission of the ES cell genome to the offspring (Ying et al, in 
press). This work provided the platform for analysis of these novel culture conditions 
and the starting point for this thesis.
3.2 Results
3.2.1 3i Supports robust self-renewal of mouse embryonic stem 
cells
ES cells grown in 3i form colonies of tightly packed, rounded up cells that exhibit 
reduced adhesion to gelatine-coated culture dishes. There is little or no evidence of 
spontaneous  differentiation  as  judged  by  the  absence  of  morphologically 
differentiated cells (Fig3.2a). 3i-cultured cells are readily distinguished from those in 
LIF and BMP4 or in serum and LIF which tend to grow in more flattened monolayer 
cultures. An important property of self-renewal is the ability of single cells to give 
rise to undifferentiated colonies (Smith, 2001). To test this rigorously for cells grown 
in 3i single cells were plated in individual wells of 96-well plates using a MoFlo cell 
sorter.  These were incubated  for 10-11 days  and the number  of ES cell  colonies 
formed scored according to expression of GFP under control of the promoter of the 
pluripotency marker Oct4 (Ying et al., 2002)  and/or colony morphology (Fig3.2b). 
3i conditions supported colony formation with efficiency similar to that observed for 
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LIF  and  BMP4  (Fig3.2c,d),  established  ES  cell  culture  conditions  (Ying  et  al., 
2003a). 
Marker analysis  of ES cells grown in 3i confirms that they express pluripotency-
associated genes  Oct4, Nanog and Rex1 but do not express detectable levels of the 
differentiation associated genes Sox1 and Brachyury (Fig3.2e). 
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3.2.2 Analysis of the major signalling pathways in 3i
As discussed in the general introduction many signalling pathways have confirmed 
or proposed roles in the regulation of self-renewal. Here I investigate the activation 
status of these signalling pathways in 3i as compared to other culture conditions. All 
of the experiments are performed on cells grown for at least 24 hours in the indicated 
conditions  and  are  therefore  considered  to  be  steady-state  measurements  of  the 
activation status of the gene or protein in question. This should be the most relevant 
analysis when considering the effect of a pathway on the long-term culture of ES 
cells as opposed to acute responses that occur immediately following changes in the 
culture environment. 
As expected, the level of phospho-ERK (pERK) was reduced by addition of either 
SU or  PD18  (Fig3.3a).  Interestingly,  their  combined  effects  (the  combination  of 
PD18 and SU is  referred  to as  ‘PS’)  at  concentrations  optimised  for cell  culture 
appeared to be synergistic. While either inhibitor used alone resulted in only a slight 
reduction  in  pERK,  together  they  significantly  reduced  pERK  to  levels  just 
detectable  by  immunoblotting.  Thus,  combining  the  inhibitors  had  allowed  their 
concentrations to be reduced which should reduce off-target effects and toxicity of 
the  compounds.  Note  that  CHIR had  no  effect  on  ERK phosphorylation.  These 
results also show that ES cells cultured in N2B27 alone have high levels of ERK 
activity indicating that ERK can be activated independently of added cytokines and 
growth factors or factors contained in serum. This is attributable to production of 
FGF4  by  the  ES  cells  themselves  and  activation  of  the  FGFR  and  downstream 
MAPK signalling (Fig3.4c) (Kunath et al., 2007).
Inhibition of GSK3 is predicted to decrease levels of phosphorylation on a range of 
well  characterised  targets.  Accordingly,  I  found  that  western-blotting  using  an 
antibody  raised  against  NDRG1  (Murray  et  al.,  2004)  showed  loss  of  the 
phosphorylated form as indicated by an increase in electrophoretic mobility and loss 
of the slower migrating band (Fig3.3b). Importantly, neither the presence of LIF and 
BMP4 nor PS affected NDRG1 phosphorylation. Treatment with CHIR also reduced 
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the phosphorylation of β-catenin. However, no significant increase in the levels of 
total β-catenin could be detected (Fig3.3c) as might have been predicted since the 
loss  of  GSK3-mediated  phosphorylation  stabilises  β-catenin  (Doble  et  al.,  2007). 
This  is  likely  to  reflect  the  fact  that  a  large  proportion  of  cellular  β-catenin  is 
incorporated into adherens junctions (reviewed in (Bienz, 2005)) and the increase in 
β-catenin caused by GSK3 inhibition does not reflect a significant increase in total β-
catenin.  The stabilisation and nuclear  accumulation of β-catenin can be tested by 
assaying the activation of the TCF/LEF-sensitive luciferase reporter, TOPFlash. β-
catenin  accumulating  in  the  nucleus  interacts  with  TCF/LEF  TFs  to  activate 
transcription and this can be clearly seen in the dose-dependent response of the TCF/
LEF reporter to CHIR (Fig3.3d). Note that 3μM CHIR, the concentration used in 3i, 
does not maximally activate the TCF/LEF reporter indicating incomplete inhibition 
of GSK3. Given that the CHIR concentration was optimised for ES cell propagation 
this  implies  that  optimal  self-renewal  may  occur  when  GSK3  is  only  partially 
inhibited. 
The  PI3K  signalling  pathway  is  an  important  cell  survival/proliferation  signal 
(Takahashi  et  al.,  2005)  and  has  also  been  implicated  in  the  inhibition  of 
differentiation in m- and hES cells (Paling et al., 2004; Watanabe et al., 2006). PKB 
is phosphorylated in a PI3K-dependent manner on Ser473 (Alessi et al., 1996). An 
antibody that specifically recognises this phosphorylated form can therefore be used 
as  an  indicator  of  PI3K activity.  Little  variation  was  observed  in  the  degree  of 
steady-state pPKB indicating that the inhibitors did not influence the level of PI3K 
activity in this context (Fig3.3e). The high levels of basal PI3K phosphorylation can 
be attributed to the inclusion of insulin in the media as a component of N2 and B27. 
Removal of insulin and B27 from the media results in a severe reduction in pPKB 
and reveals that in this context the PI3K pathway becomes responsive to the MEK 
inhibitor PD03 (Fig3.3f). The increase in pPKB phosphorylation is likely to result 
from  a  loss  of  negative  feedback  signalling  from  activated  ERK  which  inhibits 
activation of the PI3K and MAPK pathways downstream of FGFRs (Lax et al., 2002) 
(see discussion). PI3K can be activated by multiple signalling pathways. In ES cells 
FGF4  produced  by  the  cells  themselves  (see  section  3.2.3)  could  activate  PI3K 
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through FGF receptors. To test the contribution of this the potent FGFR inhibitor, 
PD173074, was used. Reduction of pERK confirmed that the FGFR was effectively 
inhibited  but  there  was  no  effect  on  basal  or  insulin-stimulated  pPKB  levels 
(Fig3.3f). This suggests that FGFs do not play a significant role in the activation of 
PI3K and that ES cells possess FGF- and insulin-independent PI3K activity, perhaps 
through  Eras  (Takahashi  et  al.,  2003).  However,  the  upregulation  of  pPKB  in 
response to PD03 is abolished by PD17 (Fig3.3f) demonstrating that FGF signalling 
is required for this response. PS had no discernible effect on pPKB in the presence or 
absence of insulin (Fig3.3f) in agreement with the effect of combining the alternative 
MEK- and FGFR-inhibitors PD03 and PD17. Note the difference in pPKB activity 
between PD03 and PS (ie. 2i and 3i) indicates that these two media compositions do 
not behave identically although phenotypically there is little difference.
GSK3 is inhibited by phosphorylation on residues serine 9 (GSK3β) and 21 (GSK3α) 
(Ser9/21) (Doble and Woodgett, 2003). These residues are phosphorylated by PKB 
(Cross et al., 1995) and p90RSK (Saito et al., 1994) placing GSK3 downstream of 
PI3K and MAPK signalling, respectively. Inhibition of MAPK signalling by PS or 
PD03  may  therefore  have  affected  GSK3  activity.  However,  although  phospho-
Ser9/21 was readily detected, levels of phosphorylation were largely unaffected in 
steady-state cultures in the presence of the inhibitors (Fig3.3g). Counter-intuitively, 
Ser9/21 phosphorylation appeared to be slightly elevated in the presence of PD03. 
This may reflect increased PKB activity as anticipated from the observed increase in 
PKB-Ser473 phosphorylation in the presence of PD03 (Fig3.3f). CHIR appeared to 
reduce the total amount of GSK3 present in the cells while LIF had little discernible 
effect  on  total  GSK3 or  on  phosphorylation  levels  (Fig3.3g).  The  basal  level  of 
GSK3 phosphorylation  is  likely  attributable  to  active  PI3K signalling,  driven  by 
insulin present in N2B27. 
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3.2.3 The effect of SU5402 and PD184352 is mediated through 
inhibition of the FGF4-MEK-ERK signalling pathway 
As discussed above, a major concern in the use of pharmacological inhibitors is off-
target  effects  (Bain  et  al.,  2007).  To  have  confidence  in  the  interpretation  of 
experiments  employing  these  inhibitors  researchers  should  test  alternative, 
structurally distinct inhibitors of their pathway in expectation that the results will be 
the same and should demonstrate that the effect of the inhibitor is dependent on the 
presence  of  the  molecular  target  by  complementary  genetic  studies.  To  this  end 
alternative inhibitors have been used for each of the three included in 3i  and the 
phenotype of ES cells either lacking the molecular target or with decreased levels of 
activity in the pathway in question examined. 
The FGFR inhibitor  SU is included in 3i  at  a concentration of 2μM. I  examined 
whether an alternative inhibitor of the FGFR, PD17, could substitute for SU. I found 
that PD17 could substitute for SU at significantly lower concentrations, consistent 
with  its  higher  potency.  Furthermore,  PD17  appeared  sufficient  to  replace  PS, 
supporting self-renewal in combination with CHIR (Fig3.4a), even at the single cell 
level (Fig3.2c). The sufficiency of PD17 likely reflects its potent inhibition of the 
FGFR and the significant down-regulation of pERK observed even at relatively low 
concentrations (Fig3.4b). However, colonies formed in the presence of PD17 tended 
to  be smaller,  perhaps  indicating  that  PD17 affects  the  activity  of  pathways  that 
promote ES cell growth or exhibits a degree of non-specific toxicity.  An obvious 
candidate is PI3K which is activated downstream of the FGFR (see discussion). 
ERK1/2  signalling  can  be  activated  by  a  range  of  cytokines  and  growth  factors 
including LIF (Burdon et al., 1999b) and FGFs (reviewed in (Eswarakumar et al., 
2005)).  The  effect  of  FGFR  inhibitors  on  ERK  activation  in  defined  conditions 
strongly  suggests  that  FGF  ligands  are  largely  responsible  for  activation  of  this 
pathway. FGF4 is expressed by ES cells (Rathjen et al., 1990; Ma et al., 1992) under 
the control of the pluripotency-associated TFs Oct4 and Sox2 (Yuan et al., 1995) and 
I sought to examine whether this is responsible for the high background levels of 
pERK observed in ES cells. ES cells lacking Fgf4 have been generated (Wilder et al., 
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1997) and I assessed their molecular and phenotypic properties in defined growth 
conditions.  Levels  of  pERK  were  significantly  lower  in  Fgf4-null  than  in 
heterozygote ES cells and the activation of pERK by the addition of LIF indicated 
that these cells  were not unable to activate ERK and that the reduction in pERK 
could be attributed to the absence of FGF4  (Fig3.4c). The reduced ERK activity 
predicts that the requirement for SU and PD18 should be reduced and indeed Fgf4-
null ES cells could readily be propagated in CHIR alone while heterozygote controls 
underwent differentiation (Fig3.4d) and could not be maintained long-term in CHIR 
alone.  No  clear  difference  was  discernible  between  null  and  heterozygote  lines 
grown in LIF and BMP4 or in 3i  indicating that the heterozygote cells  were not 
inherently compromised in their ability to self-renew. These findings were supported 
by the observation that  Fgf4-null cells formed colonies from single cells in CHIR 
alone with much higher efficiency than heterozygote controls (Fig3.4e).  
Further  support  for  the  specificity  of  SU  and  PD18  for  the  FGF-MEK-ERK 
signalling cascade came from the use of a more potent inhibitor of MEK, PD03 (Bain 
et al., 2007). PD03 blocked the activation of ERK similarly to PS when used alone at 
a concentration of around 1μM (Fig3.4f). Accordingly, the addition of 1μM PD03 
and 3μM CHIR to N2B27 in the absence of FGFR inhibitors supported self-renewal 
of ES cells with a similar efficiency to 3i as judged by single-cell colony formation 
(Fig3.2c,d) and long-term bulk culture (Fig3.4g). This combination of inhibitors is 
termed ‘2i’. The removal of the requirement for FGFR inhibition demonstrates that 
inhibition of other signalling pathways activated by the FGFR is not critical for self-
renewal in 3i and that the key downstream targets are likely to be ERK1/2.
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3.2.4 The inhibitor CHIR99021 specifically targets GSK3
To  inhibit  GSK3  CHIR99021,  the  best  characterised  and  most  specific  of  the 
available GSK3 inhibitors (Murray et al., 2004; Bain et al., 2007), was used. As a 
control  for  the  specificity  of  the  phenotype  for  GSK3  two  alternative  GSK3 
inhibitors,  SB21  and  SB41  (Smith  et  al.,  2001),  were  tested  for  their  ability  to 
promote self-renewal  in  combination  with PS. ES cells  were cultured in  PS plus 
SB21 or SB41 at a range of concentrations and assessed by morphology and growth 
rate to establish the most effective concentration. SB21 was found to support self-
renewal at a concentration of approximately 4μM, the ES cells acquiring a similar 
morphology to those grown in 3i and retaining expression of pluripotency markers 
(Fig3.5a).  At higher concentrations of SB21 the colonies formed were smaller and 
the cells proliferated poorly upon passaging. In contrast,  SB41 had no discernible 
effect on cellular phenotype. Both compounds were tested for their ability to activate 
the  TCF/LEF  reporter.  SB41  failed  to  activate  the  reporter  even  at  higher 
concentrations (Fig3.5b). It is not clear why it had no effect but these results explain 
the lack of a cellular phenotype. SB21 produced robust activation of the TCF/LEF 
reporter in a dose-dependent manner (Fig3.5b). Notably, the concentration optimised 
for cell culture activates TCF/LEF to a similar degree to 3μM CHIR suggesting that 
incomplete GSK3 inhibition is optimal for self-renewal. 
ES cells  have  been  engineered  that  have  both  alleles  of  both isoforms  of  GSK3 
targeted and do not therefore express any functional GSK3 – they are referred to as 
double knockout (DKO) cells (Doble et al., 2007). Their study revealed considerable 
redundancy  between  the  two  GSK3  isoforms  with  a  clear  phenotype  becoming 
apparent only when 3 of the 4 alleles had been inactivated. These cells provide an 
excellent control for the effect of CHIR. However, the lack of GSK3 confers a strong 
phenotype on the cells. They have highly elevated levels of β-catenin (Doble et al., 
2007) (Fig3.5c) and correspondingly high tonic expression of β-catenin/TCF target 
genes  Axin2, Brachyury and  Cdx1, and highly elevated TCF/LEF reporter activity 
(Doble  et  al.,  2007)  (Fig3.5d).  The  cells  have  a  highly  refractile,  tightly  packed 
colony morphology and although it is not mentioned by the authors they have a high 
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degree  of  spontaneous  differentiation  with  differentiated  cells  surrounding  the 
undifferentiated colonies (Fig3.5e). Paradoxically,  the cells resist differentiation in 
EBs with Oct4 and Nanog expression persisting long after they have been lost from 
wild-type controls  (Doble et al., 2007). In accordance with this DKO cells could be 
passaged  several  times  in  the  absence  of  cytokines  (Fig3.5e) but  could  not  be 
maintained indefinitely. In a range of other conditions tested including the standard 
LIF and BMP4 the cells could be cultured long-term but spontaneous differentiation 
was always high (Fig3.5e; 3.6.1a,b). It was predicted that in the absence of GSK3 the 
requirement for CHIR would be lost in 3i or 2i culture and that the cells would self 
renew in PS or PD03 alone. Indeed, it was found that spontaneous differentiation was 
eliminated by inhibition of the MEK-ERK signal (Fig3.5f; 3.6.1a,b) and that long-
term cultures could be maintained. The emergence of differentiated cells from the 
refractile  colonies,  a  high  proportion  of  which  were  found to  be  Gata4  positive 
(Fig3.6a,b), was not evident in the presence of PS or PD03 (Fig3.6a,b). However, 
DKO cells grew more slowly under these conditions than wild-type cells cultured in 
3i and appeared to be more readily maintained when cell density was kept relatively 
high. This suggests that the cells were in some way compromised by the absence of 
GSK3. This may be attributable to the elevated levels of β-catenin and associated 
high rates of transcription of differentiation-associated genes. To stringently test the 
capacity of these cells for self-renewal clonal density colony forming assays were 
performed.  DKO cells  formed undifferentiated colonies in N2B27 alone or in PS 
(Fig3.5g). This clearly demonstrates the self-renewal phenotype resulting from loss 
of GSK3 since wild-type ES cells undergo differentiation in N2B27 alone and cannot 
be cloned efficiently  in  PS alone (see chapter  4).  As expected,  PS increased the 
proportion  of  totally  undifferentiated  colonies,  indicating  that  differentiation  was 
inhibited.  Interestingly,  self-renewal  was  enhanced  by  the  addition  of  LIF  to  PS 
(Fig3.5g) or PD03 (Fig3.6b) demonstrating that LIF can activate signalling pathways 
that  promote  self-renewal  independently  of  GSK3  and  that  DKO  cells  are  not 
intrinsically compromised by the absence of GSK3. Addition of CHIR to these cells 
had no discernible effect on the cellular phenotype or on TCF/LEF reporter activity 
(Fig3.5d) and did not enhance colony forming efficiency (Fig3.5g) indicating that its 
effect on wild-type cells was dependent on the presence of GSK3. 
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3.2.5 Embryonic Stem Cell Self-Renewal in 3i is LIF and BMP4 
Independent
To date two signalling pathways have been clearly demonstrated to be capable of 
supporting  self-renewal:  LIF-STAT3  (Niwa  et  al.,  1998;  Burdon  et  al.,  1999b; 
Matsuda  et  al.,  1999)  and  BMP-Id  (Ying  et  al.,  2003a).  I  investigated  whether 
signalling through these pathways is required for self-renewal in 3i. 
BMP4 is added to serum-free ES cell cultures to prevent neural commitment. It has 
been demonstrated that induction of  Id genes through BMP-Smad1/5 signalling is 
sufficient to mediate this effect (Ying et al., 2003a) but it has also been suggested 
that BMP signalling results in a reduction in ERK and p38 activity and that this is 
responsible  for  the  pro-self-renewal  effect  of  BMP4  (Qi  et  al.,  2004).  Both 
possibilities  were investigated  in  the context  of 3i.  Transcript  levels  of  Id1 were 
significantly lower in 3i than in LIF and BMP4 (Fig3.7a). It has previously been 
shown that PD18 or SU can replace the requirement for BMP4 (Ying et al, in press). 
The effect of PS on Id expression was therefore assessed. Reduced phospho-ERK 
clearly shows that the inhibitors are active but there was no evidence of any effect on 
Id expression (Fig3.7b). Similarly, Id levels were clearly increased in the presence of 
BMP4  but  BMP4  had  no  effect  on  the  steady  state  levels  of  ERK  or  p38 
phosphorylation  compared  to  N2B27  or  LIF  alone  (Fig3.7b).  Therefore  these 
pathways are unlikely to be effectors downstream of BMP signalling, consistent with 
previous conclusions (Ying et al., 2003a).
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Prior to commencing this project it had already been shown that ES cells grown in 3i 
do not have detectable levels of phosphorylation on Tyr705 of STAT3 (Ying et al, 
submitted).  Phosphorylation  at  this  site  is  considered  essential  for  canonical 
activation of STAT3 (reviewed in (Darnell et al., 1994)) but it has been reported that 
STAT3 phosphorylation at Ser727 can promote self-renewal in mouse NS cells and 
hES cells  (Androutsellis-Theotokis  et  al.,  2006).  I  therefore  undertook to  further 
investigate the requirement for LIF-Stat3 in 3i by genetic methods.  Cells lacking the 
LIFR  (Hyg34)  are  normally  maintained  in  the  presence  of  IL6  and  its  soluble 
receptor which engage the gp130 receptor and activate STAT3 (Yoshida et al., 1996; 
Dani et al., 1998). These cells differentiate in LIF but are readily maintained in 3i. 
RT-PCR analysis of marker expression in ES cells maintained in LB, 3i or IL6 shows 
that  pluripotency  markers  are  down-regulated  in  LB,  as  expected,  while  the 
differentiation  marker  Brachyury is  upregulated  (Fig3.8a). In  contrast,  cells 
maintained  in  3i  or  IL6  remained  undifferentiated. This  demonstrates  that  cells 
grown in 3i do not depend on paracrine LIF signalling. Socs3 is a well characterised 
transcriptional  target  of  STAT3 (Auernhammer  et  al.,  1999).  Real-time  PCR for 
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steady state levels of the Socs3 transcript revealed that they were significantly lower 
in 3i than in LIF and BMP4 (Fig3.8b), indicating reduced activity of STAT3. 
As there remains the possibility that STAT3 has functions separate from its role as a 
TF we attempted  to  derive ES cells  carrying  a  deletion  of  the  Stat3  gene.  Mice 
heterozygous for  Stat3 were crossed, ICMs isolated from expanded blastocysts and 
plated  on  a  feeder  layer  of  MEFs  in  3i  (derivation  and initial  cell  culture  by J. 
Nichols,  Ying  et  al,  in  press).  Several  lines  were  isolated  and  PCR  genotyped 
revealing  several  heterozygous  and  one  homozygous  null  line  (Fig3.8c).  One 
heterozygous and the homozygous null line were used for further analysis. A wild-
type line established independently from the same mouse strain (J. Nichols) served as 
a  further  control.  To  confirm  the  absence  of  STAT3  from  these  cell  lines 
immunoblotting was performed. STAT3 was undetectable in the null line and the 
heterozygous line expressed low levels of STAT3 compared to the wild-type control. 
Similar  levels  of  Oct4  in  all  of  the  lines  (Fig3.8d) indicated  that  they  remained 
undifferentiated. Morphologically, the lines were indistinguishable when maintained 
in 3i and all  exhibited reduced substrate attachment necessitating their  growth on 
feeders or on laminin. The fact that they can be maintained on laminin demonstrates 
that the feeder layer is not strictly required to maintain these ES cells and that 3i 
culture  conditions  are  sufficient.  Stat3 heterozygous  and  null  cells  grown  in  3i 
retained expression of pluripotency markers as judged by immunostaining for Oct4 
(Fig3.8e) and RT-PCR analysis of pluripotency markers (Fig3.8f). 
As further indication of the loss of STAT3 activity transcriptional responses to LIF 
were examined by real-time PCR. While heterozygous cells upregulated both Socs3 
(STAT3 target) and Egr1 (ERK target (Weinhold et al., 2000)) in response to LIF, 
null cells upregulated only  Egr1 (Fig3.8g) indicating that the ERK signalling arm 
was left intact while STAT3 signalling was abolished. When transferred to standard 
ES cell growth conditions (serum plus LIF on MEFs) the wild-type line efficiently 
formed  undifferentiated  colonies  while  both  the  heterozygous  and  null  lines 
underwent  rapid  differentiation  and  failed  to  give  rise  to  any  morphologically 
undifferentiated  colonies  (Fig3.8h).  This  indicates  that  Stat3  exhibits 
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haploinsufficiency, presumably because the lower levels of Stat3 observed in these 
cells (Fig3.8d) are not sufficient to balance the differentiation-inducing MEK-ERK 
signal.  Low  STAT3  levels  in  the  heterozygous  cells  may  be  confounded  by 
maintenance in 3i where expression levels of STAT3 were observed to be lower in 
wild-type cells when compared to LIF-containing culture conditions (Fig3.8d). Stat3 
is a transcriptional target of STAT3 itself so transcription is likely to be lower in 3i 
where STAT3 is inactive (Fig3.8b) (Ying et al, in press).
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As a test of pluripotency in vitro differentiation of Stat3-null ES cells was examined. 
In  suspension,  in  the  presence  of  serum  EBs  were  allowed  to  form  and  were 
harvested at days 3 and 6 for RNA isolation. Real-time PCR indicated up-regulation 
of  the  lineage  associated  genes  Brachyury  (T,  marker  of  early  mesoderm 
progenitors), and Gata-4 and 6 (markers of endoderm) as the pluripotency associated 
genes, Oct4, Nanog and Rex1 were down-regulated (Fig3.8.1a). Formation of EBs in 
serum-free conditions for approximately 10 days and plating onto laminin resulted in 
neuronal differentiation as indicated by immunostaining for the neuronal marker β-
III Tubulin (Tuj1) and the clear neuronal morphology (Fig3.8.1b). Plating on gelatine 
in the presence of EGF and FGF2 after 10 days of serum-free suspension culture 
allowed derivation of neural stem (NS) cells (Conti et al., 2005) from Stat3-null ES 
cells.  Genotyping  by PCR (Fig3.8.1c) and immunoblotting  (Fig3.8.1d)  confirmed 
that the NS cells did not express STAT3. The NS cells were assessed for expression 
of a panel of immunohistochemical markers whose expression are associated with 
NS cell  phenotype  (Conti  et  al.,  2005)  (Fig3.8.1e,f).  The  cells  were  positive  for 
Nestin,  Blbp,  Rc2  and  Sox2,  had  morphology  typical  of  adherent  NS  cells  and 
proliferated rapidly.  Stat3-null NS cells could provide a tool to examine the role of 
STAT3 in NS cells  themselves and in differentiation into neurons, astrocytes  and 
oligodendrocytes. 
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3.2.6 Are N2 and B27 Supplements Absolutely Required for Self-
Renewal?
As  a  base  for  our  serum-free  culture  systems  the  media  N2B27  is  used.  To  a 
combination  of  commercial  medias,  Neurobasal  and  Dulbecco’s  Modified  Eagle 
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Medium (DMEM): F12, the commercial supplement B27 and an in house- prepared 
N2 (see materials and methods for composition) are added. N2 contains hormonal 
components capable of activating signalling pathways in the cell and while there is 
little  evidence  in  the  literature  to  suggest  that  these  widely  used  supplements 
influence anything other than the growth and survival of the cells it is quite possible 
that in certain contexts the signalling pathways they activate become instructive in 
cell fate decisions. N2 contains high levels of insulin which activates PI3K signalling 
(Fig3.3e,f)  through binding  to  its  cognate  receptor  (reviewed in  (Hawkins  et  al., 
2006)) resulting in activation of downstream pathways known to be involved in cell 
cycle  and  proliferation  and  implicated  in  ES  cell  self-renewal  (Takahashi  et  al., 
2005). Previous work shows that despite significantly decreased viability ES cells 
can be maintained in a basal media, supplemented with BSA and transferrin, that 
does not contain insulin, for at least one month (Ying et al, in press) although under 
these conditions the cells show increased sensitivity to the inhibitors and reduced 
concentrations of PD18 (0.5μM) and SU (1μM) were used. This demonstrates that 
insulin is not strictly required for self-renewal. 
B27 contains a range of defined components including free radical scavengers and 
anti-oxidants. I found that ES cells could be propagated long term in 3i when B27 
was removed from the media (Fig3.9a) but that clonal propagation was not possible 
(Fig3.9c,d). As our cells are routinely grown in atmospheric oxygen they are likely to 
be subject to oxidative stress. Colony forming efficiency at oxygen concentrations 
closer  to  physiological  levels  (5%)  was  tested.  Significantly,  clonal  propagation 
became possible in the absence of B27 (Fig3.9c,d) with two independent cell lines. 
Oct4GIP ES cells retained expression of their  GFP transgene (Fig3.9b) indicating 
that  the  colonies  formed  remained  undifferentiated.  I  conclude  that  B27  is  not 
required for self-renewal but enhances viability, particularly when oxygen levels are 
high. 
In  the  absence  of  B27 the  media  contains  only  the  N2 supplement.  N2 is  fully 
defined with the exception of bovine serum albumin (BSA) fraction V. To eliminate 
the  possibility  that  undefined  components  of  BSA  affect  self-renewal  BSA  was 
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replaced with recombinant human serum albumin (rHSA) and the cloning efficiency 
of  E14  IV  C  ES  cells  (a  subclone  of  E14Tg2a  recently  tested  for  germ-line 
competency)  assessed. As B27 was excluded from the media the experiment  was 
performed under low O2 conditions. Colonies with ES morphology were obtained 
using BSA or rHSA (Fig3.9f). Notably, clonogenicity was enhanced in media with 
rHSA  as  compared  to  BSA  (Fig3.9e).  This  may  reflect  a  degree  of  toxicity  of 
undefined components in BSA. It was also possible to maintain long-term cultures in 
the defined media supplemented with PD03 and CHIR (2i). E14 IV C ES cells were 
cultured  for  6  passages  in  a  low O2 incubator.  Although  proliferation  was  slow 
relative  to  cells  cultured  in  full  complement  N2B27 there  was  little  evidence  of 
differentiation  and  immunostaining  revealed  that  the  cells  retained  expression  of 
Oct4 and Nanog (Fig3.9.1a). 
Colony forming efficiency was also examined in the absence of insulin (and B27), 
using reduced concentrations of PD03. Surprisingly, colonies formed with reasonable 
efficiency in the absence of insulin (Fig3.9e) indicating that insulin is not required 
for  clonal  ES  cell  growth.  Once  again,  the  efficiency  of  colony  formation  was 
slightly higher in media containing rHSA as compared to BSA. Colonies formed in 
the absence of B27 and/or insulin tended to be much smaller than those formed in 
full N2B27 media (Fig3.9f), probably reflecting a lower proliferation rate. Given that 
the  clonal  growth  of  ES  cells  in  the  absence  of  B27  and  insulin  is  somewhat 
unexpected  some  of  the  colonies  that  had  formed  were  passaged  to  assess  their 
ability  to  expand.  Upon  passaging,  colonies  with  ES  cell  morphology  formed 
(Fig3.9.1b) but expanded extremely slowly and were not maintained beyond passage 
3. The poor expansion of ES cells under these growth conditions appeared to result 
from a decrease in viability and proliferation rather than differentiation. The colonies 
remaining  at  passage 3 expressed Oct4 and Nanog as judged by immunostaining 
(Fig3.9.1c). Together, these data indicate that the supplements included in N2B27 
serve to reduce oxidative stress and to enhance clonogenicity and cell proliferation 
but that they are not absolutely required for self-renewal.
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3.3 Discussion
With proven ES cell culture conditions as a starting point I set out to characterise 
cells grown under these conditions with respect to signalling pathways previously 
implicated in ES cell self-renewal and to establish confidence in the mode of action 
of  the  three  pharmacological  inhibitors  used  in  3i.  It  is  significant  that  the 
concentrations of inhibitors employed were optimised for ES cell culture before they 
were characterised by molecular biology. This approach means that there were no 
initial  biases  or  assumptions  directing  the  concentrations  or  combinations  of 
inhibitors used. For example,  CHIR is used at a dose that activates the TCF/LEF 
luciferase reporter sub-maximally but this became apparent only in retrospect. 
3.3.1 3i supports robust self-renewal of ES cells
ES colonies in 3i assume a rounded morphology more typical of ES cells grown on 
feeders and often cited as a desirable quality in ES cell culture. When isolated single 
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cells are plated they form undifferentiated colonies with similar efficiency to cells 
plated in LIF and BMP4 in side-by-side experiments.  Together with the previous 
demonstration  that  these  conditions  support  derivation  and  culture  of  germ-line 
competent ES cells (Ying et al, in press) it is clear that 3i satisfies the criteria for 
sufficiency for self-renewal (Smith, 2001). 
3.3.2 Signalling pathway activation in 3i
As an initial analysis of signalling pathway activity western blots were performed to 
assess activity in key proteins in these pathways. All three inhibitors affected their 
targets as predicted. Significantly, a combination of PD18 and SU (PS) appeared to 
mediate  potent  inhibition  of  ERK  phosphorylation  at  concentrations  that  had 
relatively little effect  independently.  I surmise from this that  to achieve the same 
phenotypic  effect  with  either  PD18  or  SU  alone  it  would  be  necessary  to  use 
significantly  higher  concentrations,  increasing  the  chances  of  off-target  and toxic 
effects on the cells.  Toxicity has previously been noted by our group for the less 
potent  MEK  inhibitors  PD98059  and  U0126  and  may  explain  why  it  has  not 
previously been possible to establish growth conditions based on MEK inhibition. 
Thus PS may provide a sufficient level of ERK inhibition while minimising negative 
effects of the two inhibitors on ES cell culture. CHIR blocked phosphorylation of its 
well characterised targets, NDRG1 and β-catenin, and induced activation of the TCF/
LEF reporter  construct.  Note that  the concentration of CHIR used in cell  culture 
(3μM)  does  not  maximally  activate  the  TCF/LEF  reporter  implying  that  GSK3 
activity is not totally blocked. In support of this, cells lacking GSK3 (DKO cells) 
grew less well in MEK inhibitor or PS alone than wild-type cells cultured in 3i or 2i. 
This may be attributable to the elevated activity of canonical Wnt targets in these 
cells. 
Phosphorylation  of  PKB was high in  all  insulin-containing  media  tested  with no 
evidence that the inhibitors affected its activity with the exception of PD03 which 
caused increased phosphorylation of PKB. While it cannot be ruled out that PI3K 
activity is required for self-renewal from these experiments note that cells cultured in 
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the absence of inhibitors in N2B27 have high PI3K activity but undergo efficient 
neural  commitment  (Ying  et  al.,  2003b)  and  that  3i  mediates  inhibition  of 
differentiation without significantly altering levels  of PKB activity.  I have shown 
that PI3K signalling is activated by insulin in serum-free culture conditions. A non-
essential role for insulin in self-renewal is supported by the observation that in its 
absence ES cells can be propagated in 3i for at least one month and can form clones 
from single cells albeit with reduced clonogenicity and growth rate. However, the 
removal of insulin from the media does not mean that the PI3K pathway becomes 
inactive. The data provided in this chapter indicate that MEK-inhibition results in 
increased  PKB  phosphorylation  in  the  absence  of  insulin.  ES  cells  have  some 
constitutive activation of this pathway as a result of the activity of ES cell-specific 
Ras, Eras (Takahashi et al., 2003) and PI3K may also be activated by FGF4 through 
the FGFR (reviewed in (Eswarakumar et al., 2005)). The effect of FGFR inhibition 
proved to be informative. In insulin-containing or insulin-free media PD17 alone had 
no effect indicating that activation of PI3K through the FGFR was not significant in 
this  context  and that  phosphorylation  of PKB was likely to be FGF-independent, 
probably resulting from Eras activity (Takahashi et al., 2003). However, when PD17 
was added together with PD03 it abolished the upregulation of pPKB. This shows 
that the effect of the MEK inhibitor is dependent on activation of the FGFR and 
probably reflects autoregulation of MAPK signalling. It has been shown that ERK 
can phosphorylate  the docking protein FRS2α on threonine residues and that this 
negatively  regulates  the  interaction  with  Grb2  and  hence  coupling  to  PI3K  and 
MAPK pathways through Gab1 and Sos respectively (Lax et al.,  2002) (Fig3.10). 
Thus, MEK inhibitors will decrease ERK activity and FRS2α phosphorylation, and 
increase activity immediately downstream of the FGFR. This suggests an explanation 
for  the increase in  PKB activity  in  response to PD03 but  not  PD17.  While  both 
inhibitors  reduce  ERK  activity,  PD17  directly  inhibits  the  FGFR  and  hence  its 
interaction with FRS2α, blocking activation of both PI3K and MAPK pathways.
Elevated PKB activity is likely to be responsible for the modest increase in GSK3 
phosphorylation observed in the presence of PD03. Notably, however, GSK3 Ser9/21 
phosphorylation  is  largely  unaffected  by  other  inhibitors  or  by  LIF  under  these 
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conditions.  This suggests that their effects are not mediated through regulation of 
GSK3 activity.  However,  the slight  decrease  in  GSK3 activity  anticipated  in  the 
presence of PD03 may in part explain small  phenotypic differences between cells 
cultured in PD03 and PS (see chapter 4). 
These  observations  pave  the  way  for  further  investigation  of  ERK  and  PKB 
signalling in ES cells. I predict that the basal levels of pPKB will be abolished in 
Eras-/- ES cells (Takahashi et al., 2003) and that upregulation of pPKB in response 
to MEK inhibition will  be reduced or abolished in  Fgf4-/-  ES cells.  It should be 
possible to correlate the activity of PI3K with insulin-dependence for growth and 
survival. It is anticipated that upregulation of PI3K signalling in response to MEK 
inhibition is a significant factor in the insulin-independent growth observed in 2i and 
that such a phenotype would not be observed in Fgf4-/- ES cells or in 3i where PKB 
activity is not upregulated. These experiments will be addressed in the near future. 
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Several attempts were made to directly investigate the role of the PI3K pathway in 
ES cell self-renewal. The PI3K inhibitor, LY294002, and the PKB-specific inhibitor, 
AKT-I1/2, both killed ES cells rapidly in serum-free conditions and cultures could 
not be maintained in their presence. Differentiation was not evident in the cultures 
but  the  degree  of  cell  death  made  it  impossible  to  interpret  the  effects  of  these 
inhibitors. As a further test of the requirement for this pathway I also attempted to 
culture Pdk1-/- ES cells which cannot activate PKB. While these cells were readily 
maintained  in  serum-containing  media,  when transferred to  serum-free conditions 
most  cells  died  and  the  cultures  could  not  be  passaged.  Again,  although 
differentiation was not evident, it was impossible to determine whether the cells that 
were  dying  would  have  undergone differentiation.  Clearly,  investigation  of  PI3K 
signalling as a self-renewal signal presents a significant problem. Its established role 
in anti-apoptotic and pro-proliferative pathways means that its inhibition promotes 
cell death and it is difficult to assess whether a dead cell will self-renew or commit to 
differentiation. 
3.3.3 Inhibitor Specificity
Establishing  the  specificity  of  the  pharmacological  inhibitors  is  essential  if  the 
mechanisms governing self-renewal are to be elucidated, especially given the heavy 
reliance on a combination of three for this study. I have established that the major 
pathway activating  ERK1/2  in  cells  cultured  without  added  cytokines  or  growth 
factors is activation of the FGFR by FGF4 produced by the ES cells themselves. In 
ES cells lacking Fgf4 neither FGFR inhibitors nor MEK inhibitors were required for 
propagation of the cells. This clearly indicates that the target of PS is the FGF-MEK-
ERK pathway.  The  possibility  that  the  FGFR inhibitors  were  required  to  inhibit 
another pathway downstream of the FGFR is excluded by the demonstration that a 
potent  MEK  inhibitor,  PD03,  can  substitute  for  PS  demonstrating  that  direct 
inhibition of the FGFR is not required for efficient self-renewal. This is supported by 
work on ES cell differentiation which shows that ES cells lacking Fgf4 or Erk2 are 
similarly compromised in their ability to initiate differentiation and that inhibitors of 
MEK or the FGFR can inhibit ES cell differentiation (Kunath et al., 2007). 
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In the case of GSK3 cells were made available to us that are null for both isoforms of 
GSK3. The critical observation is that CHIR has no effect on these cells and that it is 
no  longer  required  to  obtain  a  3i-like  phenotype.  However,  the  high  degree  of 
background  differentiation  also  provided  a  further  test  of  ERK  inhibition. 
Impressively,  it  was  found  that  the  only  conditions  that  supported  self-renewal 
without a high degree of background differentiation were those in which PS or PD03 
were included, largely recapitulating the 3i phenotype. The phenotype of these DKO 
cells  and  the  abolition  of  differentiation  through ERK1/2  inhibition,  as  observed 
through morphological criteria and the striking elimination of Gata4-positive cells, 
illustrate the potent anti-differentiation effect exerted by PS and PD03. No increase 
in cell death was evident in these cultures implying that differentiation was inhibited 
as opposed to the selective elimination of differentiated cells from the cultures. These 
observations are consistent with recent work showing that ERK signalling is required 
for ES cells to differentiate into both neural and non-neural lineages (Kunath et al., 
2007). However, DKO cells appeared to be compromised in their growth even when 
differentiation was eliminated and I found that addition of LIF was required to fully 
restore proliferation. This in itself indicates that LIF can function through parallel 
pathways to exert effects independently of GSK3. 
3.3.4 ES cells cultured in 3i are LIF- and BMP-independent
The dogma of ES cell  biology is that  ES cells  rely on exogenous signals  for the 
activation  of  pathways  that  promote  their  self-renewal.  The best  characterised  of 
those pathways is LIF-STAT3 which supports self-renewal in the presence of signals 
that inhibit neural differentiation, provided by serum or BMP4. In examining novel 
culture conditions it is important to investigate the requirement for these signalling 
pathways even though the cytokines have not themselves been included in the media. 
During the development of 3i it was shown that BMP4 was not required if PD18 or 
SU was added to LIF-containing media (Ying et al, in press). Again this is consistent 
with the requirement for FGF-ERK signalling for neural differentiation of ES cells 
(Kunath et al., 2007; Stavridis et al., 2007). In 3i Id gene expression was much lower 
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than in LIF and BMP4 while the addition of PD18 or SU to LIF-containing media 
did  not  increase  Id1  protein  expression  above  background  levels  where  neural 
differentiation proceeds efficiently. I conclude that ERK blockade relieves ES cells 
from their  reliance  on BMP4 through mechanisms  independent  of  Id  expression. 
During  these  experiments  the  complementary  question  was  also  addressed:  does 
BMP4 act through inhibition of ERK signalling as has been suggested (Qi et  al., 
2004)? No evidence was found that BMP4 affects the activity of ERK, in agreement 
with previous work (Ying et al., 2003a). Furthermore, while the effect of BMP4 on 
self-renewal  appears  to  be  specific  to  inhibition  of  neural  commitment,  ERK 
inhibition  appears  to  have  a  more  universal  effect,  imposing  a  block  on 
differentiation that is not lineage specific (Kunath et al., 2007).
Independence from STAT3 signalling has never been demonstrated for mouse ES 
cell  self-renewal  despite  numerous  publications  implicating  alternative  signalling 
pathways (Paling et al., 2004; Sato et al., 2004). In this chapter it was demonstrated 
that STAT3 is not phosphorylated on Tyr705, a site believed to be required for its 
activation (Ying et al, in press), and that STAT3 target genes are not activated in 3i. 
However, conclusive proof that self-renewal can proceed independently of STAT3 
requires that it is eliminated genetically.  Mice heterozygous for a  Stat3-null allele 
were crossed, embryos lacking Stat3 isolated, and ES cells lacking Stat3 derived. The 
capacity for self-renewal and differentiation was tested and the cells behaved as ES 
cells but as expected they could not self-renew in standard culture conditions that are 
dependent  on a  LIF-STAT3 signal  (Niwa et  al.,  1998).  The prospect  of  a  novel, 
STAT3-independent  mechanism  of  self-renewal  is  exciting  because  the  only 
physiological relevance of STAT3 is its requirement during diapause (Nichols et al., 
2001), a phenomenon that does not occur in humans.  The hope is that by further 
understanding  the  mechanisms  of  self-renewal  in  3i  our  findings  might  be 
generalised to other mammalian species and ES cells derived that can be cultured 
under similar conditions.
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pathway the critical requirement for self-renewal?
4.1 Introduction
ES cells were originally derived by culturing isolated ICMs or delayed implantation 
blastocysts on a feeder layer in serum-containing media (Evans and Kaufman, 1981; 
Martin, 1981). Similar conditions are still in routine use by many groups today. Both 
feeders and serum are sources of undefined signals. In 1988 it was demonstrated that 
LIF could replace the requirement for feeders (Smith et al., 1988; Williams et al., 
1988) but not until 2003 were culture conditions developed that did not require the 
use of serum – serum was replaced by BMP4 (Ying et al., 2003a). So, in the 27 years 
or so since ES cells were established they have always been grown in the presence of 
cytokines  and growth  factors  and  often  in  the  presence  of  sources  of  undefined 
signals. It is therefore generally accepted that self-renewal is instructed by extrinsic 
signals (Cartwright et al., 2005b; Li et al., 2005). 
It is now well documented that blockade of the FGF-MEK-ERK signalling cascade 
promotes  self-renewal  (Cheng  et  al.,  1998;  Qu  and  Feng,  1998;  Burdon  et  al., 
1999b). In fact,  in defined culture conditions deletion of  Fgf4 or pharmacological 
inhibition of downstream signalling components prevents differentiation of ES cells 
(Kunath et al., 2007; Stavridis et al., 2007). Since there were several means available 
to us to suppress the differentiation of ES cells I was in a position to assess the nature 
of ES cells cultured in the absence of extrinsic growth factors. 
4.1.1 ERK Signalling in Mouse ES Cells
Activation  of  receptor  tryrosine  kinases  by  their  ligands  results  in 
autophosphorylation on tyrosine residues on the intracellular domain of the receptor 
(reviewed  in  (Yarden  and Ullrich,  1988)).  These  serve  as  binding  sites  for  SH2 
domain-containing proteins including Shp2 and Grb2. Grb2 may directly bind the 
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receptor  and  recruit  Sos  but  it  can  also  be  recruited  to  the  receptor  by  Shp2. 
Localisation of Sos to the membrane brings it into contact with Ras. Ras in turn 
becomes activated initiating a cascade of phosphorylation that results in activation of 
ERK1/2  (Fig3.1).  ES cells  deficient  for  Shp2 do not  differentiate  efficiently  into 
cardiac cell types. They also show a higher efficiency of secondary EB formation 
(Qu and Feng, 1998), consistent with the idea that Shp2-null ES cells in primary EBs 
are refractory to differentiation.  Similarly,  Grb2-null ES cells do not differentiate 
into endodermal cell types in EB or adherent differentiation conditions (Cheng et al., 
1998). The phenotype can be rescued by expression of Grb2 or by a fusion protein 
consisting of a C-terminal truncated Sos fused to the SH2 domain of Grb2. Mutation 
of the SH2 domain abolished the ability of this construct to rescue differentiation 
implying  that  interaction  with  the  receptor  was  required  for  activation.  These 
experiments  clearly  demonstrate  that  Grb2-Sos  signalling  promotes  endodermal 
differentiation.  Furthermore,  an  activated  form  of  H-Ras  restored  differentiation 
implicating the Ras-Raf signalling cascade as the downstream effector. 
Consistent with these studies, it has been shown that activation of the MEK-ERK 
signalling cascade downstream of LIF is dispensable for ES cell propagation (Burdon 
et al., 1999b). When the Shp2 binding site was mutated on a chimeric gp130 receptor 
activation of the receptor resulted in STAT3 activation but not activation of ERK1/2. 
Not only was this receptor able to support self-renewal, efficiency was enhanced in 
the absence of the ERK signal.  This finding could be confirmed by the use of a 
pharmacological  inhibitor  of  MEK,  PD98059,  which  promoted  self-renewal  and 
blocked differentiation in EBs. 
A subsequent study focused on the role of ERK signalling in differentiation under 
defined  conditions  confirmed  that  inhibition  of  the  FGF-MEK-ERK  signalling 
pathway  biochemically  or  through  genetic  manipulation  prevents  efficient 
differentiation. ES cells lacking Fgf4 or treated with an FGFR-inhibitor, and with a 
corresponding  reduction  in  ERK activation,  failed  to  upregulate  the  early  neural 
differentiation markers Sox1 (Stavridis et al., 2007) and Nestin (Kunath et al., 2007) 
and only sporadic  βIII-Tubulin-positive neurons  could be detected  after  10 days’ 
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differentiation (Kunath et al., 2007). Importantly, the phenotype in Fgf4-null ES cells 
could be rescued by the addition of recombinant FGF4, proving that the resistance to 
differentiation was a result of the loss of FGF4 expression. Strikingly, the same cells 
were resistant to differentiation into mesoderm and into the large flattened cells that 
result from BMP4 treatment (Kunath et al., 2007). This indicates that the lack of an 
FGF  signal  compromises  differentiation  along  multiple  lineages  and  is  not 
exclusively associated with differentiation into neural lineages. ERK signalling may 
therefore act as a trigger for differentiation, pushing cells into a state where they are 
competent to respond to differentiation cues (Fig4.5). This hypothesis is supported 
by  the  observation  that  neural  commitment  is  blocked  by  the  MEK  inhibitor 
PD184352 but removal  of the MEK inhibitor  for just  three hours is  sufficient  to 
statistically increase the degree of subsequent differentiation while 9 hours without 
inhibitor fully restores differentiation efficiency (Stavridis et al., 2007). It appears 
that a discrete period of ERK activity is sufficient to initiate differentiation.
Taken together the findings outlined above lead to the hypothesis that ES cell self-
renewal may be ERK-independent. Moreover, the evidence strongly implicates ERK 
signalling in the positive regulation of differentiation. Although the studies of Shp2-
null (Qu and Feng, 1998) and Grb2-null (Cheng et al., 1998) ES cells report lineage-
specific defects in differentiation the nature of differentiation observed is limited by 
the culture conditions used and the markers of differentiation examined. These cells 
may exhibit similarly compromised differentiation to  Fgf4-null ES cells (Kunath et 
al.,  2007) if examined under conditions designed to promote differentiation along 
specific  lineages  (Nishikawa et  al.,  1998;  Ying et  al.,  2003b).  ERK signalling  is 
clearly active under self-renewing conditions as it is activated by LIF (Burdon et al., 
1999b) and by autocrine FGF4 (Kunath et al., 2007) and is readily detected in self-
renewing ES cells by immunoblotting (see chapter 3). Therefore, ERK signalling is 
required but not sufficient to drive differentiation,  which is prevented in standard 
culture conditions by activation of STAT3 (Niwa et al., 1998; Matsuda et al., 1999) 
and serum or BMP-induced expression of Id genes (Ying et al., 2003a). In chapter 3 
it was demonstrated that in 3i ES cells are relieved from their dependence on STAT3 
and BMP signalling.  In this chapter the question of whether ES cells  require any 
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further signalling input to self-renew when differentiation is prevented by inhibition 
of the ERK1/2 signal is addressed.
 
4.2 Results
4.2.1 Propagation of ES cells in PD184352 plus SU5402 (PS) or 
PD0325901
ES cells cultured in the presence of a MEK inhibitor or an FGFR inhibitor retain 
expression  of  pluripotency-associated  genes  under  conditions  where  they  would 
otherwise  be  expected  to  differentiate  (Ying  et  al.,  2003b;  Kunath  et  al.,  2007; 
Stavridis et al., 2007). In chapter three I showed that a combination of PD18 and SU 
(PS) reduced ERK phosphorylation at concentrations where the individual inhibitors 
had little effect. A more potent MEK-inhibitor, PD03, was also tested and substituted 
effectively for PS at 1μM, providing a near-total block of ERK phosphorylation at 
this concentration. To examine the effect of ERK inhibition I attempted to culture ES 
cells in PS alone and later PD03 alone.
To grow cells in PS alone it was important to first culture the cells in serum-free 
conditions for 1-2 passages and to expose the cells to PS alone only after they had 
been allowed to attach to the plate in the presence of LIF or CHIR. Passaging cells 
directly from LIF- or CHIR-containing conditions into media containing PS alone 
results in a large degree of cell death and failure of the passaged cells to adhere to 
gelatine. However, once cells are established in PS as described above they can be 
maintained in culture for more than one month and 8 passages (Fig4.1a). ES cells 
grown in  PS alone  proliferated  slowly and exhibited  poor  viability  with cultures 
containing a large number of floating, dead cells. The cells had a doubling time at 
least twice that of side-by-side cultures in LIF and BMP4 or 3i and as a result were 
passaged at relatively high density.  With the exception of a few poor colonies in 
colony forming assays it was not possible to obtain clonal propagation of ES cells in 
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PS  or  PD03  alone,  suggesting  that  their  survival  might  be  density-dependent. 
Although  long-term  culture  in  PS  or  PD03  was  demonstrated  for  multiple 
independent ES cell lines (Oct4GIP, E14Tg2a and 46C (Q-L. Ying, unpublished)) 
the failure to support clonal propagation means that the conditions do not pass one of 
the ‘tests’ normally applied to demonstrate sufficiency of any culture condition to 
support self-renewal. There are several possible reasons for the insufficiency of these 
conditions.  If  differentiation  is  incompletely blocked,  either  because ERK retains 
some activity or because a degree of differentiation can proceed in the absence of 
ERK signalling then cells at low density may become more vulnerable and fail to 
establish undifferentiated colonies. Alternatively, differentiation may be effectively 
blocked but the cells are otherwise compromised in terms of their viability or growth 
and proliferation. 
In PS cultures a degree of spontaneous differentiation was observed, including the 
appearance  of rosette-like structures  indicative  of  neural  differentiation  (Fig4.1b). 
This neural differentiation can be inhibited by the addition of BMP4 (10ng/ml) but 
efficient self-renewal is not restored. Rather, the neural rosettes are replaced by flat 
sheets  of  cells  (Fig4.1b,c)  typical  of  BMP4-induced  differentiation  (Ying  et  al., 
2003a). Notably, however, cultures in PS plus BMP4 can be maintained for at least 7 
passages (Fig4.1b,c) unlike cultures in BMP4 alone which cannot be passaged (Ying 
et  al.,  2003a)  indicating  that  PS partly  blocks  the  potent  differentiation-inducing 
activity of BMP4. This is an important point; the block in differentiation imposed by 
PS is  not  specific  to  neural  lineages,  in  agreement  with  recently  published  work 
(Kunath et al., 2007). When late-passage PS cultures were immunostained for Oct4 
there  were  a  significant  number  of  Oct4  negative  cells  (Fig4.1a)  indicating 
heterogeneity in the culture. Analysis of gene expression by real-time PCR showed 
that the primitive ectoderm marker,  Fgf5, and the early neural marker, Nestin, were 
upregulated in PS relative to LIF and BMP4 or 3i cultures (Fig4.1d) implying that 
the  cultures  contain  a  proportion  of  cells  undergoing  differentiation.  I  conclude 
therefore  that  differentiation  it  not  completely  blocked  in  PS.  In  an  attempt  to 
establish  if  this  results  from  residual  ERK  activity  ES  cells  were  cultured  in 
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relatively high concentrations  of  PD03.  At  1-2μM pERK is  barely detectable  by 
immunoblotting  (see  chapter  3).  However,  ES  cells  cultured  in  1-2μM  PD03 
proliferated poorly and could not be maintained beyond passage 4. The failure to 
expand cells further in PD03 alone could result from toxic effects of the inhibitor but 
may also reflect a requirement for low levels of ERK activity for continued growth 
or proliferation. However, the apparent heterogeneity of cultures in PS suggests that 
incomplete inhibition of ERK activity may permit some differentiation to proceed. 
Addition  of  LIF  or  CHIR  to  PS  fully  restores  self-renewal  with  minimal 
differentiation evident (Fig4.1e, note flattened morphology as compared to rounded 
up colonies formed in presence of LIF or CHIR respectively). When single cells are 
plated into individual wells of a 96-well plate the efficiency of colony formation in 3i 
or LIF plus PS is similar to that observed in LIF plus BMP4 (Fig4.1f). In fact, CHIR 
could fully rescue propagation in 2μM PD03 (Fig4.1g) even in clonal assays using an 
ES cell line subcloned from E14Tg2a (E14 IV C) (Fig4.1h) and recently tested for 
germ-line transmission, suggesting that ERK activity is fully dispensable if viability 
and/or proliferation are promoted by the addition of LIF or CHIR. Both LIF and 
CHIR are predicted to have pleiotropic effects on ES cells with potential  roles in 
inhibition of differentiation and regulation of cell metabolism and the cell cycle. It is 
therefore difficult to distinguish the ‘essential’ contributions of these molecules from 
effects that are beneficial for ES cell culture but not strictly required to instruct cell 
fate decisions in favour of self-renewal over differentiation. 
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4.2.2 Inhibition of apoptosis by forced expression of Bcl2 
facilitates the examination of self-renewal in PS.
The phenotype of ES cells cultured in PS or PD03 alone became difficult to assess. 
While  differentiation was largely inhibited cell  viability was poor.  The failure  to 
form colonies at low density could have resulted from differentiation, cell death or 
proliferation  arrest.  The  effect  of  LIF  and  CHIR  could  be  to  inhibit  residual 
differentiation, to increase cell viability or proliferation, or a combination of these 
effects. In an attempt to separate the role for anti-apoptotic signals from instructive 
signals in cell fate decisions the effect of overexpressing Bcl2, an anti-apoptotic gene 
(reviewed in (Zinkel et al., 2006)) was assessed. It was predicted that in PS cultures, 
where cell death is high, inhibition of apoptosis would reveal the fate of the dying 
cells. If ES cells themselves were undergoing apoptosis then self-renewal would be 
improved by inhibition of apoptosis whereas if the cell death reflected apoptosis in 
cells  that  had  committed  to  differentiate,  their  terminally  differentiated  products 
would be observed in the culture.
Bcl2  expression  is  ordinarily  expressed  at  low  but  detectable  levels  in  ES  cell 
populations. Bcl2-coding sequence was amplified by PCR from total ES cell cDNA 
and subcloned into an expression vector. This vector drives Bcl2 expression from a 
constitutively  active  CAG  promoter  and  can  be  selected  for  by  the  addition  of 
puromycin as a puromycin-resistance cassette is transcribed from the same promoter 
and translated from an internal ribosome entry site (IRES). ES cells stably expressing 
Bcl2 (Bcl2-ES) were isolated following electroporation of linearised plasmid DNA 
and  selection  for  puromycin  resistance.  As  a  control,  equivalent  amounts  of  the 
vector plasmid were transfected into a separate pool of ES cells and selected. In side-
by-side experiments Bcl2- and vector-transfected ES cells were cultured in N2B27 
alone,  PS or 3i.  After 10 days  of selection  the plates  were fixed and stained for 
alkaline-phosphatase to identify undifferentiated colonies. In N2B27 alone, colonies 
failed  to  form  with  either  plasmid  while  in  3i  undifferentiated  colonies  formed 
efficiently in both cases. In PS however, significantly more colonies formed in Bcl2-
transfected cells than in the case of the vector (Fig4.2a). This implies that preventing 
apoptosis does permit colony formation in PS. Note however that these conditions do 
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not represent expansion of colonies from isolated cells as the initial plating density is 
high. Only after elimination of a large proportion of the ES cells  by selection do 
colonies appear that are assumed to have arisen from a single, stably transfected cell. 
Clones were expanded from duplicate plates for further analysis.
To  assess  the  level  of  apoptosis  in  PS  cultures  and  the  effect  of  forced  Bcl2 
expression  the  loss  of  membrane  asymmetry  was  examined  using  an  AnnexinV 
assay.  Co-staining with propidium iodide (PI)  allowed dead cells  to be excluded. 
Apoptotic cells are defined as those cells which are PI negative (live) but AnnexinV 
positive (apoptotic)  (Fig4.2b).  Note that  neither PS nor PD03 increased apoptosis 
relative to N2B27 alone indicating that inhibition of ERK signalling does not result 
in  increased  apoptosis.  Cultures  of  wild-type  ES cells  in  PS alone  had  a  higher 
proportion of apoptotic cells than cultures containing LIF or CHIR (Fig4.2b,c). LIF 
and CHIR can therefore inhibit apoptosis either directly or indirectly. As expected, 
Bcl2-ES cells exhibited decreased apoptosis in all conditions examined (Fig4.2b,d). 
As Bcl2 was apparently functioning to inhibit apoptosis in ES cells it was possible to 
examine the effect of this on ES cell self-renewal in different culture conditions.  
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4.2.3 Bcl2 does not inhibit differentiation of ES cells
The use of Bcl2 to inhibit apoptosis presented a potential problem. Bcl2 has been 
reported to support self-renewal of ES cells in the presence of LIF and the absence of 
serum (Yamane et al., 2005). It has previously been shown that cells cultured in LIF 
alone undergo neural differentiation which can be inhibited by the addition of BMP4 
or serum (Ying et  al.,  2003a). The finding that  Bcl2 relieves ES cells  from their 
dependence on BMP4 or serum implies that it can prevent neural differentiation. For 
forced Bcl2 expression to be a useful tool for our analyses it was important that it did 
not inhibit differentiation. To examine this, Bcl2-ES cells were cultured in LIF alone. 
Culture  in  N2B27 in  the  absence  of  LIF  served  as  a  positive  control  for  neural 
differentiation  while  addition  of  PD03,  which  blocks  differentiation,  served  as  a 
negative  control.  Cultures  were  fixed  and  stained  on  the  2nd passage  in  these 
conditions. Survival in the parental cell line was poor in N2B27 alone so no cells 
survived to the 2nd passage for staining.  Neural differentiation was judged by the 
appearance  of  β-III-Tubulin  positive  cells  (reactive  to  the  Tuj1  antibody)  with 
distinct  neuronal  morphology.  Efficient  neural  differentiation  was  observed  in 
N2B27 alone as expected and also in the presence of LIF although ES cells persisted 
for longer when LIF was added to the media as judged by the persistence of Nanog-
positive  cells  (Fig4.3a).  If  anything,  the expression of  Bcl2  appeared  to  enhance 
differentiation (Fig4.3a, compare E14Tg2a to Bcl2-ES cells in LIF alone), probably 
by  decreasing  the  amount  of  cell  death  normally  seen  upon  monolayer  neural 
differentiation (Ying et al., 2003b). Differentiation in LIF-containing conditions was 
almost totally eliminated by the addition of 1μM PD03 (Fig4.3a) with only very rare 
Tuj1-reactive cells detected. Confident that Bcl2 does not block neural commitment 
the growth of Bcl2-ES cells in PS or PD03 alone was assessed. 
Wild-type  ES cells  can  be  maintained  in  PS but  cell  death  is  high  and  there  is 
evidence of heterogeneity (Fig4.1). Bcl2-ES cells exhibit reduced cell death in PS as 
expected. Bcl2-ES cells were cultured in PS, PD03 or 3i for several passages, plating 
onto laminin for the purposes of staining on the final passage (increased substrate 
attachment  results  in  the flattened  morphology observed in  3i,  Fig4.3b).   Mature 
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neurons  emerge  in  PS  culture  conditions  (Fig4.3b)  indicating  that  neural 
differentiation is proceeding even with the reduced levels of ERK signalling in PS. 
Neural differentiation was completely abrogated by the addition of CHIR (Fig4.3b, 
3i). 3i-cultured Bcl2-ES cells appeared homogeneous with virtually all cells retaining 
expression of Oct4 (Fig4.3b). This indicates that the high proportion of ES cells in 3i 
is  unlikely to result  from selection in favour of ES cells  over their  differentiated 
progeny as differentiated cells would be expected to be evident in Bcl2-ES cultures if 
differentiation was occurring. This is consistent with the low levels of cell death seen 
in established 3i cultures.  
To determine if the neural differentiation observed in PS cultures could be eliminated 
by further reduction of the ERK signal Bcl2-ES cells  were cultured in 1 or 2μM 
PD03. Unlike WT-ES cells Bcl2-ES cells grew in the higher concentrations of PD03 
implying that Bcl2 expression rescues them from apoptosis induced by greater MEK 
inhibition  or  non-specific  effects  of  the  inhibitor.  A  substantial  decrease  in  the 
number of Tuj1-reactive neurons formed (Fig4.3b,c) as compared to PS conditions 
was observed but neural differentiation was not entirely eliminated indicating that 
either the ERK signal was not totally eliminated or that some differentiation proceeds 
in  the  absence  of  ERK activity.  It  is  worth  noting  here  that  our  assays  of  ERK 
activity can only be as sensitive as immunoblotting permits and that ERK activity is 
assessed in the population, not at the level of individual cells where variation may 
still exist. It is not possible from these studies to conclude that individual cells have 
succeeded  in  entering  the  differentiation  program without  activating  ERK.  From 
these experiments claims can be made only about how the population behaves in 
response  to  the  inhibitors  and  how  this  correlates  with  global  levels  of  ERK 
activation.
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Given the reduction of differentiation in PD03 the cultures were maintained long-
term. The cells were readily passaged and grew well albeit less quickly than LIF- or 
CHIR-containing cultures. After 8 passages and more than a month in continuous 
culture  the  cells  were  stained  for  markers  of  pluripotency,  Oct4  and  Nanog 
(Fig4.3.1a). A significant proportion of the remaining cells were Oct4- and Nanog-
negative  (Fig4.3.1a,b)  indicating  that  the  population  was  heterogeneous  and  that 
despite the apparent efficiency of long-term culture the combined effects of ERK 
inhibition  and anti-apoptotic  signals  did  not  reproduce  the  homogeneous  ES cell 
growth  seen  in  3i  or  in  standard  LIF-containing  culture  conditions.  The 
immunostaining results are supported by real-time PCR analysis showing that  Oct4 
and  Nanog are  approximately 2-fold down-regulated  while  Nestin is  significantly 
upregulated  and  Gata4 slightly,  but  reproducibly  upregulated  (Fig4.3.1c). 
Interestingly, increasing the dose of PD03 from 1μM to 2μM did reduce the level of 
Nestin detected in the population (Fig4.3.1c), suggesting that there may be a further 
reduction in differentiation resulting from increased MEK inhibition. 
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4.2.4 Nanog
Nanog is one of three TFs essential for the establishment of a pluripotent epiblast 
(Mitsui et al., 2003) and required for the efficient self-renewal of ES cells (Mitsui et 
al., 2003; Chambers et al., 2007). Nanog overexpression permits self-renewal in the 
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absence of LIF and BMP4 (Chambers et al., 2003) demonstrating that it is capable of 
suppressing differentiation. It has recently been shown that Nanog expression is not 
homogeneous  in  self-renewing  ES  cells  (Chambers  et  al.,  2007).  Cells  can  be 
identified  that  retain  the  expression  of  Oct4  but  express  little  or  no  Nanog. 
Importantly, these cells can reexpress Nanog as demonstrated by the isolation of the 
Nanog-negative  population  and  the  subsequent  emergence  of  a  Nanog  positive 
population from those cells. The Nanog-negative population are however more prone 
to differentiation suggesting that elevated Nanog levels do enhance self-renewal. The 
implication of these studies is that culture conditions promoting elevated levels of 
Nanog  expression  or  increased  homogeneity  of  Nanog  expression  within  the 
population should increase the efficiency of self-renewal. 
The phenotype of ES cells cultured in PS or PD03 is similar to that observed for 
Nanog-overexpressing cells (Chambers et al., 2003). They are compromised in their 
ability to differentiate  and self-renewal is  enhanced in response to LIF or CHIR. 
Notably however, Nanog-overexpressing cells retain the ability to form colonies at 
clonal density, unlike wild-type cells in PS or PD03 (Fig4.4g). I hypothesized that 
the phenotype of 3i culture could result, at least in part, from regulation of Nanog 
expression and in particular that the inhibition of differentiation resulting from ERK 
inhibition might be mediated by elevated levels of Nanog expression.  
Regulation of Nanog has been linked to the MEK-ERK pathway. One group showed 
that treatment of ES cells with sodium vanadate, a tyrosine phosphatase inhibitor, 
results  in  Nanog  down-regulation  and  differentiation  into  primitive  endoderm 
(Hamazaki et al., 2006). This does not occur in the absence of Grb2 and is inhibited 
by  the  MEK  inhibitor,  PD98059,  implicating  receptor  tyrosine  kinase  coupling 
through Grb2 to activate the MEK-ERK signalling pathway in the down-regulation 
of  Nanog.  However,  this  study  provides  no  evidence  that  Nanog  is  a  direct 
downstream target of ERK signalling. In the preimplantation embryo there is also 
evidence of Grb2-mediated regulation of Nanog. In Grb2-null blastocysts all of the 
ICM cells express Nanog at a point when wild-type embryos show ‘salt and pepper’ 
expression of Nanog and Gata6 and subsequently a clear segregation of the Nanog 
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positive epiblast from the Gata6 positive primitive endoderm (Chazaud et al., 2006). 
This phenotype is consistent with the hypothesis that signalling downstream of Grb2 
results in Nanog down-regulation and Gata6 upregulation although no mechanism 
has  been  proposed  for  this  phenotype  and  it  is  not  known if  or  how signalling 
through Grb2 is activated in some cells but not others in the ICM. The phenotype of 
Grb2-null blastocysts can be reproduced by culturing embryos from the 8-cell stage, 
prior to primitive endoderm specification, in the presence of PS or PD03. Embryos 
developing in the presence of these inhibitors homogeneously express Nanog in all 
cells of the ICM and fail to form the Gata4-positive primitive endoderm (J. Silva and 
J. Nichols, unpublished). This appears to result from an expansion of the epiblast at 
the expense of primitive endoderm as the total cell number in the embryo is similar 
and the total  cell  number  in the ICM increased in the presence of the inhibitors. 
Furthermore,  when blastocysts  are cultured in the presence of inhibitors  after  the 
primitive endoderm has formed, the primitive endoderm does not die indicating that 
pre-formed primitive endoderm can survive and the inhibitors function to block its 
specification  as  opposed  to  selectively  eliminating  somatic  cells  (J.  Silva  and  J. 
Nichols,  unpublished).  From these studies I predicted that  MEK inhibition would 
result in upregulation of Nanog in the ES cell population. 
Examination  of  Nanog expression  in  steady-state  conditions  reveals  that  Nanog 
mRNA is  present  at  slightly  higher  levels  in  3i  than  in  LIF  and  BMP4 despite 
equivalent  levels  of  Oct4 expression (Fig4.1d).  Elevated  levels  of  expression are 
consistent with increased Nanog transcription in individual cells or an increase in the 
proportion  of  cells  in  the  population  expressing  Nanog.  Steady-state  expression 
levels are subject to changes in cell phenotype and do not therefore indicate direct 
regulation. The direct response of Nanog to short term treatment with the inhibitors 
was examined. ES cells were starved of serum and cytokines and then stimulated for 
1 hour with LIF or PS. LIF served as a positive control for activation of the ERK 
target  Egr1 but had no effect on  Nanog  expression. Neither were Nanog  transcript 
levels affected by MEK inhibition despite clear down-regulation of Egr1 (Fig4.4a), 
suggesting that Nanog transcription is not directly regulated by ERK activity.
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Nanog protein levels were examined next. When cultured in N2B27 alone, Nanog is 
substantially down-regulated after just 24 hours in culture (Fig4.4b). The degree of 
Nanog  down-regulation  is  reduced  in  the  presence  of  MEK  inhibitor  or  FGFR 
inhibitor and the two inhibitors combined in PS further support Nanog expression. 
CHIR alone was also able to maintain Nanog expression during this relatively short 
term assay,  consistent  with the undifferentiated phenotype  of ES cells  after  short 
periods in CHIR alone (see chapter 5). The combination of all three inhibitors, 3i, 
showed  the  highest  level  of  Nanog  expression  after  the  24  hour  culture  period 
(Fig4.4b) suggesting that the inhibitors  work together  to  upregulate  Nanog either 
directly or indirectly by maintaining a high proportion of undifferentiated cells in the 
population. To test the direct response of the cells to the inhibitors or to LIF cells 
were cultured in N2B27 alone for 12 hours and then treated for a further 4 or 8 hours. 
There  was no direct  response to either  LIF or  CHIR but  PS clearly  induced up-
regulation of Nanog protein at both time points (Fig4.4c). No significant change in 
Oct4 levels was observed indicating that the change in Nanog levels did not reflect 
an increase in the proportion of ES cells  in the population.  As this response was 
observed following just 4 hours’ treatment it seems that Nanog expression levels are 
extremely  sensitive  to  ERK  activity.  The  response  of  Nanog  to  PS  was  not 
significantly  enhanced  by  the  addition  of  CHIR  (Fig4.4c,  compare  PS  and  3i), 
implying  that  ERK-  but  not  GSK3-inhibition  results  in  increased  Nanog  protein 
levels.
As discussed above, the regulation of Nanog is likely to contribute to the phenotype 
of ES cell cultures. To assess the importance of Nanog upregulation for 3i culture ES 
cells from which  Nanog has been deleted were cultured.  Nanog-null ES cells have 
been established and maintained previously in standard ES cell culture conditions 
(Chambers  et  al.,  2007).  They  exhibit  substantially  increased  spontaneous 
differentiation which is effectively eliminated by selecting for antibiotic resistance 
genes  expressed  from  the  Nanog locus.  In  the  absence  of  selection  two 
independently-established  Nanog-null  lines  (44Cre6  and  BT12)  were  readily 
maintained in 3i, 2i or in PD03 plus LIF (Fig4.4d,4.5a). Both lines were maintained 
for  at  least  one  month  (8  passages)  in  culture  and  retained  the  expression  of 
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pluripotency  markers  as  assessed  by  RT-PCR  (Fig4.4e)  and  immunostaining  or 
Nanog-GFP expression (44Cre6 has a GFP reporter  knock-in in the  Nanog  locus 
(Chambers et al., 2007)) (Fig4.5a). However, a degree of spontaneous differentiation 
persisted, particularly in clone 44cre6 (Fig4.4d,4.5a). Our observations indicate that 
Nanog expression is not essential for the culture of ES cells in 3i but that the absence 
of Nanog does increase spontaneous differentiation, which is virtually absent from 
wild-type cultures. The direct effect of the MEK inhibitor can most easily be seen by 
comparing cultures of 44Cre6 in N2B27 alone or plus PD03. PD03 alone results in 
persistence of  Nanog-GFP positive cells  while  it  is  completely lost  from cells  in 
N2B27  alone  within  two  passages  (Fig4.5b).  These  results  indicate  that  MEK 
inhibition can inhibit differentiation independently of Nanog expression. 
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4.3 Discussion 
I found that ES cells could be propagated in N2B27 supplemented with only PS. In 
the absence of inhibitors ES cells undergo neural differentiation (Ying et al., 2003b) 
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and  cannot  be  passaged  more  than  once.  Propagation  over  8  passages  and  the 
maintenance  of  Oct4  expression  clearly  demonstrates  that  ERK inhibition  has  a 
profound effect,  preventing otherwise inevitable differentiation and accompanying 
deterioration  and  loss  of  the  cultures.  However,  the  cell  population  is  clearly 
heterogeneous and clonal propagation is not possible so ERK inhibition cannot be 
described as sufficient for ES cell self-renewal. The inability to grow from single 
cells suggests that paracrine signalling might be involved in growth at higher density. 
It would be interesting to test if ES cells lacking the LIFR or STAT3 (see chapter 3) 
could be grown in PS. This would at least rule out a role for paracrine LIF signalling. 
4.3.1 Inhibition of apoptosis by Bcl2 facilitates the study of cell 
fate 
The use of  Bcl2  as  an anti-apoptotic  agent  proved to  be  informative.  It  is  often 
difficult  to assess the contribution of signalling pathways to self-renewal because 
their disruption leads to a decrease in viability or proliferation. If the cells become 
difficult to propagate it is difficult to assess the role of the disrupted pathway in the 
instruction of cell fate choice. The PI3K pathway is a good example with contrasting 
reports  on  the  relative  contribution  to  cell  cycle  (Jirmanova  et  al.,  2002),  anti-
apoptosis  (Sun  et  al.,  1999;  Stiles  et  al.,  2002)  and  inhibition  of  differentiation 
(Paling et al., 2004; Watanabe et al., 2006). If cells were prevented from undergoing 
apoptosis it might become possible to tease out a role for PI3K signalling in cell fate 
choice. The experiments described here suggest that this might be made possible by 
Bcl2 overexpression. In the context of PS culture Bcl2 expression resulted in the 
accumulation of mature neurons revealing that the ES cells were in fact committing 
to the neural lineage in PS and that the dead cells habitually present in PS cultures 
are likely to have come from cells that have initiated differentiation and subsequently 
undergone  apoptosis.  The  death  of  differentiating  cells  in  PS may  result  from a 
requirement for ERK signalling in somatic cell derivatives of pluripotent ES cells. 
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4.3.2 ERK inhibition prevents differentiation but efficient self-
renewal requires signalling downstream of LIF or GSK3
The established role of ERK signalling in the promotion of differentiation (Burdon et 
al., 1999b) and the demonstration here of our ability to culture cells in PS or in PD03 
for an extended period suggest that inhibition of ERK signalling may represent a 
minimum  requirement  for  self-renewal  through  the  prevention  of  differentiation. 
Having removed LIF from the culture conditions it will surprise many that the cells 
grew at all.  However, the high rate of spontaneous differentiation that persists in 
cultures  of  ES  cells  in  PS  or  PD03  alone  demonstrates  that  inhibition  of  ERK 
signalling is not sufficient to support efficient self-renewal.  
The addition of LIF or CHIR to PS or PD03 eliminates residual differentiation from 
the  cultures.  LIF  and  CHIR  may  activate  signalling  pathways  that  inhibit 
differentiation independently of ERK activity. This is known to be the case for LIF 
because  it  prevents  the  non-neural  differentiation  that  occurs  in  the  presence  of 
serum or BMP4 (Ying et al., 2003a) despite activating ERK signalling (Burdon et al., 
1999b). Wnt/β-catenin signalling has also been implicated in self-renewal even under 
conditions where ERK is known to be highly active (Sato et al., 2004; Liu et al., 
2006). Activation of STAT3 or of β-catenin may therefore promote self-renewal in 
the context of ERK inhibition by blocking residual differentiation. This effect is most 
obvious  from the  elimination  of  neural  differentiation  caused  by  the  addition  of 
CHIR  to  PS.  Wnt  signalling  has  previously  been  reported  to  inhibit  neural 
differentiation of ES cells (Aubert et al., 2002; Haegele et al., 2003) and this is likely 
to  be  replicated  by  CHIR  through  stabilisation  of  β-catenin.  However,  this 
explanation does not fully support the observed phenotypes. PS and PD03 largely 
prevent  differentiation  and permit  long term bulk  culture  but  colonies  cannot  be 
obtained at clonal density. If inhibition of differentiation were sufficient for clonal 
propagation  some colonies  would be expected  to  form in PD03 alone.  I  propose 
therefore  that  LIF  and  CHIR  do  not  simply  repress  residual  differentiation  but 
enhance cell survival and proliferation.
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STAT3  is  the  key  signalling  molecule  downstream  of  LIF  (Niwa  et  al.,  1998; 
Matsuda  et  al.,  1999).  Elevated  levels  of  STAT3  activity  are  often  detected  in 
cancers and constitutively active STAT3 is capable of transforming in vitro cultured 
cell lines (reviewed in (Calo et al., 2003)). STAT3 is implicated in the regulation of 
cell  cycle  and  cell  survival,  likely  through  transcriptional  targets  such  as  cMyc,  
CyclinD1 and Bcl-XL (Calo et al., 2003). LIF can also activate the PI3K pathway, a 
well known pro-survival signal and this may be significant if LIF further enhances 
PI3K activity in insulin-containing media where constitutive PKB phosphorylation is 
already observed (see chapter 3). Similarly, GSK3 can negatively regulate many cell 
processes  implicated  in  cell  metabolism and is  involved in  cell  cycle  regulation. 
GSK3 phosphorylates targets including cMyc (He et al., 1998; Gregory et al., 2003) 
and CyclinD1 (Diehl  et  al.,  1998),  targeting  them for  proteolysis  and  negatively 
regulates  protein  synthesis  through  phosphorylation  of  targets  such  as  eIF2 
(eukaryotic translation initiation factor 2) (Welsh et al., 1998). It is likely that the 
modulation of pathways such as these is an important aspect of the promotion of self-
renewal by LIF and GSK3 inhibition.
The question of enhanced cell survival was addressed through the forced expression 
of  Bcl2.  Bcl2-expressing  ES  cells  cultured  in  higher  concentrations  of  PD03 
exhibited reduced differentiation as compared to cultures in PS but morphologically 
differentiated  cells  were  never  totally  eliminated  from  the  culture  despite  ERK 
phosphorylation  being  undetectable  by  immunoblotting.  This  shows  that  the 
combination  of  inhibition  of  differentiation  by  blocking  ERK  signalling  and 
inhibition of apoptosis  through forced expression of Bcl2 does not reproduce the 
efficient  self-renewal  observed  in  3i  or  in  standard  ES  cell  culture  conditions. 
Therefore, both LIF and CHIR must have effects that extend beyond the inhibition of 
apoptosis. 
4.3.3 ERK Signalling is dispensable for self-renewal of ES cells
ES  cells  are  somewhat  unique  in  their  apparent  independence  from  the  ERK 
signalling  pathway.  Robust  culture  in  high  concentrations  of  the  MEK-inhibitor, 
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PD03, demonstrates that the cells can survive and proliferate when ERK activity is 
low  or  absent.  In  somatic  cells  transit  through  the  G1/S  checkpoint  very  often 
requires active ERK signalling and CyclinD1 expression is under the control of TFs 
activated by ERK (Treinies et al., 1999). In ES cells, however, CyclinD expression 
levels  are  low and do  not  appear  to  respond  to  activation  of  the  ERK pathway 
(Jirmanova  et  al.,  2002).  Constitutive  inactivation  of  retinoblastoma  (RB)  and 
constitutive expression of CyclinE/CDK2 are thought to promote entry of ES cells to 
S-phase (Stead et al., 2002). In fact, ES cells cannot be induced to arrest at G1/S 
(Schratt  et  al.,  2001).  A consequence  of  this  is  that  somatic  cells  that  appear  in 
culture as a result of spontaneous differentiation cannot survive and are selectively 
eliminated. This may in part underlie our ability to culture ES cells through multiple 
passages  in  PS alone  but  little  cell  death  is  evident  in  3i  cultures  and no  overt 
differentiation is detected,  even when Bcl2 is constitutively expressed,  suggesting 
that the rate of spontaneous differentiation in 3i is low and that selection plays little 
or no part in long-term self-renewal in 3i. However, the anticipated bias for ES cell 
survival in conditions where ERK signalling is blocked provides us with a culture 
condition that will expand ES cells at the expense of somatic cells. This may have 
applications  in reprogramming where pluripotent  cells  arising at  a low frequency 
from cultures of somatic cells (Takahashi and Yamanaka, 2006) must be isolated and 
expanded (see general discussion). 
4.3.4 How does ERK activity promote differentiation?
ERK activity  downstream of  FGF signalling  promotes  differentiation  of  ES cells 
(Burdon et al., 1999b; Kunath et al., 2007; Stavridis et al., 2007) and compromised 
signalling  in  this  pathway  prevents  primitive  endoderm  differentiation  in  the 
blastocyst  (Chazaud  et  al.,  2006).  However,  the  downstream targets  involved  in 
promoting differentiation are not yet known. Perhaps the most informative piece of 
evidence is that inhibition of differentiation by blocking the FGF4-MAPK signalling 
pathway is not lineage-restricted (Kunath et al., 2007). It therefore seems unlikely 
that ERK directly activates genes associated with commitment to a particular lineage. 
Rather, ERK signalling may function in ES cells to promote a state of responsiveness 
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to  differentiation  cues  (Fig4.6).  Furthermore,  ERK  activation  does  not  result  in 
inevitable differentiation since ERK activity is high in ES cells cultured in standard 
conditions.  Under  these  circumstances  differentiation  appears  to  be  inhibited  by 
lineage-specific blockade of differentiation mediated by signals downstream of LIF 
and serum/BMP4 (Ying et al., 2003a). Inhibition of signalling downstream of FGF4 
may  remove  the  need  to  impose  lineage-specific  blockade  of  differentiation  by 
maintaining ES cells in a state where they are unresponsive to signals promoting 
differentiation.
One hypothesis was that ERK signalling promotes down-regulation of Nanog. If this 
were the case Nanog expression would be expected to increase in response to PS or 
PD03. Indeed, ERK inhibition does result in elevated levels of Nanog protein and 
Nanog  transcript  levels  are  elevated  in  3i  relative  to  LIF  and  BMP4  culture 
conditions.  However,  while  the  elevated  Nanog  levels  are  likely  to  increase  the 
efficiency of self-renewal (Chambers et al., 2007) the fact that Nanog-/- ES cells can 
be maintained in 3i demonstrates that elevated Nanog expression is not required for 
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the  self-renewal  phenotype  observed  in  3i.  A  direct  comparison  of  cultures  of 
Nanog-/- ES cells in N2B27 alone or plus PD03 clearly shows that differentiation is 
inhibited  by  the  presence  of  the  MEK  inhibitor  despite  the  absence  of  Nanog 
expression. 
It  has  been  suggested  that  in  transcriptionally  permissive  ES cells  expression  of 
lineage-associated genes fluctuates  at  levels  below a threshold required to induce 
differentiation until exposure to an environmental cue leads to initiation of a somatic 
transcriptional  program and  differentiation (Silva  and  Smith,  2008).  Might  ERK 
signalling  serve  to  promote  activation  or  stabilisation  of  somatic  transcriptional 
programmes? At present this is not known but we can speculate on the predictions of 
such a hypothesis. Comparison of gene expression in self-renewal conditions with 
either  high  (LIF  plus  serum/BMP4)  or  low  ERK  activity  (3i/2i)  should  reveal 
whether  or  not  lineage-associated  gene  expression  correlates  with levels  of  ERK 
activity.  Global transcriptional  profiling or real-time PCR examination of a more 
limited set of candidate genes, selected to reflect  markers of early differentiation, 
would be appropriate to examine this. For gene expression analysis on a population 
of ES cells it  would be important to ensure that differentiated cells in the culture 
were not included. This could be achieved by using transgenic ES cells lines that 
express  antibiotic  resistance  genes  under  the  control  of  pluripotency-specific 
promoters  or  by  sorting  undifferentiated  cells  from  the  population  using  flow 
cytometry. 
Active  ERKs  can  regulate  transcription  through  direct  phosphorylation  of 
transcription factors (Marais et al., 1993) and through direct or indirect modulation 
of  nucleosome  phosphorylation  and  acetylation  (reviewed  in  (Hazzalin  and 
Mahadevan, 2002)). The immediate early genes (IEGs), which include  cFos,  Egr1 
and JunB, are downstream targets that respond rapidly to ERK-mediated activation 
of  TFs  such  as  cFos  (reviewed  in  (Whitmarsh,  2007)).  ES  cells  lacking  serum 
response factor (SRF) are unable to activate IEGs in response to mitogens but show 
no apparent compromise to their proliferation rate or ability to self-renew (Schratt et 
al.,  2001).  Interestingly,  their  colony-forming  efficiency  was  lower  than 
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heterozygous  controls  implying  that  there  may be a  role  for these transcriptional 
targets in ES cells, although the authors suggest the difference may be caused by 
decreased plating efficiency as a result of down-regulation of actin expression.  Srf-
null ES cells were also found to differentiate inefficiently upon LIF withdrawal and 
in response to DMSO treatment (Weinhold et al., 2000). The authors of that work 
attributed the phenotype to a non cell-autonomous loss of mesodermal induction but 
did not rigorously test the ability of Srf-null ES cells to differentiate into other cell 
types. An examination of these cells in defined, serum-free conditions might reveal a 
more  general  compromise  in  their  ability  to  differentiate.  If  the  gene  products 
activated by ERK signalling, in particular the IEGs, promote differentiation Srf-null 
ES  cells  would  not  differentiate  efficiently.  Similarly  to  Fgf4-null  ES  cells  (see 
chapter  3),  they may no longer  require  inhibition  of  the FGF4-MAPK signalling 
cascade for efficient self-renewal and may phenocopy 3i culture in the presence of 
CHIR alone.  Furthermore,  if  ERK transcriptional  targets  have  a  role  in  ES  cell 
viability  and  proliferation  the  Srf-null  ES  cells  would  be  predicted  to  exhibit 
decreased colony forming efficiency, an effect that might be more readily observed 
in serum-free culture. 
In addition to regulation of TF activity,  MAPK signalling can regulate chromatin 
conformation. For example, phosphorylation of the co-activators CBP and p300 by 
ERK stimulates  their  histone  acetyl  transferase  (HAT) activity  (Liu  et  al.,  1999; 
Gusterson et al.,  2002). The resulting increase in histone acetylation is associated 
with  increased  transcription.  In  some  cases  nucleosome  acetylation  activity  is 
required  for  efficient  gene activation  by MAPK signalling  (Alberts  et  al.,  1998). 
Furthermore,  downstream  targets  of  ERK,  the  mitogen-  and  stress-activated 
kinases-1  and -2 (MSK1/2),  are  known to  phosphorylate  histone  H3 on residues 
Ser10 and Ser28 (Soloaga et al., 2003). Chromatin immunoprecipitation experiments 
show that  H3-phosphorylation  is  associated  with  active  IEGs.  Together  with  the 
observation  that  Ras-transformed  cells  have  increased  H3 phosphorylation  and a 
more open chromatin formation (reviewed in (Dunn et al., 2005)) this suggests that 
increased ERK activity may promote open chromatin and increased gene expression. 
If levels of lineage-associated gene transcription increase in response to ERK activity 
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this could increase the chances of initiating differentiation (Silva and Smith, 2008). It 
would be interesting to examine the activation status of MSK1/2 and the chromatin 
structure of ES cells in 3i culture conditions. If MSK1/2 are involved in promoting 
differentiation inhibition of their activity would be expected to recapitulate the effect 
of inhibiting ERK activation.   
The  work  described  in  this  chapter  builds  on  a  growing  body  of  information 
implicating the ERK pathway in the promotion of differentiation. The fact that the 
phenotypes described for ES cells in vitro (Burdon et al., 1999b; Kunath et al., 2007; 
Stavridis et al., 2007) can be directly related to the failure of the ICM to form the 
primitive endoderm when this pathway is inactivated (Chazaud et al., 2006) gives us 
confidence  that  the  phenomenon  is  of  relevance  to  the  behaviour  of  ES  cell 
equivalents  in  vivo.  This  is  not  the  case  for  other  pathways  implicated  in  the 
maintenance  of ES cells  with the exception  of the role  of signalling  through the 
gp130 receptor in diapause (Nichols et al., 2001). It is hoped that these findings will 
translate  to  humans  where  the  regulation  of  early  differentiation  events  may  be 
conserved and that this will allow us to establish ‘true’ ES cells from human embryos 
as opposed to existing lines which correspond more closely to the post-implantation 
epiblast and EpiSC lines (Brons et al., 2007; Lovell-Badge, 2007; Tesar et al., 2007).
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Chapter 5: The role of GSK3 inhibition in the culture 
of mouse embryonic stem cells
5.1 Introduction 
CHIRON99021 (Nikoulina et  al.,  2002) (CHIR) is a critical  component of 3i.  Its 
removal from 3i to leave only PS results in a degree of spontaneous differentiation 
into neurons and a severe compromise in cell viability and proliferation (see chapter 
4).  In  this  chapter  the  role  of  this  small  molecule  inhibitor  in  self-renewal  is 
examined by investigating candidate targets that are predicted to be affected by the 
inhibition of GSK3. 
5.1.1 CHIRON99021
The  choice  of  CHIR in  the  wider  context  of  GSK3 inhibition  has  already been 
discussed (see chapter 3) but here the inhibitor is described in more depth. A series 
of  substituted  aminopyrimidines  were  generated  and  found  to  be  capable  of 
inhibiting GSK3 activity at concentrations in the nanomolar range (Nikoulina et al., 
2002).  Testing  of  two  such  compounds,  named  CHIR98014  and  CHIR99021, 
revealed that they inhibited the activity of GSK3-α and –β at concentrations at least 
500 times lower than the effective concentrations obtained for a panel of 20 other 
kinases which included the closest homologues of GSK3, Cdc2 and Erk2 (Nikoulina 
et al., 2002). They act as inhibitors of ATP binding and were similarly potent against 
both isoforms of GSK3. 
GSK3 is  a  promising target  for the treatment  of TypeII  diabetes.  In resting cells 
GSK3 is active and phosphorylates and inactivates its substrate glycogen synthase 
(GS) (Embi et al., 1980). Insulin secretion in response to elevated blood sugar results 
in activation of PI3K/PKB signalling, phosphorylation and inhibition of GSK3 and 
subsequent release of GS from inhibition (Alessi and Cohen, 1998). TypeII diabetics 
are insulin-insensitive and this pathway operates less effectively leaving them prone 
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to episodes of hyperglycemia. It is hoped therefore that direct inhibition of GSK3 
might restore GS activity and glycogen synthesis in patients who do not respond to 
insulin. Promisingly, both CHIR compounds were shown to increase GS activity and 
to reduce hyperglycemia in Rat diabetes models (Cline et al., 2002; Nikoulina et al., 
2002). More recently, CHIR99021 has been tested against a larger panel of kinases 
and compared directly to other well known GSK3 inhibitors. It was found to be both 
the most potent and the most specific inhibitor and was recommended by the authors 
for use in the study of GSK3 (Bain et al., 2007).
5.1.2 Upstream and downstream of GSK3
GSK3 is regulated by multiple signalling pathways and phosphorylates many targets, 
usually resulting in their inactivation (reviewed in (Doble and Woodgett, 2003)). It 
exists  in  a  constitutively  active  state  and  is  negatively  regulated  in  response  to 
various  signals.  Phosphorylation on an N-terminal  serine (Ser21 for GSK3-α and 
Ser9 for GSK3-β) inhibits the kinase activity of the enzyme (McManus et al., 2005). 
The  phosphorylated  serine  acts  as  a  “pseudosubstrate”  for  the  active  site  of  the 
enzyme,  preventing  it  from  binding  to  other  phosphorylated  residues.  Ser9/21 
phosphorylation  can  be  catalysed  by several  kinases  including  S6K,  RSK,  PKA, 
PKC and the best known, PKB (Cross et al., 1995). This makes GSK3 sensitive to 
regulation by growth factors and changes in nutrient availability.  The best studied 
example  is  phosphorylation  by  PKB  in  response  to  insulin  signalling,  allowing 
insulin to increase glycogen synthesis by de-inhibition of GS (Fig5.1) (McManus et 
al.,  2005).  This  mechanism  of  inhibition  reflects  GSK3’s  preference  for  primed 
substrates.  GSK3  recognises  a  motif  of  Ser/ThrXXXSer/Thr-P  (where  X  is  any 
amino acid and P indicates phosphorylation). The N-terminal Ser/Thr is the residue 
targeted for phosphorylation and the C-terminal Ser/Thr is phosphorylated, serving 
as  a  priming  site  for  recruitment  of  GSK3.  GSK3  is  thought  to  bind  to  the 
phosphorylated residue, positioning its kinase domain optimally relative to the target 
site (reviewed in (Doble and Woodgett, 2003)). 
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There are other GSK3 targets that are regulated in a similar manner to GS. That is, 
they  are  negatively  regulated  and  released  from  inhibition  following  Ser9/21 
phosphorylation  of  GSK3.  The  activity  of  TF  c-Jun  is  inhibited  by  GSK3 
phosphorylation while c-Myc is targeted for proteolysis. CyclinD1 is also targeted 
for proteolysis (Diehl et al., 1998), implicating GSK3 in the regulation of cell cycle 
while inhibition of eukaryotic translation initiation factor 2B (eIF2B) reduces protein 
synthesis  by  inhibiting  translation  (Welsh  et  al.,  1998).  GSK3  activity  can  be 
implicated in activities as diverse as glycogen metabolism, translation and apoptosis 
all  of  which  are  therefore  subject  to  regulation  by  pathways  promoting 
phosphorylation of GSK3 on Ser9/21. 
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GSK3 is also regulated by Wnt signalling (Fig5.1). GSK3, together with proteins 
including  Axin,  APC and  β-catenin,  forms  a  complex  known as  the  destruction 
complex.  This  complex  is  active in  ‘resting’  cells,  phosphorylating  β-catenin and 
targeting it for ubiquitin-dependent proteolysis (reviewed in (Clevers, 2006)). GSK3 
is  the  kinase  responsible  for  β-catenin  phosphorylation.  β-catenin  is  ‘primed’  by 
casein  kinase  I  (CKI)-mediated  phosphorylation  on  Ser45  and  subsequently 
phosphorylated by GSK3 on residues Thr41, Ser37 and Ser33 (reviewed in (Patel et 
al., 2004)). GSK3 is also thought to modulate the activity of the destruction complex 
by phosphorylating its components. Phosphorylation of Axin, which is believed to 
serve  as  a  scaffolding  protein  for  the  complex,  results  in  its  stabilization  and 
increased affinity for β-catenin (Rubinfeld et al., 1996; Jho et al., 1999; Yamamoto et 
al.,  1999)  while  phosphorylation  of  APC also  increases  its  binding  to  β-catenin 
(Rubinfeld et al., 1996). Active GSK3 therefore regulates β-catenin proteolysis by 
promoting  its  interaction  with  the  destruction  complex  and  by  directly 
phosphorylating it. 
When exposed to Wnt ligands β-catenin phosphorylation is reduced and the protein 
is stabilized. Wnt ligands bind to the transmembrane receptor, Frizzled (Fz), which 
can cooperate with another receptor, low-density lipoprotein (LDL)-receptor-related 
protein  5 or  6 (LRP5/6).  LRP5/6 is  required for transmission of  the Wnt signal. 
Surprisingly,  activation  of  LRP5/6  and  transmission  of  the  Wnt  signal  requires 
phosphorylation of LRP5/6 by GSK3 and Casein Kinase-Iγ (CKIγ) (Davidson et al., 
2005;  Zeng  et  al.,  2005).  Phosphorylation  is  activated  through  a  poorly  defined 
mechanism  in  response  to  Wnt  ligands  and  appears  to  occur  sequentially,  with 
GSK3-mediated  phosphorylation  first  (Zeng  et  al.,  2005).  In  this  instance  GSK3 
appears to act in the absence of priming phosphorylation. The activity of both GSK3 
and CKIγ is required for the activation of a TCF/LEF reporter (Zeng et al., 2005). 
The most  up to date model  of Wnt signalling proposes that ligand binding to Fz 
results in recruitment of LRP5/6 and Dishevelled (Dsh), another protein crucial for 
transmission of the Wnt signal. Dsh in turn recruits Axin to which GSK3 is known to 
bind. In this manner it is thought GSK3 is brought into contact with LRP5/6 where it 
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can mediate phosphorylation of motifs on the LRP5/6 intracellular domain, creating 
binding sites for the recruitment of Axin to LRP5/6 which it is known to bind (Zeng 
et  al.,  2008).  Axin-bound  GSK3  may  then  further  phosphorylate  LRP5/6,  fully 
activating the receptor. 
The  conflicting  effects  of  GSK3  in  this  signalling  pathway,  both  positive  and 
negative regulation,  appear to be mediated by membrane-bound and cytoplasamic 
pools respectively. Expression of wild-type GSK3 antagonizes Wnt3a activation of 
the  TCF/LEF  reporter  whereas  expression  of  a  membrane-bound form of  GSK3 
synergizes with Wnt3a to promote TCF/LEF reporter activity (Zeng et al., 2005). In 
a  complementary  experiment  expression  of  a  peptide  capable  of  binding  and 
inhibiting GSK3 activated Wnt signalling but expression of the same protein fused to 
a motif that directs it to the membrane actually inhibits signalling (Zeng et al., 2008). 
Thus, GSK3 is involved in the regulation of canonical Wnt signalling at multiple 
levels and precisely how binding of Wnt ligands to Fz results in a decrease of GSK3-
mediated β-catenin phosphorylation remains unclear. 
Axin is a limiting factor in Wnt signalling. Increasing its levels decreases β-catenin 
activity and can rescue the loss of destruction complex function observed upon loss 
of APC (reviewed in (Clevers, 2006)). Loss of Axin results in a severe reduction of 
Wnt-induced LRP5/6 phosphorylation (Zeng et al., 2008), suggesting that Axin is 
required  for  activation  of  Wnt  signalling,  but  the  absence  of  Axin  from  the 
destruction  complex  is  epistatic  to  this,  abolishing  β-catenin  phosphorylation  and 
proteolysis. Similarly, the loss of GSK3 totally abolishes activation of LRP5/6 but its 
absence from the destruction complex releases β-catenin from inhibition (Doble et 
al., 2007). GSK3-inhibitors would be predicted to inhibit both positive and negative 
regulation of Wnt signalling but the outcome is determined by the most downstream 
effect, inhibition of GSK3 in the destruction complex. 
There are likely to be multiple levels of control in β-catenin regulation but notably 
the  amount  of  GSK3 does  not  become  limiting  until  at  least  3  of  the  4  alleles 
encoding the  two isoforms  are  knocked out  (Doble et  al.,  2007).  Thus,  although 
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GSK3 is the enzyme ultimately responsible for targeting β-catenin for destruction, 
regulation of this activity is complex and may be mediated through modulation of 
structural components of the destruction complex.
Stabilized  β-catenin  accumulates  in  the  cytoplasm in  response  to  Wnt  signalling 
before translocating to the nucleus. In the nucleus β-catenin displaces corepressors 
such  as  Groucho  from  DNA-bound  TCF/LEF  TFs,  activating  transcription  of 
TCF/LEF  target  genes  including  components  of  the  destruction  complex, 
demonstrating another layer of autoregulation in the Wnt signalling pathway. Other 
target  genes,  such  as  cMyc and  CyclinD1,  have  created  a  great  deal  of  interest 
because of their implications for cancer. Mutations affecting the destruction complex 
or β-catenin itself are frequently found in cancers (reviewed in (Clevers, 2006)).
It is important to note that the two mechanisms described above for the regulation of 
GSK3 act independently. Insulin/PKB-mediated GSK3 inhibition does not result in 
stabilization  of  β-catenin  while  Wnt  signalling  does  not  lead  to  Ser9/21 
phosphorylation of GSK3 or result in decreased phosphorylation of targets such as 
GS. Several elegant studies have demonstrated this. ES cells which carry knock-in 
mutations of Ser9/21 become insensitive to insulin signalling but retain their Wnt 
response (McManus et  al.,  2005).  Similarly,  ES cells  lacking  wild-type  GSK3 in 
which GSK3α carrying a substitution of Ser21 has been expressed re-establish Wnt-
sensitive  control  of  β-catenin  (Doble  et  al.,  2007)  clearly  demonstrating  the 
independence of this pathway from Ser21 phosphorylation. This separation of GSK3 
activities  is  likely caused by the incorporation  of  a  proportion  of  GSK3 into the 
destruction  complex  where  it  is  inaccessible  to  the  kinases  that  mediate  Ser9/21 
phosphorylation  and  is  regulated  exclusively  by  Wnt  signalling  (reviewed  in 
(Clevers, 2006)). Thus, it is important to bear in mind that pharmacological inhibitors 
of GSK3 will simultaneously mimic the effects of canonical Wnt signalling and of 
inhibition  by  Ser9/21  phosphorylation,  a  situation  that  cannot  be  completely 
recapitulated by the activation of any one signalling pathway. 
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5.2 Results
5.2.1 ES cell culture in CHIR99021
In chapter three I provided evidence that the effect of CHIR is specific to GSK3 
inhibition  and  that  CHIR  activates  canonical  Wnt  signalling  and  leads  to 
dephosphorylation  of  known  GSK3  targets.  However,  the  effects  of  CHIR  on 
molecular targets tell us nothing in themselves about how CHIR regulates ES cell 
self-renewal. As a first step towards elucidating this I examined the morphology and 
growth of cells cultured with CHIR in combination with different factors known to 
modulate self-renewal. 
Cells cultured in CHIR alone, using N2B27 as a basal medium, initially proliferated 
as  morphologically  undifferentiated  cells  in  three-dimensional  colonies  similar  to 
those  observed  in  3i  (Fig5.2a).  However,  with  increasing  time  in  culture 
differentiated cells emerged (Fig5.2a) and increasing cell death was observed upon 
passaging.  Cultures  could  be  maintained  with  the  presence  of  morphologically 
undifferentiated cells  for several  passages (Fig5.2.1) but eventually differentiation 
and cell death mean that the cells can no longer be passaged. The differentiated cells 
that emerged were non-neural (Fig5.2a,b), consistent with a role for Wnt signalling 
in the inhibition of neural differentiation (Aubert et al., 2002; Haegele et al., 2003), 
which would normally proceed in N2B27 alone (Ying et al., 2003b). The persistence 
of undifferentiated cells for at least 7 passages (Fig5.2.1) is consistent with a partial 
block of differentiation as cells cultured in N2B27 alone cannot be passaged more 
than once. The highly proliferative cells observed in the initial culture also suggest 
that CHIR maintains cell proliferation. Contrast this effect with PS cultures where 
differentiation was mostly blocked but proliferation was poor (Fig5.2a). The non-
neural differentiation observed also suggested that CHIR promotes differentiation or 
alters the fate of spontaneously differentiating cells. I conclude that GSK3-inhibition 
has pleiotropic effects on ES cells and is not sufficient to support long-term culture. 
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BMP signalling has been demonstrated to promote self-renewal in the presence of 
LIF by blocking neural differentiation. As neural differentiation does not occur in the 
presence  of  CHIR it  seemed  unlikely  that  the  addition  of  BMP4  would  have  a 
positive  effect  on  self-renewal.  However,  it  has  been  suggested  that  BMP4 can 
promote self-renewal by modulating MAPK signalling pathways (Qi et al., 2004) and 
the effect of any signalling pathway is altered by the context in which it is activated. 
When ES cells were cultured in the presence of BMP4 and CHIR there was little 
difference  as compared  to CHIR alone other  than a morphological  change in  the 
differentiated  cells  (Fig5.2b).  Interestingly,  however,  the  normally  potent 
differentiation-inducing  activity  of  BMP4 appeared  to  be  partially  suppressed  as 
judged by the persistence of ES cells over several passages (Fig5.2b), which is never 
seen in BMP4 alone (Ying et al., 2003a), and the absence of the large, flattened cells 
characteristic  of BMP4-induced differentiation  (Fig5.2b).  The effect  of  BMP4 on 
culture in the presence of CHIR was further investigated by attempting to maintain 
cultures  long-term.  BMP4  addition  to  3i  slightly  increased  the  amount  of 
spontaneous  differentiation  observed  but  cultures  could  readily  be  maintained 
(Fig5.2.1).  ES cells  cultured  in  CHIR and BMP4 were highly heterogeneous  but 
could be maintained for at least 7 passages and retained a population of cells that 
express Oct4 (Fig5.2.1), a phenotype similar to that seen for CHIR alone (Fig5.2.1). 
These results suggest that GSK3 inhibition not only inhibits neural differentiation but 
also prevents BMP-induced differentiation. It appears that GSK3 inhibition restricts 
differentiation to a limited set of lineages but does not homogeneously drive ES cells 
to differentiate. In fact, persisting ES cells expand and can be passaged, indicating 
that, at least in bulk culture, GSK3 inhibition helps maintain a population of ES cells. 
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LIF is the best characterised of the pro-self-renewal signalling molecules. It appears 
to prevent differentiation by inhibiting the differentiation-inducing effects of serum 
or BMP4 and is also likely to play a role in cell survival and proliferation. It was 
reasoned that the combination of LIF and CHIR might inhibit non-neural and neural 
differentiation  respectively  and  in  doing  so  promote  self-renewal.  In  fact,  it  has 
already been reported that LIF and Wnt signalling can synergize to promote efficient 
self-renewal (Ogawa et al.,  2006). ES cells  cultured in a combination of LIF and 
CHIR  formed  highly  refractile,  rounded  up  colonies  with  an  extremely  regular 
undifferentiated  morphology  (Fig5.2c).  They  could  be  passaged  for  an  extended 
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period in  culture  with little  evidence of differentiation  and formed colonies  from 
single cells with efficiency as high as that seen for any other growth condition tested 
(Fig5.2d). The colonies formed in LIF plus CHIR also tended to be larger and more 
regular in appearance (Fig5.2e). It appears that this combination effectively blocks 
differentiation and the high clonogenicity suggests that cell survival is enhanced. A 
similar effect on clonogenicity and colony size was observed when LIF was added to 
3i (see chapter 3) providing further evidence that LIF and CHIR have additive effects 
on  cell  survival  and/or  proliferation.  Similarly,  cells  lacking  GSK3 (DKO cells) 
exhibited significantly enhanced self-renewal in the presence of LIF although LIF is 
insufficient  to  block  the  spontaneous  differentiation  observed  in  DKO cells  (see 
chapter 3). This implies a dosage effect with optimal self-renewal occurring upon 
incomplete GSK3 inhibition while a total lack of GSK3 promotes differentiation that 
cannot  be  blocked  by  the  addition  of  LIF,  although  it  is  effectively  blocked  by 
inhibition of ERK activity. 
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To further investigate the interaction between LIF and GSK3 inhibition a chimeric 
receptor that permits activation of STAT3 by the addition of the cytokine GCSF but 
does  not  activate  ERK1/2  (Burdon  et  al.,  1999b)  was  utilised.  The  intracellular 
domain  of gp130 is  fused to the  extracellular  domain  of  the GCSF receptor  and 
addition of GCSF causes receptor dimerization and activation. The tyrosine residue 
(Y118) responsible for binding Shp2 has been substituted for phenylalanine (Y118F) 
to prevent activation of ERK1/2. This mutation has the added effect of preventing 
SOCS3-mediated  negative  feedback  and  promotes  hyperactivation  of  STAT3  at 
higher concentrations of GCSF. Lines stably expressing the chimeric receptor were 
generated  by  electroporating  E14Tg2a  ES  cells  with  linearised  plasmid  DNA 
encoding the fusion protein and selecting for zeocin resistance. Colonies were picked 
after  10-12 days  of selection and expanded to form clonal lines termed ‘Y118F’. 
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Clones were readily established and were indistinguishable from parental cells when 
cultured in standard conditions.
The  receptor  can  be  activated  by  the  addition  of  media  conditioned  with  GCSF 
(GCSF-CM). Conditioned media is generated by transiently transfecting Cos7 cells 
with a plasmid encoding GCSF and harvesting the media in which they are grown. 
The activity of GCSF-CM was tested by treating a previously described cell  line 
(Burdon et al., 1999b), generated by introducing the chimeric receptor into D027 ES 
cells  which  express  β-galactosidase  from  the  Oct4  locus,  with  increasing 
concentrations of GCSF-CM and assessing the expression of β-galactosidase in cell 
lysates.  As  previously  described,  total  β-galactosidase  activity  initially  increased 
with increasing GCSF but was reduced at high concentrations (Fig5.3a). This GCSF-
CM was subsequently used to assess the phenotype of Y118F ES cells.
The activation of STAT3 was assessed in the clonal line, Y118F(1), in response to 
increasing  concentrations  of  GCSF-conditioned  media.  A  STAT3-responsive 
luciferase  reporter  was  activated  in  a  dose-dependent  manner  (Fig5.3b).  Even 
dilutions  of  the  conditioned  media  of  1:20000  produced  an  effect  on  STAT3 
activation comparable to that seen with saturating concentrations of LIF. The low 
amounts of conditioned media used at these dilutions argue against the possibility of 
unintended effects of the conditioned media.  The effect  of combining GCSF with 
3μM CHIR was assessed at a range of concentrations and it was found that together 
they  promoted  self-renewal  more  efficiently  than  either  did  separately.  At  low 
concentrations  of  GCSF,  which  did  not  support  efficient  self-renewal  (1:80000 
dilution),  the  addition  of  CHIR  fully  restored  the  formation  of  undifferentiated 
colonies at  clonal density (Fig5.3c).  I  conclude that STAT3 activation and GSK3 
inhibition  act  together  to  promote  efficient  self-renewal.  Specifically,  GSK3 
inhibition  lowered  the  threshold  for  STAT3 activation  required  for  optimal  self-
renewal. This is in agreement with Ogawa et al who found that Wnt3a supported ES 
cell self-renewal at sub-threshold concentrations of LIF (Ogawa et al., 2006). This 
may in part explain the behaviour of ES cells cultured in CHIR alone if there is a 
degree of paracrine activation of STAT3 signalling in bulk cultures.
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From our initial observations of 3i ES cell culture it is clear that blockade of the 
ERK1/2  signal  eliminates  the  spontaneous  differentiation  seen  in  CHIR99021 
cultures and allows self-renewal to proceed efficiently (see chapter 3). By examining 
the effects of combining CHIR with two other self-renewal factors, LIF and BMP4, I 
have established that LIF but not BMP4 can promote self-renewal in this context. 
The evidence suggests that CHIR promotes self-renewal only when its differentiation 
promoting activities are blocked and that this can be achieved by imposing a general 
restriction  on  differentiation  through ERK inhibition  (Kunath  et  al.,  2007)  or  by 
blocking non-neural differentiation through activation of STAT3 (Niwa et al., 1998; 
Ying et al., 2003a). Furthermore, the effects of LIF and CHIR on cell viability, which 
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are clearly observed upon the addition of either to PS, can be combined to further 
enhance viability,  as evidenced by increased clonogenicity (Fig5.1d). This implies 
that LIF and CHIR activate independent pathways capable of functioning in parallel 
to enhance self-renewal. The targets of these pathways remain to be identified. They 
may be distinct or the pathways may converge on a common effector(s). 
 5.2.2 A role for Canonical Wnt Signalling?
As  described  above,  GSK3  inhibition  can  mimic  the  effects  of  canonical  Wnt 
signalling by preventing β-catenin phosphorylation on the residues that target it for 
proteolysis  (Clevers,  2006).  Several  reports  have  attributed  the  effects  of  GSK3 
inhibitors  to  activation  of  β-catenin  and have  shown that  similar  phenotypes  are 
observed upon addition of Wnt ligands (Sato et al., 2004; Ogawa et al., 2006; Takao 
et al., 2007). However, these studies are conflicting in their conclusions and often 
rely on the use of relatively unspecific GSK3 inhibitors and conditioned media as a 
source of Wnt ligands. I wished to investigate the significance of β-catenin activation 
for the phenotype observed with CHIR.
CHIR reduces  β-catenin  phosphorylation  and  activates  a  TCF/LEF  reporter  in  a 
dose-dependent manner (see chapter 3). TCF/LEF reporter activation was assessed in 
response to recombinant Wnt3a and compared directly to the effect of CHIR. Wnt3a 
elicited  a  dose  dependent  response  from the  TCF/LEF  reporter  but  to  obtain  an 
equivalent level of activation to that observed with 3μM CHIR high concentrations 
(~100ng/ml) of Wnt3a were required (Fig5.4a). To assess the effect of Wnt3a on ES 
cells  Wnt3a was substituted  for  CHIR in 3i  at  a  range of concentrations.  It  was 
capable of supporting a limited degree of self-renewal at concentrations approaching 
100ng/ml. The cells assumed a morphology similar to that observed in 3i, ie. rounded 
up colonies (Fig5.4b). However, spontaneous differentiation was more evident, the 
cells  proliferated  relatively  poorly  in  bulk  culture  and  the  robust  self-renewal 
observed  in  3i  was  never  reproduced.  To  further  test  this  clonal  assays  were 
performed and the colony forming efficiency of ES cells in PS, 3i or PS plus Wnt3a 
scored (Fig5.4c). Virtually no colonies formed in PS alone and those that did were 
153
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
either  extremely small  or  extensively differentiated  (Fig5.4d).  Addition of Wnt3a 
increased  the  number  of  colonies  formed  (Fig5.4c)  and  the  appearance  of  the 
colonies  formed  was  shared  between  completely  undifferentiated  and  colonies 
surrounded by a skirt of differentiation (Fig5.4d). However, Wnt3a failed to fully 
recapitulate the results obtained in 3i where more colonies were formed, a higher 
proportion of which were totally undifferentiated (Fig5.4c,d). The effect of Wnt3a 
may  be  to  inhibit  the  residual  neural  differentiation  observed  in  PS  as  this  was 
eliminated in PS plus Wnt3a cultures but additional effects cannot be ruled out. 
The best characterised signal downstream of Wnt ligands is activation of β-catenin. 
Activation of β-catenin independent of Wnt signalling can be achieved by expressing 
a stabilized form of β-catenin although high levels of transgene expression elicit a 
hyperactivation  phenotype.  Stabilized  β-catenin  lacks  the  residues  normally 
phosphorylated  by  GSK3  and  is  therefore  immune  to  proteolysis.  A  fusion  of 
stabilized  β-catenin  and  a  modified  oestrogen  receptor  (β-cateninER),  which  is 
activated by the addition of 4-hydroxy tamoxifen (4OHT), was used. ES cells stably 
expressing this fusion protein were generated (transfection performed by Q-L. Ying) 
and used to assess the effect of β-catenin activation on self-renewal in the context of 
PS (Fig5.4e). In PS alone both parental and β-cateninER cells grew poorly with a 
high degree of cell  death. This suggests that  expression of the construct does not 
confer a strong phenotype in the absence of 4OHT. Both lines exhibited rounded up 
morphology in CHIR alone and a degree of spontaneous differentiation although the 
β-cateninER  appeared  to  have  a  higher  proportion  of  morphologically 
undifferentiated cells suggesting clonal differences or a 4OHT-independent effect of 
β-cateninER expression. As expected, addition of 4OHT resulted in morphological 
changes similar to those observed with Wnt3a in the β-cateninER but not the parental 
cell  line,  indicating that  the 4OHT had no effect  on wild-type  cells.  Similarly to 
Wnt3a,  activation  of  β-catenin  in  the  presence  of  PS  enhanced  self-renewal  as 
compared  to  PS  alone.  Rounded  up,  morphologically  undifferentiated  colonies 
formed  but  the  degree  of  cell  death  was  higher  than  that  observed  in  3i.  With 
continued  passaging  β-cateninER  cells  cultured  in  PS+4OHT deteriorated.  These 
results  indicate  that  while  stabilized  β-catenin  expression  causes  morphological 
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changes similar to those caused by CHIR and enhances ES cell growth relative to 
that observed in PS alone it cannot fully replace CHIR. 
155
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
156
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
From these experiments I conclude that β-catenin activation may in part mediate the 
effect of CHIR in 3i, perhaps by promoting the expression of TCF/LEF target genes 
that  antagonise  neural  differentiation.  The  morphology  of  the  ES  cell  colonies 
suggests that β-catenin stabilisation is responsible for the rounded up morphology of 
cells cultured with CHIR. This may be caused by increasing the amount of β-catenin 
available  for  incorporation  into  adherens  junctions  and  an  increase  in  cell-cell 
interactions. It remains unclear from these findings, however, what additional effects 
CHIR has on self-renewal and whether β-catenin stabilisation is indispensable for 
efficient self-renewal in 3i. 
One  effect  of  β-catenin  stabilisation  is  the  activation  of  TCF/LEF  target  genes. 
Robust activation of the TCF/LEF reporter, TOPFlash (Fig5.4a), and upregulation of 
known TCF/LEF target genes  Brachyury, Axin and Cdx1 in response to CHIR was 
observed (Fig5.9c). This transcriptional activation can be inhibited by the expression 
of a dominant negative form of the human TCF/LEF TF, hLef1, termed ΔN-hLef1. 
This protein lacks the N-terminal domain responsible for interaction with β-catenin 
and is not therefore activated upon accumulation of β-catenin in the nucleus but acts 
as a constitutive repressor of its target genes. ES cells stably expressing ΔN-hLef1 
were  generated  (Q-L.  Ying).  The  cells  were  readily  expanded  and  grew 
indistinguishably from the parental cell line. The TCF/LEF reporter response in these 
cells was assessed and a small but reproducible reduction in the response to CHIR 
observed. As the block to TCF/LEF transcription was incomplete it was not possible 
to  assess  the  possibility  that  it  is  completely  dispensible  for  self-renewal  in  3i. 
However,  a  competition  assay  was  performed  to  assess  whether  down-regulated 
TCF/LEF transcription has any effect on self-renewal (Ying et al, in press). The ΔN-
hLef1 transgene could be excised from the genome by expression of Cre, activating 
GFP expression from a cassette downstream. Cre-excision was performed and GFP 
positive and negative cells mixed at a ratio of 1:1 in either serum plus LIF or in 3i. 
The proportion of GFP positive cells was examined after several passages. In 3i the 
proportion of GFP+ cells decreased implying that the expression of ΔN-hLef1 (in the 
GFP- cells) actually conferred a growth advantage. In serum and LIF conditions the 
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ratio of GFP+ to GFP- cells did not change. These results suggest that  TCF/LEF 
signalling  does  not  promote  self-renewal  in  3i  and  may  in  fact  antagonize  self-
renewal.
Several attempts were made to further block TCF/LEF transcription by episomally 
expressing ΔN-hLef1. Episomal expression allows for highly elevated transcription 
(Chambers et al., 2003). However, ES cells could not be maintained in any condition 
when  episomal  expression  was  attempted.  This  suggests  that  a  total  block  of 
TCF/LEF transcription is incompatible with ES cell propagation or that expression of 
the construct at these levels has non-specific toxic effects.  
In a further attempt to address the role of β-catenin in 3i-directed self-renewal cells 
genetically deficient for β-catenin (Anton et al., 2007) were obtained and cultured. β-
catenin-null ES cells were maintained on feeders in serum and LIF and exhibited a 
more flattened morphology than heterozygote controls (Fig5.5.1a). When cultured on 
gelatine they differentiated spontaneously and grew poorly (Fig5.5.1a). Addition of a 
MEK-inhibitor (PD03) enhanced self-renewal of heterozygous cells but appeared to 
promote  differentiation  of  null  cells  into  large,  flattened  cells  that  ceased 
proliferating (Fig5.5.1a). Viability was extremely poor when the cells were cultured 
in  serum-free  conditions  with  the  cells  adopting  a  dispersed  morphology  and 
increasing cell death (Fig5.5.1b). Cultures could not be maintained in any serum-free 
condition tested. The behaviour of these cells, in particular their response to MEK-
inhibition, is inconsistent with the ES cell phenotype. The loss of β-catenin may have 
irreversibly changed the properties of these cells such that they no longer respond to 
signalling  pathways  in  the  same  way  as  wild-type  ES  cells.  Analysis  of  gene 
expression by real-time PCR confirms that β-catenin-null ES cells differ from wild-
type  ES cells  (Fig5.5.1c).  They express  significantly  lower  levels  of  Nanog and 
elevated levels of Fgf5 (Fig5.5.1c). Oct4 levels were reduced approximately 2-fold. 
This may be consistent with an EpiSC phenotype (Brons et al., 2007; Tesar et al., 
2007) or another differentiated derivative of ES cells. I conclude that the cells are not 
appropriate to test the requirements for β-catenin in 3i culture. 
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Conditional  deletion  of  a  floxed  allele  in  β-catenin heterozygote  cells  (Fig5.5) 
provided an opportunity to test directly the effect of loss of β-catenin in the context 
of  3i.  β-catenin-/flox  ES  cells  were  cultured  in  3i  and  transfected  with  a  plasmid 
encoding Cre. Transfected cells could be identified by expression of GFP transcribed 
downstream of Cre and translated from an IRES. 24 hours after transfection cells 
were sorted by flow cytometry for GFP expression and plated onto MEFs in serum 
and LIF or in 3i. The GFP- population efficiently formed colonies in 3i on MEFs as 
expected but the GFP+ population formed significantly fewer colonies (Fig5.5.1d). 
The colonies formed from the GFP+ population were morphologically distinct. They 
formed flat colonies rather than rounded up colonies and had poor cell-cell adhesion 
(Fig5.5.1e) perhaps as a result of the loss of adherens junctions (Bienz, 2005). These 
colonies grew poorly and could not be picked and expanded as clones. The reduction 
in  colony  forming  ability  and  the  apparent  cessation  in  growth  suggests  that  β-
catenin  is  essential  for  growth  in  3i.  However,  the  cells  also  grew  poorly  in 
conditions intended to serve as a positive control, serum and LIF, making it difficult 
for us to interpret this experiment with confidence. It may be that it is not possible to 
generate bona fide ES cells lacking β-catenin. It would be informative to repeat this 
experiment and to include growth conditions that support the growth of EpiSCs to 
investigate the possibility that the loss of β-catenin promotes a conversion to this cell 
type. 
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5.2.3 Adherens Junctions
 
Adherens  junctions  are  protein  complexes  occurring  at  cell-cell  junctions  that 
mediate  cell-cell  interactions  (reviewed  in  (Bienz,  2005)).  Cadherins  are 
transmembrane  proteins  and  essential  components  of  adherens  junctions.  They 
dimerize with other cadherins on adjacent cells and are linked through catenins to the 
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actin  cytoskeleton  (reviewed  in  (Weis  and  Nelson,  2006)).  E-cadherin  (Ecad)  is 
expressed in the oocyte and in all cells of the early embryo (Larue et al., 1994). It is 
required  for  compaction  and  for  trophectoderm  formation.  Embryos  lacking  E-
cadherin die around the time of implantation (Larue et al., 1994).  Ecad-/- ES cells 
exhibit decreased cell-cell adhesion and fail to form aggregates in suspension culture 
but  they  retain  expression  of  Oct4  and  can  form  teratomas  when  injected  into 
immuno-compromised mice (Larue et al., 1996). The teratomas display markers of 
differentiation  but  fail  to  form  organized  structures.  β-catenin  binds  directly  to 
cadherins and is thought to be essential for the interaction of adherens complexes 
with the actin cytoskeleton (reviewed in (Weis and Nelson, 2006)). The pool of β-
catenin  incorporated  in  these  complexes  is  thought  to  be  relatively  stable  and 
separate  from the  pool  that  interacts  with  the  destruction  complex  and  mediates 
canonical  Wnt  signalling  (reviewed  in  (Bienz,  2005)).  However,  it  remains  a 
possibility that stabilisation of β-catenin through inhibition of GSK3 may influence 
adherens junctions. In fact, our observations that ES cells grown in the presence of 
CHIR  form  rounded  up  colonies,  a  phenotype  indicative  of  increased  cell-cell 
adhesion, suggests that this may be the case. 
ES cells lacking E-cadherin were obtained (Larue et al., 1996). These cells adhere 
well to gelatine but assume a more dispersed morphology than wild-type controls 
(Fig5.6a). They are routinely cultured in serum plus LIF and upon transfer to serum-
free conditions exhibit a degree of cell death. Seemingly, an initial adaptation period 
is  required  after  which  the  cells  grow  robustly  in  3i,  2i  or  LIF  plus  BMP4 
(Fig5.6a,b). Failure to form the rounded up colonies observed in wild-type 3i cultures 
indicates that Ecad is required for this morphological change. To assess the effect of 
CHIR  cells  were  transferred  from  2i  to  PD03  or  CHIR  alone.  They  could  be 
propagated in both conditions but grew poorly compared to 2i. In CHIR alone the 
cells  assumed a more  refractile  morphology and tended to  detach from the plate 
while in PD03 alone spontaneous differentiation was more evident (Fig5.6a). After 5 
passages in 3i or in LIF plus BMP4  Ecad-/- cells remained positive for Oct4 and 
Nanog (Fig5.6b).  To assess the effect of the inhibitors quantitatively the cells were 
plated  at  clonal  density  in  different  culture  conditions  and the  resulting  colonies 
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stained for alkaline phosphatase after 6 days’ growth. In standard growth conditions, 
serum plus LIF, colony forming efficiency was high (Fig5.6.1a) with most colonies 
having  a  core  of  AP-positive  cells  surrounded  by  a  skirt  of  differentiation 
(Fig5.6.1b). In N2B27 alone very few colonies formed (Fig5.6.1a). Addition of either 
PD03 or CHIR enhanced the efficiency of colony formation and the 2i combination 
gave rise to undifferentiated colonies with the highest efficiency of all conditions 
tested  (Fig5.6.1a).  Morphologically,  colonies  formed  in  all  serum-free  conditions 
were smaller than in serum plus LIF and they tended to be dispersed although in LB 
or 2i colonies remained more compact (Fig5.6.1b). 
In section 5.2.2 a positive effect of canonical Wnt signalling on colony formation in 
wild-type ES cells was observed. However, the downstream effectors remain unclear. 
Addition of Wnt3a to bulk cultures of  Ecad-/- ES cells had little discernible effect 
(Fig.5.6.1c). Colony forming efficiency was not enhanced by the addition of Wnt3a 
in the presence or absence of PD03 (Fig5.6.1a) raising the possibility that the effect 
of Wnt3a on wild-type cells is mediated through an increase in adherens junction-
mediated cell-cell  adhesion.  No consistent  morphological  difference was apparent 
between colonies grown with or without Wnt3a (Fig5.6.1c). Batch-to-batch variation 
in Wnt3a activity is possible. To test that the Wnt3a used in this experiment was 
active, wild-type ES cells were cultured side-by-side short term in N2B27 alone or 
plus Wnt3a. While in N2B27 alone most cells died and only a few colonies persisted, 
in  the  presence  of  Wnt3a  cell  survival  was  enhanced  and  a  morphologically 
heterogeneous  culture  developed (Fig5.6.1d).  The difference clearly  demonstrated 
that the Wnt3a was active. To eliminate the possibility that prior adaptation to Wnt3a 
culture conditions was required for an effect  to be observed on colony formation 
Ecad-/- cells were cultured for two passages in PD03 plus Wnt3a prior to plating at 
clonal density. Furthermore, media was changed after three days to control for a loss 
of Wnt3a activity over the course of the 6 day experiment. Cells were plated in the 
presence of PD03 in the presence or absence of CHIR or Wnt3a. While the addition 
of CHIR to cultures enhanced the number of colonies formed and the proportion that 
were totally undifferentiated, Wnt3a had no significant effect (Fig5.6.1e). I conclude 
from  these  findings  that  increased  cell-cell  adhesion  is  not  critical  to  ES  cell 
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maintenance in 3i but that it may have a role in the promotion of self-renewal by 
Wnt3a. To be confident of this it would be necessary to rescue the response to Wnt3a 
by  re-expressing  Ecad.  Similarly,  reduced  Ecad  function  in  wild-type  cells  may 
ablate the response to Wnt3a (Fig5.4c). These data also raise the question of whether 
expression of stabilized β-catenin would have any effect on ES cells lacking Ecad. 
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5.2.4 Candidate Identification and Analysis of the role of 
CHIRON99021
The data  presented in  chapter  4  show that  ES cells  cultured  in  PS or  PD03 are 
partially prevented from differentiating but that efficient propagation and clonal self-
renewal only occurs if either LIF or CHIR are included in the culture media. CHIR 
eliminates residual neural differentiation but also has a clear effect on the survival 
and proliferation of ES cells. This is perhaps most clearly seen in the enhancement of 
colony formation of Nanog-overexpressing cells  (Fig5.8a). I  reasoned that known 
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targets of GSK3 and genes identified in the literature that enhance self-renewal were 
candidate downstream targets of CHIR. 
5.2.4.1 cMyc
Myelocytomatosis  oncogene  (Myc  or  cMyc)  is  a  basic  helix-loop-helix  leucine 
zipper  (bHLH-LZ)  TF  that  controls  the  expression  of  target  genes  through  its 
interaction with co-factors (reviewed in (Dang et  al.,  2006)). cMyc interacts  with 
Max  to  activate  transcription  but  the  Myc:Max  heterodimers  can  also  inhibit 
transcription  through  interaction  with  Miz1.  Mad  can  also  bind  Max  to  inhibit 
transcription and the relative levels of cMyc and Mad influence the activity of the 
ubiquitously  expressed  Max.  Global  analyses  of  the  influence  of  cMyc  on  gene 
expression suggest it  may regulate up to 15% of the genes in the genome.  cMyc 
target  genes  can  be  grouped  according  to  function  and  include  regulators  of 
metabolism, protein biosynthesis, the cell cycle, cell adhesion and the cytoskeleton 
(Dang et al., 2006).
Several properties of cMyc and its regulation made it an interesting candidate for 
study in the context of 3i and as a possible downstream target of GSK3 inhibition. As 
a  known  promoter  of  cell  growth  and  proliferation  (reviewed  in  (Sears,  2004)) 
elevated cMyc expression might promote the growth of ES cells, particularly in the 
context of PS where proliferation was observed to be compromised (see chapter 4). 
cMyc  has  also  been  implicated  in  the  regulation  of  stem  cell  self-renewal  and 
differentiation (Murphy et al., 2005). Of particular relevance for our studies is the 
apparent  demonstration  that  cMyc  is  a  transcriptional  target  of  STAT3 and  that 
forced  expression  of  cMyc  can  relieve  ES  cells  from their  dependence  on  LIF-
STAT3 signalling (Cartwright et al., 2005a). The authors of this work also suggested 
that cMyc represents a common target of canonical Wnt signalling and LIF-STAT3 
and  might  be  a  point  of  convergence  in  their  ability  to  promote  self-renewal.  It 
should be noted, however, that cMyc-null mice do not die until after the formation of 
the pluripotent epiblast  (Trumpp et al.,  2001) and that  cMyc-null ES cells can be 
derived and maintained, exhibiting only a slight decrease in growth rate (Baudino et 
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al., 2002). However, it is likely that cMyc exhibits redundancy with the related N-
Myc. Testing the Myc-dependence of ES cells would require the derivation of double 
knockout lines (Murphy et al., 2005). 
cMyc is regulated at the level of transcription and also at the level of protein stability 
(Fig5.7). cMyc transcription has been shown to increase in response to mitogenic 
stimuli  through activation of the ERK signalling cascade.  It is also a target of β-
catenin (He et al., 1998), placing it downstream of Wnt or of GSK3 inhibition. Given 
that in 3i ERK activation is blocked while GSK3 is inhibited it is conceivable that 
their contrasting effects on cMyc transcription might act to balance one another and 
maintain a critical level of cMyc. cMyc is also highly regulated at the level of protein 
stability (Sears, 2004; Dai et al., 2006), with significant changes in proteins levels 
sometimes occurring in the absence of any change in mRNA levels. Phosphorylation 
of cMyc at two sites in its N-terminus, Thr58 and Ser62 (Lutterbach and Hann, 1994; 
Pulverer  et  al.,  1994)  regulates  its  stability.  Ser62  phosphorylation  stabilizes  the 
protein while Thr58 phosphorylation promotes its ubiquitin-dependent proteolysis. 
Thr58  phosphorylation  is  dependent  on  prior  phosphorylation  at  Ser62  and 
ubiquitylation  requires  removal  of  the  Ser62 mark  by phosphatases  (reviewed in 
(Sears, 2004)). Ser62 is phosphorylated by ERK in response to activation of the Ras-
Raf-MEK-ERK cascade while Thr58 is phosphorylated by GSK3 (Gregory et al., 
2003). Serum stimulation of quiescent cells leads to rapid accumulation of cMyc. It 
is thought this occurs through activation of ERK and inhibition of GSK3 through 
PI3K-PKB-mediated  phosphorylation,  leading  to  the  accumulation  of  cMyc 
stabilized by phosphorylation on Ser62 but not Thr58 (Sears, 2004). The inhibitors in 
3i  are  predicted  to  influence  cMyc  protein  stability  both  positively  (CHIR)  and 
negatively (PS) (Fig5.7). 
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The level of cMyc expression was examined at both the transcript and protein level 
in 3i as compared to other growth conditions and in different combinations of the 
three inhibitors. In steady state conditions the cMyc transcript was decreased in both 
3i and PS (Fig5.7.1a) as compared to cells grown in serum and LIF, LIF and BMP4, 
or  CHIR alone.  These  results  indicate  that  transcript  levels  are  not  significantly 
affected  by  the  absence  of  serum ((Fig5.7.1a) compare  GL with  LB)  or  by  the 
presence  of  LIF  ((Fig5.7.1a)  compare  N  with  LB).  However,  in  PS  or  3i,  the 
conditions  where  ERK  activity  is  significantly  down-regulated,  cMyc transcript 
levels were significantly reduced. The presence of CHIR (either in 3i or alone) did 
not  elevate  transcript  levels,  as  would  be  expected  if  cMyc was  responsive  to 
canonical Wnt signalling in ES cells (He et al., 1998), and if anything lowered the 
level of cMyc transcript (Fig5.7.1a). The changes in cMyc occurred independently of 
changes in markers of pluripotency, Oct4 and Nanog, indicating that differing cMyc 
levels did not reflect  differentiation.  To ascertain if  cMyc  responds directly to PS 
acute response assays were performed. ES cells were starved of cytokines and then 
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treated  with  inhibitors  or  cytokines  for  one  hour.  Egr1  served  as  a  control  for 
activation (LIF) or inhibition (PS and 3i) of ERK signalling. Similar levels of Oct4 
and Nanog expression in all conditions indicate that there was little variation in the 
proportion of ES cells in the population. There was no significant change in cMyc in 
response to LIF, CHIR or Wnt3a but levels  were significantly down-regulated in 
response to PS or 3i (Fig5.7.1b) showing that cMyc transcription responds rapidly to 
inhibition of the FGF-MEK-ERK signal and is likely to be a direct target of this 
signal. Note that activation of known β-catenin target genes,  Axin2 and  T, was not 
observed in this time-frame (Fig5.7.1c) possibly because of the time needed for β-
catenin to accumulate in the nucleus. I conclude from these results that  levels  of 
cMyc transcript  decrease  in  response  to  PS  and  that  this  is  not  affected  by  the 
presence of CHIR. Furthermore, there is no evidence of a response to LIF as has 
previously been reported. However, it was not examined in the context of short-term 
stimulation  experiments  (Cartwright  et  al.,  2005a).  Interestingly,  Wnt3a  activated 
transcription of the immediate early genes (IEGs), Egr1, c-Fos and JunB, indicating 
that it may have effects independent of the canonical Wnt pathway (see discussion). 
Mice lacking N-Myc die around E11.5 (Charron et al., 1992; Stanton et al., 1992), 
beyond the point when the pluripotent epiblast has been established. Furthermore, N-
Myc-null  ES cells  have  been  reported  (Sawai  et  al.,  1991;  Malynn  et  al.,  1995) 
indicating that N-Myc is not essential for pluripotency. However, N-Myc may well 
exhibit functional redundancy with cMyc and it is expressed in ES cells (Murphy et 
al., 2005). The response of  N-Myc in the same experiments designed to assess the 
response of cMyc was examined. The N-Myc transcript responded similarly to cMyc, 
although the differences in expression tended to be smaller (Fig5.7.1a,b), suggesting 
that it is subject to the same regulatory pathways in ES cells. 
The  level  of  post-translational  control  exerted  on  cMyc  means  that  it  cannot  be 
assumed that protein levels reflect the transcript levels faithfully. The effect of GSK3 
inhibition  on  cMyc  protein  levels  was  of  particular  interest  given  that  GSK3 
phosphorylates Thr58 of cMyc and targets it for proteolysis (Gregory et al., 2003). 
Inhibiting GSK3 would be expected to lead to an increase in protein levels from an 
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equivalent  amount  of transcript.  Attempts  to assess the level  of cMyc protein by 
western  blotting  were  unconvincing  because  of  the  poor  specificity  of  several 
antibodies tested. Therefore, immunoprecipitations (IPs) of cMyc were performed on 
lysates  from  ES  cells  cultured  under  different  growth  conditions.  Subsequent 
immunoblotting with the same cMyc antibody as was used for IP revealed a clean 
band migrating in the correct size range for cMyc. The absence of a corresponding 
band  in  isotype  controls  (Fig5.7.1d,e,  MOCK)  shows  that  the  band  detected  is 
specific  for  cMyc.  cMyc  protein  levels  appeared  to  be  decreased  in  serum-free 
conditions  (Fig5.7.1d,  compare  GL  to  N2B27)  but  notably  they  were  further 
decreased  in  PS  (Fig5.7.1d),  in  agreement  with  the  transcript  data  (Fig5.7.1a). 
Addition of LIF or CHIR to PS failed to increase levels of cMyc (Fig5.7.1d,e) while 
CHIR alone  had  little  or  no  effect  (Fig5.7.1d,  compare  CHIR to  N2B27).  Note, 
however, that levels are higher in CHIR alone than in PS or 3i suggesting that lower 
levels  of  transcription  resulting  from  ERK  inhibition  and/or  decreased  protein 
stability  upon  loss  of  Ser62  phosphorylation  are  the  dominant  effects  on  cMyc 
protein  levels  in  ES cells.  I  conclude  that  cMyc  protein  levels  are  decreased  in 
response to PS and do not respond in this context to either LIF or GSK3 inhibition. 
As there is a clear phenotypic response, the efficient self-renewal of ES cells in either 
PS+LIF  or  3i,  elevated  levels  of  cMyc  are  not  critical  for  self-renewal  in  these 
culture  conditions  and  ES cells  respond to  LIF  and to  GSK3 inhibition  through 
pathways that do not affect cMyc expression. 
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5.2.4.2 Nanog
Unlike  regulation  of  MEK-ERK  signalling  there  is  little  evidence  that  GSK3 
inhibition should affect Nanog expression. It has been suggested that β-catenin can 
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promote Nanog expression through interaction with Oct4 (Takao et al., 2007) but the 
experiments in that paper fail to address the direct regulation of the Nanog promoter. 
However, the proposed role of canonical Wnt signalling in self-renewal (Sato et al., 
2004; Liu et al., 2006; Ogawa et al., 2006) and the many possible downstream effects 
of GSK3 (reviewed in (Doble and Woodgett, 2003)) inhibition make Nanog worth 
testing as a candidate target of CHIR. 
In chapter 4 I showed that Nanog levels were elevated in 3i but that Nanog did not 
appear  to  respond  directly  to  CHIR.  It  seems,  therefore,  that  the  short-term 
maintenance of Nanog expression as seen by immunoblotting (see chapter 4) and 
from the  propagation  of  ES cells  in  CHIR alone  (Fig5.1a)  that  GSK3 inhibition 
maintains  Nanog expression indirectly,  presumably by inhibiting differentiation.  I 
reasoned that if the effect of CHIR is independent of the direct regulation of Nanog 
that the effect would be evident in ES cells overexpressing Nanog or lacking Nanog 
altogether. 
When Nanog overexpression was originally  observed to  support  LIF-independent 
self-renewal it was clearly demonstrated that the addition of LIF further enhanced 
self-renewal (Chambers et al., 2003). In a similar test of the function of the inhibitors 
clonal  assays  were performed with Nanog-overexpressing cells.  The efficiency of 
self-renewal  was measured  as the number  of colonies  formed and the proportion 
staining positive for the pluripotency marker, alkaline phosphatase (AP), when the 
cells were plated at low density (60cells/cm2) and allowed to form colonies for 6-7 
days.  Formation  of  undifferentiated  and  mixed  colonies  in  N2B27  alone  is 
characteristic of ES cells overexpressing Nanog (Fig5.8a). In this assay the addition 
of CHIR, alone or in the context of 3i, significantly enhanced the number of colonies 
formed by Nanog overexpressing cells  (Fig5.8a), indicating that CHIR has potent 
effects  independent  of Nanog regulation.  The colonies  formed in the presence of 
CHIR also tended to be larger and to have a more regular, rounded up morphology, 
staining intensely for AP (Fig5.8b). Interestingly, the presence of PS had little effect 
on Nanog overexpressing cells either alone or in the context of 3i (Fig5.8a). As our 
working  hypothesis  is  that  PS functions  primarily  to  prevent  differentiation  it  is 
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likely that in the context of Nanog overexpression, where differentiation is already 
effectively blocked, PS no longer has a positive effect on self-renewal.
ES cells lacking Nanog also retain their response to CHIR. Nanog-null (44Cre6) ES 
cells retained  Nanog-GFP expression in the presence of CHIR while it was lost in 
cultures in N2B27 alone (Fig5.8c). Colonies formed in CHIR alone tended to round 
up and detach from the plate although they retained expression of the Nanog reporter 
(Fig5.8c). Growth rate was significantly enhanced in 2i as compared to PD03 alone 
indicating that Nanog-null ES cells respond to CHIR similarly to wild-type ES cells. 
Notably, spontaneous differentiation remained high in all combinations of inhibitors 
tested  (as  observed in  chapter  4).  These results,  together  with those presented in 
chapter 4, indicate that Nanog-null ES cells respond to inhibition of GSK3 and the 
ERK  pathway  by  increasing  self-renewal  but  that  in  the  absence  of  Nanog 
spontaneous differentiation remains high. 
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5.2.4.3 Klf4
Kruppel-like factor 4 (Klf4) is a zinc finger TF. It is expressed in ES cells and was 
identified  as  a  putative  target  gene  of  STAT3  signalling  (Li  et  al.,  2005).  A 
microarray expression analysis based on the hyper LIF-sensitive Shp2Δ46-110 ES cells 
identified  Socs3  and  Klf4 as targets. SOCS3 overexpression induced differentiation 
as expected for an inhibitor of STAT3 activation but Klf4 overexpression appeared 
to  inhibit  differentiation.  Forced  Klf4 expression  enhanced  the  formation  of 
secondary EBs, implying the persistence of stem cells, which was supported by the 
173
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
finding that Oct4 expression was much higher in day 6 EBs from Klf4-expressing ES 
cells than controls. It has since been shown that Klf4 cooperates with Oct4 and Sox2 
to activate the target gene Lefty1 (Nakatake et al., 2006). A Lefty1 luciferase reporter 
is not activated in a heterologous cell type when cotransfected with Oct4 and Sox2 in 
contrast to other well defined Oct4 targets. However, the analysis of candidate genes 
showed  that  Klf4  was  capable  of  activating  the  Lefty1 reporter.  Activation  was 
enhanced in the presence of Oct4 and Sox2 demonstrating cooperative activation of 
the  Lefty1  promoter. Microarray analysis of putative Klf4 targets, revealed by  Klf4 
shRNA,  and  comparison  to  target  genes  positively  regulated  by  Oct4  revealed 
overlap between targets. This raises the possibility that there is a set of genes co-
regulated by Klf4 and Oct4 (Nakatake et al., 2006). Finally, in the light of the recent 
demonstration  that  somatic  cells  can  be  reprogrammed  to  pluripotency  by 
transfection with 4 TFs (Takahashi and Yamanaka, 2006), one of which is Klf4, it 
seems that Klf4 has a significant role in the regulation of pluripotency.  While the 
precise roles of Klf4 in ES cell self-renewal or in reprogramming await further study 
there is enough evidence to make it an interesting candidate for this thesis. 
Klf4 expression levels  were examined in ES cells  cultured in different conditions 
together  with  the  related  Klf  family  member,  Klf2,  which  demonstrates  similar 
activation of the Lefty1 reporter to Klf4 (Nakatake et al., 2006). Klf2 expression was 
slightly  higher  in  steady  state  3i  culture  than  in  LB  while  Klf4 appeared  to  be 
expressed at slightly higher levels in LB (Fig5.9a). Both were down-regulated in PS 
which  may reflect  differentiation  as  suggested  by the  lower expression  levels  of 
pluripotency-associated genes (Fig5.9a). These small changes in transcript level tell 
us very little about the regulation of Klfs so their response to short-term exposure to 
the inhibitors or to LIF was tested (Fig5.9b). Activation of Socs3 and Egr1 serve as 
positive controls for activation of STAT3 and ERK respectively. Down-regulation of 
Egr1 in response to PS confirms that ERK activity was reduced under this condition. 
Targets  of  canonical  Wnt  signalling,  Axin2,  Cdx1 and  T,  were  upregulated  in 
response to 8 hours exposure to CHIR confirming that this pathway was activated 
(Fig5.9c). Klf2 showed a small but reproducible upregulation in response to CHIR (8 
hours) (Fig5.9c) while Klf4 levels increased in response to LIF (1 hour) (Fig5.9b) in 
174
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
agreement  with a previous study (Li et  al.,  2005). Neither gene responded to PS 
(Fig5.9b). 
 
To  test  a  possible  role  for  Klfs  Klf4  was  overexpressed  in  ES cells.  Linearised 
plasmind  DNA encoding  Klf4 under  the  control  of  a  CAG promoter  which  also 
drives expression of a hygromycin resistance cassette was transfected into E14Tg2a 
ES cells. Hygromycin-resistant clones were selected for in N2B27 alone, PS or 3i. 
Resistant, alkaline phosphatase-positive colonies emerged with high efficiency in 3i 
and with lower efficiency in N2B27 and PS (Fig5.10a). This contrasts with empty 
vector transfections where no colonies can be derived in N2B27 alone (Fig5.10a). 
Colonies were picked for expansion in all conditions and the remainder of the 3i 
plate  ‘pooled’.  Colonies  in  N2B27  or  PS  were  capable  of  limited  expansion 
suggesting that Klf4 was capable of supporting cytokine-independent self-renewal to 
a degree. Pooled Klf4-expressing cells were cultured in N2B27 alone, PS or 3i. Self-
renewal in 3i was indistinguishable from wild-type cultures (Fig5.10b). In N2B27 
alone  the  cultures  expanded  more  than  wild-type  controls  but  accumulated 
differentiated  cells  (Fig5.10b).  In  PS  spontaneous  differentiation  proceeded  as 
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observed for wild-type  ES cells  with both neural  (Fig5.10b, lower left)  and non-
neural  (Fig5.10b,  lower  right)  differentiation  evident.  I  conclude  that  forced 
expression  of  Klf4  has  a  partial  self-renewal  phenotype  but  does  not  wholly 
reproduce  the  effects  of  either  LIF or  CHIR.  These  results  are  supported  by the 
efficiency of colony formation at clonal density (Fig5.10c). In N2B27 alone very few 
colonies  form while  in  PS a  slightly  higher  number  of  colonies  with a  range  of 
morphologies  were  observed  (Fig5.10c).  In  LIF  and  BMP4  or  in  3i  large, 
undifferentiated  colonies  formed  efficiently  (Fig5.10c,d)  whereas  in  CHIR  alone 
fewer colonies formed (Fig5.10c) and had a tendency to exhibit more differentiation 
(Fig5.10d). Klf2 has been stably expressed by other members of the lab and found to 
have a similar phenotype to Klf4 (J. Hall, unpublished). The results described here 
suggest that stable expression of Klf4 can prolong the persistence of ES cells in the 
absence of cytokines but for efficient self renewal optimal growth conditions (LIF 
and BMP4 or 3i) are still required. While the possibility remains that the Klfs in part 
mediate the effect of LIF or CHIR they are clearly not the only targets promoting 
self-renewal.  To test  their  requirement  for  3i  culture  would  require  their  genetic 
deletion or knockdown. These are experiments we plan to pursue. 
176
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
5.2.4.4 Other pluripotency-associated genes
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A trawl of the literature quickly unearths a large number of genes that have been 
implicated  in  ES  cell  self-renewal.  They  are  usually  identified  on  the  basis  of 
expression profile, microarray data, functional screening or some combination of the 
above. I have identified a few genes whose behaviour, as described in the literature, 
suggests that they might fulfil the role played by CHIR in 3i. 
In  2006 a  paper  was  published  describing  a  screen  undertaken to  identify  genes 
implicated  in  self-renewal  (Ivanova  et  al.,  2006).  Genes  rapidly  down-regulated 
during retinoic acid-induced differentiation were identified by microarray analysis. 
From these, 65 genes were selected, consisting primarily of TFs and DNA-binding 
proteins  and  a  further  5  genes  were  included  from  a  previous  study.  shRNA 
knockdown vectors were designed for all 70 genes. Lentiviral vectors were used that 
expressed the shRNA from one promoter and GFP from another allowing transfected 
cells to be identified. Transfected (GFP+) cells were mixed at a ratio of 4:1 with non-
transfected (GFP-) cells. The mixture was cultured in self-renewing conditions and 
the proportion of GFP+ cells identified at each passage. Cultures with a decreasing 
proportion of GFP+ cells represented shRNA vectors that impaired self-renewal. 10 
of  the  70  shRNAs  tested  had  this  effect  and  were  selected  for  further  analysis. 
Ultimately  7 genes  were  identified  whose  down-regulation  caused  morphological 
differentiation and the loss of alkaline phosphatase. Among them were  Oct4,  Sox2 
and Nanog, as would be expected. The others were the TFs Tbx3 and Esrrb, the Akt1 
co-factor Tcl1 and the uncharacterized ES-specific gene Dppa4. Differentiation was 
only shown to occur in the context of LIF withdrawal in serum-containing conditions 
so  it  remains  a  possibility  that  the  differentiation  observed  is  context-specific. 
Constitutive expression of any of the 7 genes failed to prevent differentiation in EBs 
although some appeared to bias contribution to certain lineages. Interestingly, Nanog 
overexpression could rescue the differentiation observed upon knock-down of Esrrb, 
Tbx3,  Tcl1 or  Dppa4.  This  indicates  that  these  genes  are  not  functioning  down-
stream of Nanog to prevent differentiation but also implies that their requirement for 
self-renewal  is  not  absolute.  Another  interesting  phenotype  was  observed  upon 
deletion of the TF Zfx from ES cells (Galan-Caridad et al., 2007). ES cells lacking 
Zfx could  be  maintained  and  continued  to  express  Oct4,  Nanog  and  alkaline 
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phosphatase  but  exhibited  reduced  clonogenicity,  slower  growth  and  increased 
apoptosis. Furthermore, Zfx was proposed to regulate positively the expression of 
Tbx3 and Tcl1. The expression levels of  Zfx, Tbx3 and Tcl1 were examined in the 
context of 3i  and response to the inhibitors.  The antiapoptotic gene  Bcl2 and the 
related family members  Mcl1 and  Bcl2l1 were also included because the effect of 
LIF and CHIR on ES cells could be in part attributed to the inhibition of apoptosis. 
Although I have already demonstrated that forced Bcl2 expression does not support 
self-renewal (see chapter  4) its  effect  on apoptosis  might  still  be relevant  if  it  is 
regulated by the inhibitors.
When expression levels were examined in passage 3 cultures in LB, PS or 3i it was 
observed that expression levels of  Zfx did not vary significantly but that  Tcl1  and 
Tbx3 were  significantly  lower  in  PS  (Fig5.11a).  This  is  likely  to  reflect 
differentiation of the PS cultures as indicated by the down-regulation of pluripotency 
associated genes (Fig5.11a). Bcl-family members were not significantly altered with 
the exception of  Bcl2 which was expressed at higher levels in PS (Fig5.11a), the 
opposite of what might be expected given the increased apoptosis observed in PS 
cultures. The change may reflect increased Bcl2 expression in differentiated ES cell 
derivatives.  To  assess  the  more  immediate  effects  of  CHIR  cells  were  initially 
cultured in 3i  before washing out the inhibitors and further culturing the cells  in 
different conditions for 24 hours and analysing changes in gene expression. Down-
regulation of the canonical Wnt target genes, Axin2 and Cdx1, served as a control for 
the removal of CHIR (Fig5.11b, PS condition) while upregulation of the ERK target, 
Egr1,  was  as  expected  when PS was  removed  from the  media  (Fig5.11b,  CHIR 
condition).  Both  Tcl1  and  Tbx3  were  down-regulated  in  PS  as  compared  to  3i 
(Fig5.11b).  However, when the cells were cultured in CHIR alone for the same 24 
hour period  Tcl1 and  Tbx3 also showed down-regulation relative to 3i  culture.  It 
seems unlikely therefore that they are direct downstream targets of CHIR, rather, the 
change in their expression likely reflects early differentiation steps as evidenced by 
the upregulation of Fgf5 (Fig5.11b). Similarly,  Zfx levels were slightly lower in PS 
or  CHIR  than  in  3i,  perhaps  indicating  down-regulation  upon  initiation  of 
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differentiation (Fig5.11b). Over the same time period there was little response of Bcl 
family members (Fig5.11b). 
Finally, the response of the candidate genes to an 8 hour stimulation with CHIR was 
assessed.  Known  targets  of  canonical  Wnt  signalling,  Axin2, Cdx1 and T,  were 
significantly  upregulated  (Fig5.11c)  but  none of  the  candidate  genes showed any 
response  over  this  time-frame  with  the  exception  of  a  small  increase  in  Tbx3 
expression (Fig5.11c). I conclude from this analysis that while  Tcl1 and  Tbx3 are 
rapidly down-regulated upon the withdrawal of CHIR from 3i they do not show any 
direct response to CHIR and are unlikely to be significant downstream transcriptional 
targets  in  the  promotion  of  self-renewal.  No  other  changes  were  observed  that 
correlate with the cellular phenotype. 
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5.3 Discussion
5.3.1 The effect of GSK3 inhibition on ES cells
I have provided evidence that inhibition of the FGF4-MEK-ERK pathway prevents 
differentiation  of mouse ES cells  (see chapter  4).  This is  in  agreement  with past 
observations  including  recent  work  showing  that  ES  cells  treated  with 
pharmacological inhibitors of this pathway or genetically defective for components 
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of the pathway do not differentiate efficiently (Kunath et al., 2007; Stavridis et al., 
2007).  This was taken further by attempting long-term culture  of ES cells  in the 
absence of serum and growth factors with only PS. Our findings indicate that while 
this is possible at relatively high density, some differentiation is always evident and 
clonal propagation is not possible.  The addition of CHIR to PS to create 3i fully 
rescues  the  properties  of  ES  cell  self-renewal  considered  essential  for  a  growth 
condition  to  be  described  as  ‘sufficient’  (see  chapter  3).  In  this  chapter  I  have 
attempted to identify the down-stream signalling pathways that mediate the effect of 
CHIR. As discussed in the introduction there are many known targets of GSK3 that 
affect  many  different  processes.  Pleiotropic  effects  of  GSK3  inhibition  were 
anticipated but it was hoped that a candidate approach might implicate or rule out a 
role for some down-stream targets in the regulation of self-renewal. 
The phenotype of ES cells grown in serum-free conditions in the presence of CHIR 
together with other growth factors or inhibitors was examined. In CHIR alone self-
renewing colonies persist for several passages, in marked contrast to N2B27 alone 
where rapid differentiation occurs and the majority of cells die upon passaging. It is 
also possible  to establish ES colonies  at  clonal  density in  CHIR alone with high 
efficiency. These observations show that CHIR promotes short-term self-renewal but 
the  accumulation  of  differentiated  cells  and  deterioration  of  the  culture  with 
passaging clearly  indicate  that  CHIR is  not  sufficient  for  long-term self-renewal. 
Differentiation is eliminated by the addition of LIF or of PS. I propose that, in the 
context of CHIR, LIF and PS function to prevent non-neural differentiation but leave 
in-tact the effects of CHIR that appear to promote the growth and survival of ES 
cells. 
From previous work it is known that LIF can prevent the non-neural differentiation 
that occurs in serum or in the presence of BMP4 (Ying et al., 2003a) and it is likely 
that  it  functions in the same manner  to prevent differentiation in the presence of 
CHIR. It follows that CHIR is fulfilling the role of BMP4 or serum by preventing the 
neural  differentiation  that  normally  occurs  in  LIF  alone  (Ying  et  al.,  2003a). 
However, this is clearly not the only function of CHIR since ES cells grown in serum 
182
Chapter 5: The role of GSK3 inhibition in the culture of mouse embryonic stem cells
or BMP4 in the absence of LIF undergo rapid differentiation and cannot be passaged, 
unlike the ES cells that persist in CHIR alone. Inhibition of the FGF4-MEK-ERK 
signalling cascade has been shown to prevent differentiation of ES cells along neural 
and  non-neural  lineages  (Kunath  et  al.,  2007).  PS  prevents  differentiation  from 
occurring  by  blocking  this  pathway  (see  chapter  4)  so  the  differentiation  that 
normally  occurs  in  the  presence of  CHIR is  prevented  and efficient  self-renewal 
proceeds. In summary, GSK3 inhibition has potent self-renewal effects if non-neural 
differentiation is otherwise blocked. 
BMP4 was not able to prevent the spontaneous differentiation observed in CHIR. 
This was not surprising since the only clearly established role for BMP signalling in 
ES cell self-renewal is the inhibition of neural differentiation (Ying et al., 2003a). 
Notably,  however,  CHIR did  prevent  the  rapid  differentiation  normally  observed 
upon the addition of BMP4 to ES cell  cultures. This indicates an effect of CHIR 
separate  from  inhibition  of  neural  differentiation  which  is  already  effectively 
inhibited in the presence of BMP4. This phenomenon is analogous to the phenotype 
described  for  GSK3  double-knockout  ES  cells  which  exhibit  resistance  to 
multilineage differentiation (Doble et al., 2007) despite the high incidence of specific 
differentiation observed in standard culture conditions (see chapter 3).  
5.3.2 Canonical Wnt signalling
The  best  studied  effect  of  GSK3  inhibition  is  the  activation  of  canonical  Wnt 
signalling by stabilization of β-catenin. In fact, this effect is often considered to the 
exclusion  of  other  GSK3 targets  (Sato et  al.,  2004).  I  asked to  what  extent  Wnt 
ligands could substitute for CHIR, reasoning that canonical Wnt signalling would be 
activated but other GSK3 targets would be unaffected. The addition of Wnt3a to PS 
enhances  self-renewal  but  fails  to  recapitulate  the  phenotype  of  3i.  Notably,  the 
neural differentiation observed in PS alone was not evident in the presence of Wnt3a. 
This  is  expected  given  the  anti-neural  effect  of  Wnt  signalling  on  ES  cell 
differentiation (Aubert et al., 2002; Haegele et al., 2003) and may in part explain the 
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promotion  of  self-renewal.  However,  a  degree  of  non-neural  differentiation  is 
induced and proliferation is poor as compared to 3i. At this point we can speculate on 
how Wnt ligands might affect self-renewal and how their effect might differ from 
direct inhibition of GSK3. That a concentration of Wnt3a which elicited a similar 
TCF/LEF reporter  response to 3μM CHIR was necessary to support self-renewal, 
and that activation of β-catenin seemingly recapitulates this effect strongly implicates 
canonical Wnt signalling downstream of Wnt3a. The activation of TCF/LEF target 
genes is a likely candidate for the downstream effect. In particular, Tcf3 is thought to 
act as a repressor of pluripotency regulators Oct4, Sox2 and Nanog as well as many 
of  their  target  genes,  becoming  a  transcriptional  activator  upon  activation  of 
canonical  Wnt  signalling.  However,  work  by  Ying  et  al (Ying  et  al,  in  press) 
suggests that increased transcription of TCF/LEF target genes does not promote self-
renewal  in  3i.  This  implies  TCF/LEF-independent  effects  of  β-catenin  which are 
much less well documented but are known to occur (reviewed in (Mulholland et al., 
2005)). 
5.3.3 Cell-cell adhesion
The  morphology  of  cells  grown  in  3i,  with  tight-packed  round  colonies  that 
frequently detach from gelatine-coated plates and grow as floating spheres, is distinct 
from cultures in serum plus LIF or LIF plus BMP4 which form flattened monolayers. 
This morphological change is dependent on CHIR (it is not observed in PS alone) 
and is recapitulated by the addition of Wnt3a or stable expression of β-catenin. Ecad-
null  ES  cells  grow  as  dispersed  monolayers  and  do  not  form three-dimensional 
colonies. It seems likely that the morphological effect of CHIR is mediated through 
increased  β-catenin  incorporation  into  adherens  complexes  (Bienz,  2005)  but  the 
robust growth of  Ecad-null cells clearly demonstrates that this is not essential for 
self-renewal in 3i. I have ruled out that 3i functions through adherens junctions but 
the lack of a response to Wnt3a in clonal assays suggests that Ecad may be required 
for  the  response  to  Wnt3a.  If  this  is  the  case  it  suggests  that  increased  cell-cell 
adhesion mediates the observed response of wild-type cells to Wnt3a.
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Interestingly, Ecad-/- ES cells were more easily propagated in PD03 alone than wild-
type cells (see chapter 4). The formation of colonies at clonal density was also more 
efficient.  In the absence of a parental control line for the  Ecad-/- ES cells  this is 
difficult to interpret. It may simply be the case that the background of this cell line is 
more amenable to culture in the absence of LIF or CHIR. Alternatively, the absence 
of Ecad may alter the properties of the cells such that they become less dependent on 
cytokine stimulation and GSK3 inhibition.  It is anticipated that in the absence of 
functional  adherens junctions the amount  of free β-catenin  in the cytoplasm may 
increase (Bienz, 2005) and that this may result in higher basal levels of nuclear β-
catenin and target gene activation. This could be tested by immunoblotting and TCF/
LEF reporter assays and may prove informative in future attempts to define the role 
of canonical Wnt signalling in ES cell self-renewal.
5.3.4 Non-canonical Wnt signalling
Wnt  ligands  are  known  to  activate  β-catenin-independent  signalling  pathways 
(reviewed in (Kohn and Moon, 2005)), the best described of which is the planar cell 
polarity (PCP) pathway in  Drosophila. A similar pathway is believed to operate in 
vertebrates resulting in activation of c-Jun N-terminal kinases (Jnk). This pathway 
may be activated by Wnt ligands but not CHIR. c-Jun is a component of the AP-1 
transcriptional  complex  which  activates  IEGs  and  other  targets  downstream  of 
MAPK signalling (reviewed in (Whitmarsh, 2007)). If its activation was in some way 
detrimental to self-renewal this could in part explain the relatively poor self-renewal 
promoted by Wnt3a as compared to CHIR. This is supported by the observation that 
Wnt3a but not CHIR induces expression of Egr1, c-Fos and JunB in a 1 hour acute 
response  assay.  The  induction  of  these  target  genes  is  less  pronounced  than  the 
response to LIF where they are likely responding to activation of ERK1/2 and it is 
unclear  what the significance of this  is  likely to be for self-renewal.  It  would be 
informative to investigate the activation of β-catenin-independent  pathways at  the 
protein and transcriptional level in response to Wnt ligands and to assess their effect 
on self-renewal, perhaps by specifically blocking their activation. Alternative Wnt 
ligands may also elicit different responses if the balance in activation of canonical 
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Wnt  signalling  and  PCP  pathways  is  different.  However,  the  fact  that  direct 
activation of 4OHT-inducible β-catenin does not recapitulate the phenotype observed 
with  CHIR suggests  that  β-catenin  activation  is  not  sufficient  and  that  negative 
effects of Wnt signalling are unlikely to be the sole cause of the differences in the 
effects of CHIR and Wnt3a. 
5.3.5 Wnt-independent effects of GSK3 inhibition
Wnt  ligands  may  activate  signalling  pathways  not  influenced  by  CHIR  and  the 
reverse is  certainly true.  Direct  GSK3 inhibition  leads  to  dephosphorylation  (and 
usually activation) of many GSK3 targets (reviewed in (Doble and Woodgett, 2003)) 
as  exemplified  by  NDRG1  (Murray  et  al.,  2004).  GSK3  negatively  regulates 
translation  by  direct  phosphorylation  of  eukaryotic  translation  initiation  factor  2 
(eIF2) (Welsh et al., 1998) whereas activated ERK promotes translation (Kleijn and 
Proud,  2000;  Pyronnet,  2000).  CHIR  is  anticipated  to  increase  translation  by 
derepression of eIF2 and this, together with other GSK3 targets, may increase the 
biosynthetic  capacity  of  ES cells.  This  would explain  the enhanced proliferation, 
viability and clonogenicity observed in the presence of CHIR. Furthermore, studies 
in  yeast  have  suggested  that  biosynthetic  capacity  and  ‘pathway  capacity’,  the 
efficiency with which  signals  are  transmitted,  are  negatively correlated  (Colman-
Lerner et al., 2005). If this were true of ES cells cells with low biosynthetic capacity 
might be expected to have correspondingly high pathway capacity and to be more 
sensitive to signals that promote differentiation. In this hypothetical situation, ERK 
inhibition, as in PS, might, as well as inhibiting differentiation, have the paradoxical 
effect  of  lowering  the  threshold  for  differentiation  by  decreasing  biosynthetic 
capacity. The addition of CHIR might therefore indirectly influence fate choice by 
raising  biosynthetic  capacity  in  the  compromised  context  of  PS.  Other  signalling 
pathways,  including LIF-STAT3 and PI3K, might similarly influence biosynthetic 
capacity and in doing so promote self-renewal (see general discussion). 
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5.3.6 β-catenin as a filter of transcriptional noise
It has been suggested that Wnt-mediated stabilization of β-catenin can function as a 
‘filter’  for  transcriptional  noise,  functioning  primarily  to  stabilize  transcriptional 
programs  rather  than  to  activate  transcription  (Arias  and Hayward,  2006).  In  the 
context  of  ES  cell  self-renewal  β-catenin  stabilization  may  act  to  reinforce  the 
transcriptional  program  of  ES  cells.  If  this  were  done  in  a  context  where 
differentiation is  largely prohibited,  as in the presence of PS or of LIF,  ES cells 
would be expected to be highly biased towards symmetrical self-renewal. β-catenin 
is proposed to mediate this function by recruiting chromatin modifiers to enhancer 
regions (Arias and Hayward, 2006) which presumably stabilize the activation status 
of the gene in question. 
An emerging candidate that may promote or stabilize pluripotency is Tcf3. Tcf3 is 
the most abundantly expressed of the 4 TCF/LEF TFs in ES cells and its ablation 
leads to elevated Nanog levels and delayed differentiation (Pereira et al., 2006). A 
study showing that Tcf3 co-occupies many promoters with the pluripotency master 
regulators Oct4 and Nanog and that it acts to repress the transcription of Oct4, Sox2 
and  Nanog as  well  as  their  target  genes  (Cole  et  al.,  2008)  provides  a  plausible 
mechanism  for  β-catenin’s  involvement  in  self-renewal.  As  Tcf3  acts  as  a 
transcriptional repressor in the absence of β-catenin and as canonical Wnt signalling 
is  low in routine culture conditions (Ogawa et  al.,  2006) the effect  of Tcf3 is to 
repress  expression  of  pluripotency  associated  genes  (Cole  et  al.,  2008).  Upon 
activation  of  β-catenin,  however,  Tcf3  becomes  a  transcriptional  activator.  Thus, 
canonical Wnt signalling may promote self-renewal by enhancing and/or stabilizing 
expression of the core pluripotency machinery. It would be interesting to investigate 
the  effect  of  Wnt  activation  or  Tcf3  knockdown on  the  homogeneity  of  Nanog 
expression. The mechanisms underlying the fluctuations in Nanog levels observed in 
self-renewing ES cells (Chambers et al., 2007) are not known but investigations into 
the effects of canonical Wnt signalling have thus far been restricted to population 
level analyses. The observation of increased Nanog expression observed in response 
to Tcf3 knockdown (Pereira et al., 2006) or Wnt activation (Cole et al., 2008) could 
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be explained by increased expression in individual cells or increased homogeneity of 
Nanog expression in the population.
It is clear then that many effects of GSK3 inhibition are anticipated and that they are 
expected to influence ES cells in different ways. I propose that it is a combination of 
effects that elicits the ultimate phenotype and that at least some aspects of the effect 
are independent of β-catenin. Activation of canonical Wnt targets that are associated 
with lineage commitment, such as Brachyury and Cdx1, may promote differentiation 
and  may  also  be  responsible  for  the  observed  inhibitory  effect  on  neural 
differentiation. The striking effect on viability and proliferation makes it likely that 
there is an effect on biosynthetic capacity. Examining this will require further study 
beginning with an assessment of the activation status of GSK3 targets such as eIF2 
which I propose to be involved. Assessing whether biosynthetic capacity influences 
fate  choice  is  a  rather  more  difficult  task  (see  general  discussion).  Experiments 
addressing this problem in yeast required an elegant system of pathway responsive 
and non-responsive reporter genes that allowed variations in output in response to an 
input  signal  to  be  attributed  to  different  sources,  namely ‘pathway capacity’  and 
‘expression capacity’ – the ability of cells to transcribe RNA and synthesise proteins 
(Colman-Lerner  et  al.,  2005).  It  is  conceivable  that  similar  experiments  could be 
performed in ES cells but it would be a large undertaking. Similarly, to attempt to 
assess  the  effect  of  β-catenin  on  transcriptional  noise  may  require  that  reporter 
systems are devised that allow sensitive evaluation of multiple genes in single cells 
and  variation  in  expression  between individual  cells  (Arias  and Hayward,  2006). 
While the obvious experiment is to undertake global transcriptional profiling of ES 
cells in 3i this is likely to be informative of the nature of their state but not of how 
that state is established or maintained. 
5.3.7 cMyc
The manner in which cMyc expression is regulated and its proposed role in self-
renewal (Cartwright et al., 2005b) made it an attractive candidate for our studies. It 
was found to be down-regulated in PS and it was suspected that this might in part 
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underlie  the  compromised  viability  and proliferation  of  these cells.  However,  the 
addition of CHIR or LIF, both of which promote dramatically enhanced cell growth, 
did not affect cMyc expression at the transcript or protein level. This is in marked 
contrast  to published observations which claim that  cMyc transcription is  directly 
activated by STAT3 (Cartwright et al., 2005b). A critical omission in that study is 
that acute response of the cMyc gene was never tested. It is possible that activation of 
cMyc transcription by LIF occurs via activation of ERK signalling. This would be 
consistent with our observations of  cMyc downregulation in PS. These results cast 
serious  doubt  on  the  importance  of  elevated  cMyc  in  promoting  self-renewal 
downstream of either LIF or GSK3 but to formally test this it would be necessary to 
culture ES cells lacking cMyc in 3i and, if possible, to obtain ES cells lacking both 
cMyc and NMyc to exclude redundancy. 
5.3.8 Nanog 
Nanog  can  be  regulated  indirectly  by  signals  that  promote  self-renewal  over 
differentiation because its expression correlates with the undifferentiated state of ES 
cells. It appears Nanog responds in this manner to GSK3 inhibition since CHIR can 
maintain ES cells  short term and GSK3-DKO cells  are resistant to differentiation 
(Doble et al., 2007) but no evidence was found for direct regulation of the transcript 
or the protein. Increased Nanog expression in 3i may result from decreased ERK 
activity (see chapter 4) and from the maintenance of a relatively pure population of 
ES  cells.  It  has  been  proposed  that  β-catenin  activation  can  increase  Nanog 
transcription through an interaction with Oct4 (Takao et al., 2007). While this has not 
been  investigated  directly  the  lack  of  a  change  in  Nanog levels  after  an  8  hour 
exposure to CHIR contradicts these findings. It will be interesting to investigate how 
CHIR affects the expression and activity of the core TFs, particularly in the context 
of β-catenin function as a filter for transcriptional noise (Arias and Hayward, 2006).
The phenotypes of Nanog-overexpressing and knockout ES cells clearly demonstrate 
that the effect of CHIR is not mediated through Nanog. Nanog-overexpressing cells 
retained a robust response to CHIR in the form of increased colony forming ability. 
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Interestingly,  the majority of colonies formed from Nanog-overexpressing cells in 
CHIR alone had no overt differentiation,  in contrast to wild-type cells.  This is in 
agreement with our observations of ES cells in LIF plus CHIR or in 2i/3i (see section 
5.3.1).  Nanog  overexpression  presumably  provides  another  means  to  inhibit  the 
differentiation observed in CHIR alone resulting in robust self-renewal.  Nanog-null 
ES cells also self-renew with increased efficiency in response to CHIR providing 
proof that this response is not Nanog-dependent. The fact that  Nanog-null ES cells 
respond  to  CHIR  similarly  to  wild-type  cells  is  also  informative.  In  both  cases 
colonies of ES cells persist in cultures that are largely differentiated and ES cells can 
be  expanded  while  cultures  without  CHIR  become  completely  differentiated.  If 
Nanog expression was required  for  the persistence  of  ES cells  in  CHIR alone  it 
would be expected that  Nanog-null ES cells would differentiate rapidly. However, 
this is not the case and it indicates that the pleiotropic response of ES cells to CHIR 
is not caused by heterogeneity of Nanog expression (Chambers et al., 2007) and a 
resulting difference in the response of subpopulations of cells within the culture. 
5.3.9 Candidates
The view was taken that genes reported in the literature to have a role in promoting 
self-renewal  might  function  downstream of CHIR to restore  efficient  growth and 
clonogenicity  in  the  context  of  PS.  At  the  very  least  these  experiments  allowed 
obvious  candidates  to  be  eliminated  from further  enquiries.  While  several  of  the 
candidates I chose to test were expressed at higher levels in 3i than in PS there was 
no evidence that they responded directly to CHIR with the exception of  Klf2. The 
differences  observed between PS and 3i  likely reflect  the down-regulation of the 
genes in differentiated cells present in PS cultures. Forced expression of Klf4 could 
not recapitulate the effect of CHIR although it did appear to reduce differentiation. 
Similar results have been obtained for Klf2 by colleagues (J. Hall, unpublished). As 
outlined in the introduction, CHIR was expected to have pleiotropic effects and as 
such it is not surprising that transcriptional targets that can recapitulate its effect have 
not been identified. However, this work is useful if only in the sense that it excludes 
the  possibility  that  obvious  candidates  from the  literature  are  responsible  for  the 
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phenotype observed. This is another situation where global transcriptional profiling 
might  be  informative,  in  identifying  genes  with  significantly  different  levels  of 
expression in ES cells cultured in 3i as compared to other conditions that support 
self-renewal.  Caution  must  be  exercised  however  because  differences  in  the 
expression of many genes are anticipated that are incidental to the culture conditions 
and not in any way involved in promoting self-renewal.  Furthermore,  GSK3 is a 
kinase  and  its  primary  effects  are  at  the  level  of  protein  function  and  stability. 
Inhibition of its activity, together with inhibition of ERK activity, is likely to have 
broad effects  on the activity  of  proteins  in  ES cells  with transcriptional  changes 
secondary to protein regulation.
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Chapter 6: General Discussion 
6.1 Mechanism of ES cell self-renewal
In  order  to  self-renew stem cells  must  undergo  division  without  commitment  to 
differentiate.  ES cells  cultured  in  permissive  conditions  will  do  this  indefinitely, 
expanding rapidly in culture. Since they were first established the conditions for their 
growth have been progressively refined. Feeder cells can be replaced by LIF (Smith 
et al.,  1988; Williams et al.,  1988) and serum by defined media supplements and 
BMP4 (Ying et al., 2003a). Defined growth conditions make it possible to investigate 
the  precise  requirements  for  self-renewal  and  hence  the  molecular  mechanisms 
governing self-renewal. 
6.1.1 Regulation of self-renewal by intracellular signalling 
pathways
It is known that LIF acts through STAT3 to promote self-renewal (Niwa et al., 1998) 
and several  downstream targets  have been proposed to mediate  this  effect.  cMyc 
(Cartwright et al., 2005b) and  Klf4 (Li et al., 2005) are both proposed to be direct 
transcriptional targets of STAT3. While overexpression experiments implicate both 
of them in the promotion of self-renewal the critical experiment would be to assess 
the  response  of  ES  cells  lacking  these  genes  to  LIF.  However,  the  situation  is 
complicated by the effects of redundancy with both cMyc and Klf4 being part of gene 
families, multiple members of which are expressed in ES cells. The work presented 
in chapter 5 casts doubt on whether cMyc is indeed a target of STAT3 and shows that 
ES cells  retain a robust response to LIF without upregulating cMyc.  Forced Klf4 
expression appeared to promote self-renewal but efficient self-renewal continued to 
require the addition of LIF or CHIR demonstrating that upregulation of Klf4 is not 
the only important effect of LIF. In fact, the only gene described to date capable of 
supporting  robust  cytokine-independent  self-renewal  is  Nanog  (Chambers  et  al., 
2003) and there is no evidence that Nanog is directly regulated by the growth factors 
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considered  essential  for  self-renewal.  On  the  contrary,  ES  cells  overexpressing 
Nanog retain a response to LIF (Chambers et al., 2003) and Nanog-null cells can be 
derived and maintained in standard growth conditions, reliant on the provision of LIF 
(Chambers et al., 2007). Only in the case of BMP signalling has it been shown that a 
single transcriptional target,  Id genes, can substitute for the growth factor (Ying et 
al.,  2003a).  In  short,  although  LIF-STAT3 signalling  is  accepted  to  be  a  critical 
pathway  for  ES  cell  self-renewal  no  single  target  has  been  identified  that  can 
substitute for its function. 
The  work described  in  chapter  three shows that  this  ‘critical’  pathway is  in  fact 
dispensable for ES cell self-renewal. In 3i culture conditions STAT3 is inactive and 
ES  cells  have  been  derived  in  3i  that  are  genetically  deficient  for  Stat3.  It  has 
previously  been  suggested  that  ES  cells  can  self-renew  independently  of  LIF 
signalling (Dani et al., 1998) but never before has independence from STAT3 been 
formally demonstrated. It is possible that the loss of STAT3 is compensated for by 
other  members  of  the  STAT  family  but  the  observation  that  Stat3-/-  ES  cells 
differentiate in LIF-dependent growth conditions indicates that STAT3 is critical for 
self-renewal.  Clearly,  it  is  possible  to  achieve  inhibition  of  differentiation,  with 
proliferation, through STAT3-independent means. It is possible that LIF/STAT3- and 
CHIR-activated  signalling  converge  on  a  common  target(s)  that  mediates  their 
effects and drives self-renewal. An alternative explanation is that propagation of ES 
cells  can be achieved through different signalling pathway manipulations with no 
core set of signalling targets absolutely required for self-renewal.
Conceptually,  the  self-renewal  of  ES  cells  can  be  broken  down  into  two  parts. 
Firstly, cell fate decisions. At each division a cell can “choose” to self-renew or to 
differentiate. The activation status of signalling pathways will influence this choice. 
Secondly, cell survival and proliferation. The composition of the media and again the 
status  of  signalling  pathways  will  influence  viability  and  growth  rate.  Under 
hypothetical,  optimized  culture  conditions  no differentiation  would occur  and the 
cells would proliferate rapidly with no cell death. In reality ES cell cultures always 
contain a proportion of differentiated cells and often exhibit a degree of cell death. 
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Considering the phenotype of ES cells in 2i/3i culture and their behaviour in PS or 
PD03 and in  CHIR alone  in  the  context  of  this  framework  I  propose  that  ERK 
inhibition biases cell fate choices in favour of self-renewal (Burdon et al., 1999b; 
Kunath et al., 2007) while LIF or CHIR serve to activate pathways that increase ES 
cell survival and proliferation. This fits reasonably well with our observations: when 
ERK  activity  is  reduced  differentiation  is  suppressed  but  cell  proliferation  and 
viability are poor until LIF or CHIR is added when viability and proliferation are 
restored. However, several observations suggest that this is an over-simplification. 
In  LIF  alone  ES  cells  undergo  neural  differentiation  (Ying  et  al.,  2003a)  but 
differentiation is decreased as compared to cells cultured without LIF (see chapter 4). 
If LIF had no effect on fate choice it would be expected that neural differentiation 
would proceed at a similar frequency. Furthermore, as shown in chapter 4 ES cells 
maintained in either LIF or PS alone undergo neural differentiation. This indicates 
that neither condition is capable of imposing a total block on neural differentiation. 
However, when combined LIF and PS support robust self-renewal including efficient 
colony formation from single cells. Therefore, two culture conditions, independently 
insufficient to suppress neural commitment completely, prevent neural differentiation 
when combined.
In CHIR alone, non-neural differentiation proceeds but again ES cells persist through 
multiple passages and colonies are even observed at clonal density. GSK3 inhibition 
diverts ES cells from neural differentiation so it is clearly capable of influencing fate 
choice  but  why  is  the  differentiation  incomplete,  why  do  a  proportion  of  cells 
continue to self-renew? Similarly to LIF, combining CHIR with PS or PD03 almost 
totally eliminates differentiation despite the fact that neither component separately is 
capable  of preventing differentiation.  In an analogous manner  to LIF and BMP4, 
ERK inhibition could prevent non-neural differentiation (Chan et al.,  2003) while 
CHIR prevents neural differentiation (Aubert et al., 2002; Haegele et al., 2003), the 
two combining to limit the options for differentiation available to ES cells. However, 
several observations suggest that this is not the complete explanation. Firstly, ERK 
inhibition  does  not  exclusively  prevent  non-neural  differentiation,  as  reported 
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(Kunath  et  al.,  2007;  Stavridis  et  al.,  2007),  and  as  observed  when  BMP4 was 
combined with PS (see chapter  4). Secondly,  BMP4 cannot replace CHIR in this 
context.  When  combined  with  PS  non-neural  differentiation  becomes  evident  in 
place of neural differentiation. Thus, elimination of residual neural differentiation is 
not sufficient to turn PS or PD03 into efficient self-renewal conditions. Thirdly, in 
chapter 5 activation of canonical Wnt signalling by addition of Wnt3a was observed 
to  prevent  neural  differentiation  but  did  not  support  robust  self-renewal  when 
combined  with  PS  or  PD03.  Finally,  CHIR  has  the  dual  effect  of  promoting 
expansion of ES cells while causing non-neural differentiation. This is inconsistent 
with the idea that GSK3 inhibition might slot exclusively into either an “inhibition of 
differentiation” or “enhancement of viability and proliferation” role. 
So how can these observations be reconciled? It seems that the separation of fate 
choice and cell proliferation/viability is an inadequate model for ES cell behaviour. 
The phenotypes observed could be explained if LIF and CHIR raised the threshold 
for signal activation required to induce ES cells to commit to differentiate (Silva and 
Smith, 2008). In such a model ERK inhibition might become sufficient to prevent 
differentiation along any lineage when the threshold for differentiation is raised by 
the  addition  of  LIF  or  CHIR.  At  present  this  is  speculative  given  the  lack  of 
experimental  data  to  address such a hypothesis.  However,  it  has  previously been 
shown that the metabolic status of a cell and its response to environmental stimuli are 
correlated. 
An  experimental  system  in  yeast  was  developed  (Colman-Lerner  et  al.,  2005). 
Fluorescent reporter genes were placed under the control of either a promoter that 
responded to activation of the mating-type response pathway upon exposure to α-
factor  or  constitutively  expressed,  α-factor-independent  promoters.  Input  to  this 
model system was α-factor and output expression of the α-factor-dependent reporter. 
Differences  in  the  level  of  reporter  expression  between  individual  cells  were 
modelled as arising from differences in two ‘subsystems’. The pathway subsystem 
comprised everything required to transmit the pheromone signal to activation of the 
TF Ste12. The expression subsystem comprised everything required for expression of 
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the reporter in response to activation of the TF ie. transcription and translation. The 
capacity of these two subsystems was seen as dependent on the number, localization 
and activity of proteins that transmit the signal (pathway capacity) or express genes 
into  proteins  (expression  capacity).  Cell-to-cell  variation  in  expression  capacity 
could  be  measured  from  differences  in  expression  from  α-factor-independent 
promoters and this could be correlated with variation in the expression from α-factor-
responsive promoters. At lower α-factor concentrations the variation due to pathway 
capacity  was  found  to  increase  but  the  total  variation  in  system  output  did  not 
increase. This implies that expression capacity and pathway capacity are negatively 
correlated.  If similar  mechanisms are employed in ES cells  “expression capacity” 
might  be  increased  in  the  presence  of  LIF  or  CHIR  leading  to  a  reduction  in 
“pathway capacity” and a decreased sensitivity to signals that promote differentiation 
(Silva and Smith, 2008). The expression capacity or biosynthetic capacity of ES cells 
is expected to be lower in the absence of LIF or CHIR and may be lowered further 
still  by inhibition  of  ERK signalling.  This  may explain  why,  despite  a  block  of 
differentiation  imposed by PS or PD03,  ES cells  cultured  under  these conditions 
become heterogeneous. Note that the data presented in chapter 4 demonstrate that 
inhibition of apoptosis by forced expression of Bcl2 is not sufficient to convert ERK 
inhibition  into a robust condition  for  self-renewal.  This  demonstrates  that  simply 
increasing viability cannot reproduce the effect of LIF or CHIR. Rather, I propose 
that  regulatory  input  is  required  from  these  molecules  to  increase  biosynthesis 
(Fig6.1). If ES cell  self-renewal was regulated by global mechanisms interlinking 
metabolic and growth status with sensitivity to differentiation-promoting stimuli it 
would not be surprising that attempts to identify targets of LIF-STAT3 that promote 
self-renewal  have  not  yielded  a  target  that  fully  recapitulates  the  effect  of  LIF. 
Similar difficulties are expected to affect the search for the mediators of the effect of 
GSK3 inhibition (see chapter 5). 
The phenotype of ES cells cultured in the absence of insulin may also be directly 
relevant to this hypothesis. In the absence of insulin proliferation is extremely slow 
and viability is decreased. In this condition the expression capacity of ES cells might 
be decreased and they might therefore be more sensitive to differentiation cues. A 
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testable  hypothesis  is  that  removing insulin  from the media  prior to induction of 
differentiation might lead to more rapid and/or homogeneous differentiation. 
6.1.2 Signalling pathways and the core transcription factors
How does signalling relate to regulation of the core TFs Oct4, Sox2 and Nanog? 
Genetic knockout experiments have demonstrated that the expression of these three 
TFs is essential for establishment and maintenance of pluripotency in ES cells and in 
the embryo (Nichols et al., 1998; Niwa et al., 2000; Chambers et al., 2003; Mitsui et 
al., 2003; Masui et al., 2007), with the exception of the recent report that Nanog is 
dispensable for the maintenance of established ES cells although levels  of Nanog 
expression  profoundly  influence  the  efficiency  of  self-renewal  (Chambers  et  al., 
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2007). It seems reasonable to suppose that these critical  TFs will  be regulated at 
some level by the signals that are known to promote self-renewal. However, there is 
scant  evidence  for  direct  regulation  of  the  core  TFs downstream of  extracellular 
signalling  molecules.  A notable  exception  is  canonical  Wnt  signalling.  Emerging 
evidence  that  Tcf3,  a  putative  effector  of  Wnt  signalling  in  ES  cells,  regulates 
transcription of Oct4, Sox2 and Nanog (Pereira et al., 2006; Cole et al., 2008) implies 
direct regulation of pluripotency by an exogenous signal. However, it is significant 
that activation of canonical Wnt signalling is not sufficient to maintain pluripotency, 
which requires simultaneous activation of LIF-STAT3 (see chapter 5) (Ogawa et al., 
2006).  In  this  thesis  I  elaborate  on  previous  work  implicating  blockade  of,  as 
opposed to activation of, a signalling pathway in promoting self-renewal. Preventing 
activation  of  ERK1/2  inhibits  differentiation  of  ES  cells  (Burdon  et  al.,  1999b; 
Kunath et al., 2007), allowing self-renewal to proceed. Thus, the emerging picture is 
that deflection of differentiation-promoting signals, rather than instructive regulation 
of pluripotency, is the key effect of manipulation of extracellular signals.
If  positive  signalling  input  is  not  required  to  promote  expression  of  the  core 
pluripotency  TFs  they  must  be  autonomously  expressed  while  the  cells  remain 
undifferentiated. This situation is thought to be stabilized by the ability of the TFs to 
activate their own and one another’s transcription (Tomioka et al., 2002; Boyer et al., 
2005; Kuroda et al., 2005; Okumura-Nakanishi et al., 2005; Rodda et al., 2005). How 
the core transcriptional machinery maintains pluripotency is not precisely known but 
the development of techniques permitting global analysis of transcription, promoter 
occupancy and protein interactions has produced a wealth of data relating to this 
subject.  Chromatin  immunoprecipitation  analyses  revealed  that  Oct4,  Sox2  and 
Nanog co-occupy a large number of promoters (Boyer et al., 2005; Loh et al., 2006). 
Microarray  transcriptional  analyses  revealed  that  the  genes  whose  promoters  are 
occupied by these TFs can be grouped into actively transcribed and inactive genes 
(Boyer et al., 2005). Thus, the core transcription factors, presumably in combination 
with other transcriptional regulators,  appear to employ both positive and negative 
gene  regulation  in  order  to  maintain  the  pluripotent  transcriptome.  A  recent 
investigation  of  the  promoter  occupancy  of  9  TFs  associated  with  pluripotency 
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suggests that promoters bound by a single TF are inactive while those occupied by 
multiple members of the pluripotency machinery are actively transcribed (Kim et al., 
2008).  This  implies  coordinate  regulation  of  gene  expression  by  the  key  TFs. 
Actively transcribed  genes were found to  be enriched for pluripotency-associated 
genes  including  Oct4,  Sox2 and  Nanog themselves,  genes  associated  with 
proliferation, components of signal transduction machinery, and chromatin modifiers 
and  are  presumed  to  promote  self-renewal.  Silent  genes  are  enriched  for  TFs 
associated  with  lineage  commitment  and  it  is  thought  that  the  recruitment  of 
polycomb repressive complexes (PRCs) to these genes is involved in their silencing 
(Boyer et al., 2006). The idea that the core TFs may regulate gene expression through 
chromatin modifiers was supported by the finding that the proteins may interact with 
complexes including NuRD and SWI/SNF (Wang et al., 2006). It appears that the 
pluripotency-associated  TFs  regulate  both  the  expression  and  the  activity  of 
machinery capable of influencing the transcriptional profile of ES cells. However, ES 
cells are remarkably tolerant of loss of function mutations affecting the epigenetic 
machinery (Montgomery et al.,  2005; Schoeftner et al.,  2006; Pasini et  al.,  2007) 
indicating that it is direct transcriptional control by the core TFs that is essential for 
maintenance of pluripotency (Nichols et al., 1998; Chambers et al., 2003; Mitsui et 
al., 2003; Masui et al., 2007).
It  has  been  proposed  that  if  ES  cells  are  shielded  from differentiation  cues  the 
pluripotency  network  is  self-sustaining  and  ES  cells  undergo  a  programme  of 
autonomous  self-replication  (Ying  et  al,  in  press).  If  this  is  the  case  then 
differentiation would be promoted by destabilization of this network. The finding 
that  levels  of  Nanog expression fluctuate  in  the ES cell  population  and that  low 
levels are associated with an increased propensity to differentiate (Chambers et al., 
2007) suggests that Nanog is the obvious candidate for regulation by differentiation-
promoting  signals.  Indeed,  it  has  been  reported  that  ERK  signalling  negatively 
regulates Nanog expression (Hamazaki et al., 2006) and the data presented in chapter 
4  corroborates  this  although  whether  regulation  is  direct  remains  to  be  seen. 
However, loss of Nanog does not lead to inevitable differentiation (Chambers et al., 
2007) and does not therefore reflect commitment to differentiate in wild-type cells. 
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Furthermore,  Nanog-null  cells  remained  sensitive  to  the  self-renewal  promoting 
effects  of  MEK  inhibition  (see  chapter  4)  demonstrating  that  the  promotion  of 
differentiation  by ERK signalling  is  not  mediated  through negative  regulation  of 
Nanog (at least not exclusively). 
6.1.3 ERK Signalling and commitment to differentiate
ERK activation  promotes  responsiveness  to  differentiation  cues  and  I  model  the 
activation  of  ERK1/2  by  FGF4  as  a  reversible  step  in  the  initiation  of  lineage 
commitment (Fig6.1). The step is clearly reversible as ES cells cultured in routine 
conditions (serum plus LIF or LIF plus BMP4) have constitutively active ERK but 
remain responsive to MEK inhibition when culture conditions are altered. It will be 
informative  to  investigate  how ERK activity  impinges  on the components  of  the 
pluripotency network to promote differentiation. It has been suggested that lineage-
associated  transcription  fluctuates  in  ES  cells  at  levels  below  the  threshold  that 
would initiate differentiation. In self-renewing ES cells the transcriptional program 
directed by Oct4, Sox2 and Nanog remains dominant. ERK signalling may increase 
the global expression of lineage-associated genes or it may act directly on targets that 
increase the sensitivity of ES cells to signals promoting differentiation (Silva and 
Smith,  2008).  In  chapter  4  I  discussed  the  possibility  that  the  function  of  ERK 
activity is to promote open chromatin conformation, perhaps through the downstream 
kinases MSK1/2. This provides a plausible mechanism for increased expression of 
lineage-associated genes but there is no evidence that the transcriptionally permissive 
chromatin of ES cells is dependent on ERK and, as discussed above, ES cells are 
tolerant of loss of epigenetic silencers.
If the effect of ERK signalling is global it may be difficult to identify the critical 
targets but predictions can be made about the effects of decreased ERK activity. The 
level of transcription of lineage-associated genes may be reduced and this could be 
tested by transcriptional profiling. The degree of variation between individual cells, 
in  terms  of  genes  expressed,  may  also  be  reduced when  ERK activity  is  lower. 
Preliminary results suggest that Nanog is expressed more homogeneously in ES cells 
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cultured in 2i/3i conditions than in LIF plus BMP4 or serum plus LIF (T. Kalkan, 
unpublished).Tthe  same  could  be  true  of  other  markers  expressed  in  ES  cells 
including Rex1 which is known to be expressed at different levels in individual ES 
cells (Toyooka et al., 2008). Furthermore, transcriptional profiling of isolated single 
cells  (Kurimoto  et  al.,  2006)  grown in  different  culture  conditions  might  reveal 
differences in the degree of cell to cell variation. Such experiments are technically 
demanding and a large number of individual cells would have to be profiled before 
variation could be examined statistically. However, the status of individual ES cells 
and the degree of variation  across  the population  has significant  implications  for 
controlling differentiation. If, as suggested by the work presented here and by others 
(Kunath et al., 2007), ES cells proceed through an ERK high stage to differentiate 
then ES cells  cultured in standard culture conditions where ERK is constitutively 
active (see chapter 3) are closer to the point of commitment than ES cells in culture 
conditions where ERK activity is low such as 3i. EpiSCs are reliant on provision of 
FGF for self-renewal and therefore have constitutively active MAPK signalling. ES 
cells  cultured  in  standard  conditions  may  contain  EpiSC-like  intermediate  cells, 
perhaps increasing the heterogeneity of the population. The response of ES cells to 
differentiation  cues  is  likely  to  depend  on  the  status  of  the  cells,  in  terms  of 
signalling  pathway  activation  and  gene  expression.  The  homogeneity  of 
differentiation may be increased by increasing the homogeneity of the starting ES 
cell population.
6.1.4 Pluripotency and the cell cycle
Pluripotent cells have a unique cell cycle (Savatier et al., 1994). Constitutively active 
Cdk2/CyclinE and corresponding low pRb activity is thought to underlie the short 
G1 and rapid entry of ES cells to S-phase (Stead et al., 2002). Upon differentiation 
the G1 phase becomes longer and cell cycle-dependent control of CyclinE expression 
and  Cdk2  activity  is  established  (White  et  al.,  2005).  This  coincides  with  the 
observation of cell-cycle dependent activity of pRb family members and regulation 
of  E2F  target  genes.  The  simplest  interpretation  of  these  observations  is  that 
elaboration  of  cell  cycle-dependent  Cdk2  activity  and  G1/S  control  follows 
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differentiation  of  pluripotent  cell  into  somatic  cell  types.  However,  the  detailed 
dynamics of the change in cell cycle regulation have not yet been elucidated and it 
remains  to  be  clearly  shown  that  loss  of  pluripotency  precedes  these  cell  cycle 
changes.  It  remains  a  formal  possibility  that  the  development  of  G1/S  control 
actually  precedes  differentiation.  If  it  was  necessary  to  develop  G1/S  regulation 
before differentiation could initiate then signals promoting progression through the 
cell cycle might prevent differentiation simply by preventing this from occurring. In 
this  regard,  it  would be interesting  to investigate  how, if  at  all,  the cell  cycle  of 
EpiSCs differs to that of ES cells. EpiSCs are undifferentiated but correspond to a 
later developmental stage than ES cells. If they have a functional G1/S checkpoint it 
would suggest that elaboration of G1/S control precedes differentiation of ES cells.
Several lines of evidence indirectly suggest that signals promoting passage through 
the cell cycle may promote self-renewal (Niwa, 2007b). cMyc was reported to be a 
target of LIF-STAT3 signalling and its forced expression was apparently sufficient to 
sustain LIF-independent self-renewal (Cartwright et al., 2005b). cMyc is known to 
promote  progression  through  the  cell  cycle  through  transcriptional  activation  of 
genes involved in cell cycle regulation (reviewed in (Hooker and Hurlin, 2006)). The 
PI3K pathway is also known to promote cell proliferation. Mutation of Pten, which 
negatively regulates PI3K, increases the proliferation rate of ES cells  (Sun et al., 
1999)  while  loss  of  Eras,  which  positively  regulates  PI3K,  results  in  decreased 
proliferation (Takahashi et al., 2003). Several reports have implicated activation of 
this pathway in the promotion of self-renewal (Paling et al., 2004; Storm et al., 2007) 
with one report going so far as to claim that activated Akt was sufficient for self-
renewal  of  both  mouse  and  human  ES  cells  (Watanabe  et  al.,  2006).  RNAi-
knockdown of  Tcl1,  a PKB co-factor,  also promoted differentiation but its forced 
expression was not enough to prevent differentiation (Ivanova et al., 2006). While 
none of these studies attributed the observed effects to regulation of the cell cycle it 
is possible that the phenotypes observed are at least partly attributable to changes in 
cell cycle regulation. Evidence for the effect of direct perturbation of the cell cycle 
on self-renewal is scant. Inhibition of Cdk2 activity (Stead et al., 2002) or of E2F-
activated transcription (White et  al.,  2005) has been reported but no details  were 
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given as to the effect  on self-renewal.  This  suggests  that  no dramatic  effect  was 
observed but fails to address the question of whether imposition of cyclin periodicity 
promotes  differentiation.  Indeed,  these  experiments  may  be  difficult  given  the 
apparent resistance of ES cells to attempts to down-regulate Cdk activity (Stead et 
al., 2002; White et al., 2005). 
To examine the possibility that differentiation requires prior establishment of G1/S 
control would be difficult. It would require close monitoring of cell cycle dynamics 
during  differentiation  with  respect  to  a  precisely  defined  point  of  commitment 
beyond  which  the  ES  cell  state  is  irreversibly  lost.  This  is  particularly  difficult 
because differentiation does not occur synchronously in all cells within a population. 
It  would  be  interesting  to  see  if  differentiation  became  more  homogeneous  and 
synchronous when ES cells were synchronized with regard to the cell  cycle.  This 
would imply that cell cycle dynamics influenced differentiation although it would not 
directly address the relationship between cell cycle control and differentiation.
 
6.2 An in vivo role for FGF-ERK signalling
The  work  described  in  this  thesis  hinges  on  the  inhibition  of  the  FGF-MAPK 
signalling  pathway,  in  contrast  to  the  activation  of  this  pathway  employed  by 
addition  of  FGF  in  EpiSC  culture  (Brons  et  al.,  2007;  Tesar  et  al.,  2007).  As 
expected, EpiSCs cannot be maintained in 2i/3i. The relevance of the FGF signalling 
pathway  for  pre-implantation  development  is  becoming  increasingly  clear  and 
provides  a  clear  rationale  for  the  effectiveness  of  FGFR- and MEK-inhibitors  in 
enhancing ES cell self-renewal. FGF4 is expressed in the early embryo (Rappolee et 
al.,  1994)  together  with  FGFR2  (Arman  et  al.,  1998).  The  most  informative 
phenotype described to date is the failure of  Grb2-/- embryos to form the Gata6-
positive primitive endoderm (Chazaud et al., 2006). Primitive endoderm precursors 
are distinguished from epiblast precursors at E3.5 by reciprocal expression of Gata6 
and  Nanog.  Lineage  tracing  experiments  suggest  that  cells  at  this  stage  are 
committed  to  one  lineage  or  the  other.  Grb2-/-  embryos  homogeneously  express 
Nanog in all cells of the ICM at this stage indicating a failure to specify the primitive 
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endoderm.  In  wild-type  embryos  by  E4.5  a  morphologically  distinct  primitive 
endoderm is observed on the surface of the ICM and the primitive endoderm and 
epiblast  can  be  distinguished  by  reciprocal  expression  of  Gata4  and  Nanog. 
Incubation of 8 cell embryos to the blastocyst stage in 3i/2i prevents formation of the 
primitive  endoderm  (J.  Silva  and  J.  Nichols,  unpublished).  The  phenotype  is 
recapitulated by PS or PD03 alone with the addition of CHIR seemingly supporting 
formation  of  a  larger  ICM.  Culturing  embryos  which  have  already  formed  the 
primitive endoderm in 3i does not eliminate the primitive endoderm indicating that 
these cells are not killed by the inhibitors. It seems therefore that pharmacological 
blockade  of  ERK activation  also  prevents  primitive  endoderm specification.  The 
requirement  for  this  signalling  pathway  in  primitive  endoderm  specification  is 
mimicked in ES cells.  ES cells  lacking  Fgf4 (Wilder et al.,  1997),  Shp2 (Qu and 
Feng, 1998) and Grb2 (Cheng et al., 1998) have all been described and reported to 
have defects in differentiation. The work described in this thesis elaborates on this 
work  and  demonstrates  that  ERK  inhibition  is  critical  to  preservation  of  the 
pluripotent state in the absence of LIF and BMP4. In vivo phenotypes described for 
Fgf4- (Feldman et  al.,  1995) and  Fgfr2- (Arman et  al.,  1998) knockouts are also 
consistent  with  the  successful  formation  of  a  pluripotent  epiblast  but  subsequent 
compromises to development resulting from a failure to form extraembryonic tissues 
and/or a requirement for ERK signalling in tissues of the embryo proper. Similarly, 
embryos  lacking  ERK2 died  at  the  early  post-implantation  stage  with  defects  in 
trophoblast development but formed normal ICM outgrowths, indicating successful 
establishment of the epiblast (Saba-El-Leil et al., 2003). It would be interesting to re-
examine the phenotypes of these knockout embryos in light of the recent descriptions 
of preimplantation phenotypes. If FGF4 is the key signalling molecule involved in 
primitive endoderm specification I predict that the FGFR-inhibitors SU and PD17, 
used alone, will produce the same phenotype as PS or PD03, prevention of primitive 
endoderm specification. The combination of studies suggested above should give a 
clear  idea  of  the  role  of  FGF4,  produced  by  cells  of  the  ICM,  in  driving 
differentiation of the pluripotent epiblast. It appears that following specification of 
primitive endoderm cells in the E3.5 embryo they are sorted into a morphologically 
distinct  layer,  probably  as  a  result  of  differential  expression  of  cell  adhesion 
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molecules  (Chazaud  et  al.,  2006).  Understanding  why some  cells  but  not  others 
become  specified  will  be  an  interesting  avenue  for  further  investigation.  The 
responsiveness  of  ES  cells  and  ICM cells  to  differentiation  cues  is  likely  to  be 
conserved and understanding one is likely to shed light on the other. 
6.2.1 “Capturing Pluripotency”
Expression of Fgf4 is under the control of Oct4 and Sox2 (Yuan et al., 1995). Thus, 
critical  TFs in the regulation of pluripotency promote the expression of a growth 
factor that drives differentiation. Work presented here and by Kunath et al (Kunath et 
al.,  2007)  shows that  this  signal  promotes  responsiveness  to  differentiation  cues. 
Critically, FGF4 does not promote lineage-specific differentiation. This implies that 
in vivo pluripotent epiblast cells may be destabilized by ERK activity downstream of 
FGF4 before becoming further specified by signals within the environment of the 
embryo.  This  effect  is  predicted  to  be  mediated  during  a  narrow developmental 
window corresponding to the embryonic stages from which ES cells can be derived. 
Beyond this the pluripotent epiblast becomes dependent on FGF signalling and is no 
longer responsive to ES cell growth conditions instead becoming responsive to FGF 
and activin (Brons et al., 2007; Tesar et al., 2007). It is not yet clear if intermediate 
stages exist or what their properties are. Deriving ES cells requires that epiblast cells 
are  prevented  from progressing  along their  normal  developmental  pathways.  Our 
experiments  on  ES  cells,  and  the  responsiveness  of  the  embryo  to  3i/2i  culture 
conditions  (Ying  et  al,  in  press),  show  that  inhibition  of  ERK  activation  is  an 
effective  way  of  achieving  this  (Fig6.1).  If  early  developmental  pathways  are 
conserved across mammals it should be possible to ‘capture’ cells at a corresponding 
pluripotent stage to that represented by mES cells (Silva and Smith, 2008).  
ES cells are distinct from somatic cells in their independence from ERK signalling 
and the lack of G1/S cell cycle control (Stead et al., 2002). The cells of the early 
epiblast  appear  to  share  these  properties  and  it  has  been  suggested  that  it  is  the 
autonomous self-replication of ES cells and their  in vivo counterparts that underlies 
their  inherent  tumorigenicity (Silva and Smith,  2008). Both ES cells  and epiblast 
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cells can give rise to teratocarcinomas when placed in a permissive site in immuno-
deficient mice (reviewed in (Chambers and Smith, 2004)). These common properties 
seem to suggest that ES cells are not an  in vitro phenomenon but an  in vivo state 
captured  by  permanently  removing  them from the  inductive  environment  of  the 
developing embryo. 
6.3 Implications of 3i
6.3.1 Alternative culture conditions highlight new possibilities
Chapter three,  together with recent  work (Ying et  al,  in press), describes a novel 
culture condition for the propagation of ES cells  in vitro – 3i. The media was first 
developed  by  examining  the  effects  of  pharmacological  inhibitors  alone  and  in 
combination on the growth of established ES cell lines, as judged by morphology and 
growth rate. Optimisation by trial and error led to the development of a media that 
passed the “tests” normally applied to growth conditions to establish that they are in 
fact  sufficient  to maintain ES cells.  Clonal  propagation informed us that  cell-cell 
interactions were not required. De novo derivation proved that prior adaptation to in  
vitro culture was not necessary to allow ES cells to respond to this media. Germ line 
transmission of ES cells derived and propagated in 3i showed that the cells remained 
truly pluripotent and karyotypically normal. These findings bring 3i in line with all 
other established growth conditions for ES cell culture and go a good deal further 
than reports that claim to have established “sufficient” or “defined” conditions. This 
in itself is interesting but it soon became apparent that these conditions were quite 
different in their properties from those previously described. Firstly, it was possible 
to  establish  germ-line  competent  ES cells  from CBA strain mice  (Ying et  al,  in 
press), the first time this has been reported without the use of feeders and serum. 
Previous  success  in  the derivation  of ES cells  from CBA mice  was achieved by 
microdissection (Brook and Gardner, 1997) or by using a MEK inhibitor (PD98059) 
(Buehr  and  Smith,  2003)  together  with  conventional  derivation  protocols.  The 
success  of microdissection  may be the result  of  completely isolating  the epiblast 
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from the other tissues of the blastocyst which may be a source of differentiation-
promoting signals that standard culture conditions are not able to overcome. MEK 
inhibition  presumably  functions  to  prevent  the  epiblast  cells  from  initiating 
differentiation in response to those same signals. 3i similarly employs  a block of 
ERK signalling. Secondly, it is clear that LIF and BMP signalling are not required 
when ES cells are cultured in 3i. These differences suggested that there are multiple 
ways to derive and maintain ES cells. More importantly, it offers fresh impetus to 
attempt  the  derivation  of  ES  cells  from  other  species  where  the  conditions 
established for mouse have so far failed.
As discussed above, there is good evidence that preimplantation embryos respond in 
a similar  manner to ES cells to 3i/2i.  The most exciting implication of this is its 
possible application to the derivation of ‘true’ human ES cells  as opposed to the 
EpiSC-like lines already in existence. In fact, our group has already established rat 
ES  cells  in  3i  conditions  that  contribute  to  chimeras  when  reintroduced  to  the 
developing  embryo  (Buehr  et  al,  submitted).  This  property  is  critical  in 
distinguishing the cells from EpiSCs which do not contribute to chimeras (Brons et 
al., 2007).
6.3.2 Differentiation
The attraction of ES cells lies in their ability to provide an in vitro model for early 
development  and in their  potential  clinical  applications  as an unlimited source of 
cells  for  research  and  cell  replacement  therapies  (Smith,  2001).  Realising  their 
potential requires that we understand their biology and develop protocols for their 
differentiation  into  specialized  cell  types  (Murry  and  Keller,  2008).  Currently, 
differentiation protocols yield heterogeneous populations of cells, with only fraction 
of  cells  developing  into  the  desired  cell  type.  It  is  not  clear  why an  apparently 
homogeneous  population  of  genetically  identical  cells  should  give  rise  to 
heterogeneous populations when induced to differentiate. Aside from the existence of 
a fraction of committed or differentiated cells within ES cell cultures, it is becoming 
apparent  that  ES  cells  are  heterogeneous.  A  striking  example  of  this  is  the 
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fluctuations in levels of Nanog (Chambers et al., 2007). It is reasonable to suppose 
that  in  the  presence  of  such  variation  the  population  will  initiate  differentiation 
asynchronously and may enter distinct programs of differentiation. It may therefore 
be  necessary  to  devise  strategies  to  increase  the  homogeneity  of  the  starting 
population  and to  assess  the  effects  of  ES cell  culture  conditions  on  subsequent 
differentiation. In this context 3i provides an alternative to established conditions as a 
starting  point  for  differentiation.  Furthermore,  our  observations  suggest  that  the 
population in 3i is more homogeneous with regard to the low level of background 
differentiation and with regard to Nanog expression (T. Kalkan, unpublished). This 
may provide a better platform for directed differentiation although this has yet to be 
assessed. ES cells divide rapidly and asynchronously in culture and position in the 
cell  cycle  may  also  affect  initiation  of  differentiation.  Strategies  designed  to 
synchronize the population before beginning differentiation protocols might also help 
to direct homogeneous differentiation.
6.3.3 3i and Reprogramming
The  recent  demonstration  that  terminally  differentiated  cells  can  be  induced  to 
acquire pluripotency by the introduction of 4 TFs (Takahashi and Yamanaka, 2006) 
has  taken  stem cell  research  one  step  closer  to  the  goal  of  patient-specific  cell 
therapies. However, several major problems must be overcome before iPS cells can 
be used in treatments for humans. 
In most cases reported for the generation of mouse iPS cells a selection strategy was 
used  based  on  the  expression  of  antibiotic  resistance  genes  from  pluripotency-
associated promoters (Takahashi and Yamanaka, 2006; Okita et al., 2007; Wernig et 
al., 2007). This can only be done using cells that have previously been genetically 
modified and is not therefore applicable to human cells. Ideally iPS cells would be 
generated without the need for selection strategies based on genetic modifications. 
Morphological changes can be used as an indicator of the acquisition of pluripotency 
(Meissner et al., 2007) but cells with ES-like properties have been observed that do 
not contribute to chimaeras (Takahashi and Yamanaka, 2006) and are not therefore 
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truly pluripotent. Furthermore, it is as yet unclear what effect, if any, the activation 
of intracellular signalling pathways has on the generation of iPS cells. The culture 
conditions in which cells are grown prior to or after introduction of the TFs may 
influence the efficiency of generation of iPS cells and, more importantly, the status 
of the iPS cells generated. 
So, how does 3i relate to these problems of iPS cell generation? 3i could provide a 
method for selection of iPS cells from a heterogeneous population. Somatic cells and 
EpiSCs are normally dependent on active ERK signalling (Brons et al., 2007; Tesar 
et  al.,  2007)  so  the  inhibition  of  this  pathway  is  likely  to  lead  to  cessation  of 
proliferation  and/or  cell  death  in  these  populations,  permitting  expansion  only of 
cells which have acquired an ES cell phenotype. This would remove the need for 
selection  strategies  based on genetically  modified  starting populations  and would 
provide  a  more  stringent  selection  than  morphology  alone.  While  morphological 
criteria  will  not  exclude  EpiSC-like  populations  and  cells  that  have  undergone 
incomplete conversion such as those generated by  Fbx15 selection (Takahashi and 
Yamanaka,  2006),  the  ability  to  grow  in  3i  (as  opposed  to  serum  and  LIF)  is 
anticipated to exclude these populations (Silva and Smith, 2008). 
An exciting  possibility  is  that  different  ES cell  culture  conditions  might  actively 
influence the conversion to pluripotency. As yet, it is not known how each of the 4 
TFs acts to convert the somatic cell genome to pluripotency. Culture conditions may 
influence the activity of signalling pathways that have similar effects to the activity 
of  the  TFs  themselves.  Certain  signals  may  influence  the  activity  of  epigenetic 
modifiers or enhance the proliferation of cells undergoing conversion. A potential 
effect of 3i/2i in this regard is an enhancement of the expression of Nanog which 
appears to be negatively regulated by ERK signalling (see chapter 4). This would be 
anticipated  to  enhance  the  conversion of  pre-pluripotent  ES cells,  represented  by 
those ES-like cells which express only low levels of Nanog and Rex1 and do not 
contribute to chimaeras (Takahashi and Yamanaka,  2006), to fully pluripotent ES 
cells. It has been suggested that activation of the endogenous Nanog gene is a critical 
step in the conversion to truly pluripotent iPS cells (Silva and Smith, 2008). Direct, 
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side-by-side comparisons of different ES cell medias for the derivation of iPS cells 
and subsequent examination of the properties of the cells generated will reveal if the 
culture conditions do in fact influence the process of conversion to pluripotency.
6.4 Concluding Remarks
Since they were first derived in 1981 ES cells have been employed in the study of 
early  developmental  decisions  and  for  the  generation  of  transgenic  mice.  The 
significance of this was recognised with the award of the Nobel Prize for Physiology 
or Medicine to Martin Evans, together with Mario Capecchi and Oliver Smithies, for 
developing the methods that would allow genetic modifications to be introduced to 
mice.  The field of stem cell  research continues to grow, primarily because of the 
belief  that  stem  cells  will  one  day  provide  a  limitless  source  of  cells  for  cell 
replacement therapy. This goal may be some way off but stem cells may also be used 
to generate clinically relevant cells for in vitro drug screening. 
ES  cells  are  capable  of  generating  any  cell  type  of  the  adult  organism.  It  is 
theoretically possible therefore to generate any cell type in vitro. This makes ES cells 
a particularly powerful tool.  However, there are still  significant limitations to our 
understanding of ES cell biology and to our ability to control their differentiation. A 
major concern is that attempts to establish ES cells from other species which have a 
phenotype corresponding to mouse ES cells have so far failed. The human ES cells 
currently in existence are more similar to mouse EpiScs than they are to mouse ES 
cells.  The  derivation  of  ‘true’  human  ES cells  would  facilitate  the  translation  of 
research  from  the  mouse  model  and  provide  another  pluripotent  cell  type  with 
distinct properties that may prove useful in future attempts to utilize these cells in 
studies of development, in drug screening or in cell replacement therapy. 
The development of 3i ES cell culture conditions and the corresponding effects on 
the behaviour of the cells of the inner cell mass provide a rationale for the existence 
of  ES cells  and may provide a means  to  ‘capture’  pluripotency in  other  species. 
Furthermore, an increased understanding of the mechanisms controlling ES cell self-
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